id	sid	tid	token	lemma	pos
ajlm-1317	1	1	abstract	abstract	ADJ
ajlm-1317	1	2	introduction	introduction	NOUN
ajlm-1317	1	3	methods	method	NOUN
ajlm-1317	1	4	results	result	VERB
ajlm-1317	1	5	discussion	discussion	NOUN
ajlm-1317	1	6	acknowledgements	acknowledgement	NOUN
ajlm-1317	1	7	references	reference	NOUN
ajlm-1317	1	8	about	about	ADP
ajlm-1317	1	9	the	the	DET
ajlm-1317	1	10	author(s	author(s	NOUN
ajlm-1317	1	11	)	)	PUNCT
ajlm-1317	1	12	james	james	PROPN
ajlm-1317	1	13	h.	h.	PROPN
ajlm-1317	1	14	kimotho	kimotho	PROPN
ajlm-1317	1	15	innovation	innovation	NOUN
ajlm-1317	1	16	technology	technology	NOUN
ajlm-1317	1	17	transfer	transfer	NOUN
ajlm-1317	1	18	division	division	NOUN
ajlm-1317	1	19	,	,	PUNCT
ajlm-1317	1	20	kenya	kenya	PROPN
ajlm-1317	1	21	medical	medical	PROPN
ajlm-1317	1	22	research	research	PROPN
ajlm-1317	1	23	institute	institute	PROPN
ajlm-1317	1	24	,	,	PUNCT
ajlm-1317	1	25	nairobi	nairobi	PROPN
ajlm-1317	1	26	,	,	PUNCT
ajlm-1317	1	27	kenya	kenya	PROPN
ajlm-1317	1	28	abdiaziz	abdiaziz	PROPN
ajlm-1317	1	29	a.	a.	PROPN
ajlm-1317	1	30	gosar	gosar	PROPN
ajlm-1317	1	31	innovation	innovation	NOUN
ajlm-1317	1	32	technology	technology	NOUN
ajlm-1317	1	33	transfer	transfer	NOUN
ajlm-1317	1	34	division	division	NOUN
ajlm-1317	1	35	,	,	PUNCT
ajlm-1317	1	36	kenya	kenya	PROPN
ajlm-1317	1	37	medical	medical	PROPN
ajlm-1317	1	38	research	research	PROPN
ajlm-1317	1	39	institute	institute	PROPN
ajlm-1317	1	40	,	,	PUNCT
ajlm-1317	1	41	nairobi	nairobi	PROPN
ajlm-1317	1	42	,	,	PUNCT
ajlm-1317	1	43	kenya	kenya	PROPN
ajlm-1317	1	44	ronald	ronald	PROPN
ajlm-1317	1	45	inyangala	inyangala	PROPN
ajlm-1317	1	46	pharmacy	pharmacy	PROPN
ajlm-1317	1	47	and	and	CCONJ
ajlm-1317	1	48	poisons	poison	NOUN
ajlm-1317	1	49	board	board	NOUN
ajlm-1317	1	50	of	of	ADP
ajlm-1317	1	51	kenya	kenya	PROPN
ajlm-1317	1	52	,	,	PUNCT
ajlm-1317	1	53	nairobi	nairobi	PROPN
ajlm-1317	1	54	,	,	PUNCT
ajlm-1317	1	55	kenya	kenya	PROPN
ajlm-1317	1	56	paulyne	paulyne	PROPN
ajlm-1317	1	57	wairimu	wairimu	NOUN
ajlm-1317	1	58	pharmacy	pharmacy	NOUN
ajlm-1317	1	59	and	and	CCONJ
ajlm-1317	1	60	poisons	poison	NOUN
ajlm-1317	1	61	board	board	NOUN
ajlm-1317	1	62	of	of	ADP
ajlm-1317	1	63	kenya	kenya	PROPN
ajlm-1317	1	64	,	,	PUNCT
ajlm-1317	1	65	nairobi	nairobi	PROPN
ajlm-1317	1	66	,	,	PUNCT
ajlm-1317	1	67	kenya	kenya	PROPN
ajlm-1317	1	68	fred	fred	PROPN
ajlm-1317	1	69	siyoi	siyoi	PROPN
ajlm-1317	1	70	pharmacy	pharmacy	PROPN
ajlm-1317	1	71	and	and	CCONJ
ajlm-1317	1	72	poisons	poison	NOUN
ajlm-1317	1	73	board	board	NOUN
ajlm-1317	1	74	of	of	ADP
ajlm-1317	1	75	kenya	kenya	PROPN
ajlm-1317	1	76	,	,	PUNCT
ajlm-1317	1	77	nairobi	nairobi	PROPN
ajlm-1317	1	78	,	,	PUNCT
ajlm-1317	1	79	kenya	kenya	PROPN
ajlm-1317	1	80	damaris	damaris	PROPN
ajlm-1317	1	81	matoke	matoke	PROPN
ajlm-1317	1	82	-	-	PUNCT
ajlm-1317	1	83	muhia	muhia	NOUN
ajlm-1317	1	84	centre	centre	NOUN
ajlm-1317	1	85	of	of	ADP
ajlm-1317	1	86	biotechnology	biotechnology	NOUN
ajlm-1317	1	87	research	research	NOUN
ajlm-1317	1	88	development	development	NOUN
ajlm-1317	1	89	,	,	PUNCT
ajlm-1317	1	90	kenya	kenya	PROPN
ajlm-1317	1	91	medical	medical	PROPN
ajlm-1317	1	92	research	research	PROPN
ajlm-1317	1	93	institute	institute	PROPN
ajlm-1317	1	94	,	,	PUNCT
ajlm-1317	1	95	nairobi	nairobi	PROPN
ajlm-1317	1	96	,	,	PUNCT
ajlm-1317	1	97	kenya	kenya	PROPN
ajlm-1317	1	98	cecilia	cecilia	PROPN
ajlm-1317	1	99	wanjala	wanjala	PROPN
ajlm-1317	1	100	innovation	innovation	PROPN
ajlm-1317	1	101	technology	technology	NOUN
ajlm-1317	1	102	transfer	transfer	NOUN
ajlm-1317	1	103	division	division	NOUN
ajlm-1317	1	104	,	,	PUNCT
ajlm-1317	1	105	kenya	kenya	PROPN
ajlm-1317	1	106	medical	medical	PROPN
ajlm-1317	1	107	research	research	PROPN
ajlm-1317	1	108	institute	institute	PROPN
ajlm-1317	1	109	,	,	PUNCT
ajlm-1317	1	110	nairobi	nairobi	PROPN
ajlm-1317	1	111	,	,	PUNCT
ajlm-1317	1	112	kenya	kenya	PROPN
ajlm-1317	1	113	jeremiah	jeremiah	PROPN
ajlm-1317	1	114	zablon	zablon	PROPN
ajlm-1317	1	115	kenyatta	kenyatta	PROPN
ajlm-1317	1	116	national	national	PROPN
ajlm-1317	1	117	hospital	hospital	PROPN
ajlm-1317	1	118	,	,	PUNCT
ajlm-1317	1	119	nairobi	nairobi	PROPN
ajlm-1317	1	120	,	,	PUNCT
ajlm-1317	1	121	kenya	kenya	PROPN
ajlm-1317	1	122	moses	moses	PROPN
ajlm-1317	1	123	orina	orina	PROPN
ajlm-1317	1	124	innovation	innovation	PROPN
ajlm-1317	1	125	technology	technology	NOUN
ajlm-1317	1	126	transfer	transfer	NOUN
ajlm-1317	1	127	division	division	NOUN
ajlm-1317	1	128	,	,	PUNCT
ajlm-1317	1	129	kenya	kenya	PROPN
ajlm-1317	1	130	medical	medical	PROPN
ajlm-1317	1	131	research	research	PROPN
ajlm-1317	1	132	institute	institute	PROPN
ajlm-1317	1	133	,	,	PUNCT
ajlm-1317	1	134	nairobi	nairobi	PROPN
ajlm-1317	1	135	,	,	PUNCT
ajlm-1317	1	136	kenya	kenya	PROPN
ajlm-1317	1	137	lucy	lucy	PROPN
ajlm-1317	1	138	muita	muita	PROPN
ajlm-1317	1	139	innovation	innovation	NOUN
ajlm-1317	1	140	technology	technology	NOUN
ajlm-1317	1	141	transfer	transfer	NOUN
ajlm-1317	1	142	division	division	NOUN
ajlm-1317	1	143	,	,	PUNCT
ajlm-1317	1	144	kenya	kenya	PROPN
ajlm-1317	1	145	medical	medical	PROPN
ajlm-1317	1	146	research	research	PROPN
ajlm-1317	1	147	institute	institute	PROPN
ajlm-1317	1	148	,	,	PUNCT
ajlm-1317	1	149	nairobi	nairobi	PROPN
ajlm-1317	1	150	,	,	PUNCT
ajlm-1317	1	151	kenya	kenya	PROPN
ajlm-1317	1	152	jacqueline	jacqueline	PROPN
ajlm-1317	1	153	thiga	thiga	PROPN
ajlm-1317	1	154	innovation	innovation	PROPN
ajlm-1317	1	155	technology	technology	NOUN
ajlm-1317	1	156	transfer	transfer	NOUN
ajlm-1317	1	157	division	division	NOUN
ajlm-1317	1	158	,	,	PUNCT
ajlm-1317	1	159	kenya	kenya	PROPN
ajlm-1317	1	160	medical	medical	PROPN
ajlm-1317	1	161	research	research	PROPN
ajlm-1317	1	162	institute	institute	PROPN
ajlm-1317	1	163	,	,	PUNCT
ajlm-1317	1	164	nairobi	nairobi	PROPN
ajlm-1317	1	165	,	,	PUNCT
ajlm-1317	1	166	kenya	kenya	PROPN
ajlm-1317	1	167	lameck	lameck	PROPN
ajlm-1317	1	168	nyabuti	nyabuti	ADJ
ajlm-1317	1	169	innovation	innovation	NOUN
ajlm-1317	1	170	technology	technology	NOUN
ajlm-1317	1	171	transfer	transfer	NOUN
ajlm-1317	1	172	division	division	NOUN
ajlm-1317	1	173	,	,	PUNCT
ajlm-1317	1	174	kenya	kenya	PROPN
ajlm-1317	1	175	medical	medical	PROPN
ajlm-1317	1	176	research	research	PROPN
ajlm-1317	1	177	institute	institute	PROPN
ajlm-1317	1	178	,	,	PUNCT
ajlm-1317	1	179	nairobi	nairobi	PROPN
ajlm-1317	1	180	,	,	PUNCT
ajlm-1317	1	181	kenya	kenya	PROPN
ajlm-1317	1	182	eunice	eunice	PROPN
ajlm-1317	1	183	wainaina	wainaina	PROPN
ajlm-1317	1	184	innovation	innovation	NOUN
ajlm-1317	1	185	technology	technology	NOUN
ajlm-1317	1	186	transfer	transfer	NOUN
ajlm-1317	1	187	division	division	NOUN
ajlm-1317	1	188	,	,	PUNCT
ajlm-1317	1	189	kenya	kenya	PROPN
ajlm-1317	1	190	medical	medical	PROPN
ajlm-1317	1	191	research	research	PROPN
ajlm-1317	1	192	institute	institute	PROPN
ajlm-1317	1	193	,	,	PUNCT
ajlm-1317	1	194	nairobi	nairobi	PROPN
ajlm-1317	1	195	,	,	PUNCT
ajlm-1317	1	196	kenya	kenya	PROPN
ajlm-1317	1	197	joseph	joseph	PROPN
ajlm-1317	1	198	mwangi	mwangi	PROPN
ajlm-1317	1	199	centre	centre	PROPN
ajlm-1317	1	200	for	for	ADP
ajlm-1317	1	201	virus	virus	NOUN
ajlm-1317	1	202	research	research	NOUN
ajlm-1317	1	203	,	,	PUNCT
ajlm-1317	1	204	kenya	kenya	PROPN
ajlm-1317	1	205	medical	medical	PROPN
ajlm-1317	1	206	research	research	PROPN
ajlm-1317	1	207	institute	institute	PROPN
ajlm-1317	1	208	,	,	PUNCT
ajlm-1317	1	209	nairobi	nairobi	PROPN
ajlm-1317	1	210	,	,	PUNCT
ajlm-1317	1	211	kenya	kenya	PROPN
ajlm-1317	1	212	alice	alice	PROPN
ajlm-1317	1	213	mumbi	mumbi	PROPN
ajlm-1317	1	214	innovation	innovation	PROPN
ajlm-1317	1	215	technology	technology	NOUN
ajlm-1317	1	216	transfer	transfer	NOUN
ajlm-1317	1	217	division	division	NOUN
ajlm-1317	1	218	,	,	PUNCT
ajlm-1317	1	219	kenya	kenya	PROPN
ajlm-1317	1	220	medical	medical	PROPN
ajlm-1317	1	221	research	research	PROPN
ajlm-1317	1	222	institute	institute	PROPN
ajlm-1317	1	223	,	,	PUNCT
ajlm-1317	1	224	nairobi	nairobi	PROPN
ajlm-1317	1	225	,	,	PUNCT
ajlm-1317	1	226	kenya	kenya	PROPN
ajlm-1317	1	227	samuel	samuel	PROPN
ajlm-1317	1	228	omari	omari	PROPN
ajlm-1317	1	229	innovation	innovation	PROPN
ajlm-1317	1	230	technology	technology	NOUN
ajlm-1317	1	231	transfer	transfer	NOUN
ajlm-1317	1	232	division	division	NOUN
ajlm-1317	1	233	,	,	PUNCT
ajlm-1317	1	234	kenya	kenya	PROPN
ajlm-1317	1	235	medical	medical	PROPN
ajlm-1317	1	236	research	research	PROPN
ajlm-1317	1	237	institute	institute	PROPN
ajlm-1317	1	238	,	,	PUNCT
ajlm-1317	1	239	nairobi	nairobi	PROPN
ajlm-1317	1	240	,	,	PUNCT
ajlm-1317	1	241	kenya	kenya	PROPN
ajlm-1317	1	242	ann	ann	PROPN
ajlm-1317	1	243	wanjiru	wanjiru	PROPN
ajlm-1317	1	244	innovation	innovation	PROPN
ajlm-1317	1	245	technology	technology	NOUN
ajlm-1317	1	246	transfer	transfer	NOUN
ajlm-1317	1	247	division	division	NOUN
ajlm-1317	1	248	,	,	PUNCT
ajlm-1317	1	249	kenya	kenya	PROPN
ajlm-1317	1	250	medical	medical	PROPN
ajlm-1317	1	251	research	research	PROPN
ajlm-1317	1	252	institute	institute	PROPN
ajlm-1317	1	253	,	,	PUNCT
ajlm-1317	1	254	nairobi	nairobi	PROPN
ajlm-1317	1	255	,	,	PUNCT
ajlm-1317	1	256	kenya	kenya	PROPN
ajlm-1317	1	257	samson	samson	PROPN
ajlm-1317	1	258	m.	m.	PROPN
ajlm-1317	1	259	nzou	nzou	PROPN
ajlm-1317	1	260	innovation	innovation	PROPN
ajlm-1317	1	261	technology	technology	NOUN
ajlm-1317	1	262	transfer	transfer	NOUN
ajlm-1317	1	263	division	division	NOUN
ajlm-1317	1	264	,	,	PUNCT
ajlm-1317	1	265	kenya	kenya	PROPN
ajlm-1317	1	266	medical	medical	PROPN
ajlm-1317	1	267	research	research	PROPN
ajlm-1317	1	268	institute	institute	PROPN
ajlm-1317	1	269	,	,	PUNCT
ajlm-1317	1	270	nairobi	nairobi	PROPN
ajlm-1317	1	271	,	,	PUNCT
ajlm-1317	1	272	kenya	kenya	PROPN
ajlm-1317	1	273	missiani	missiani	PROPN
ajlm-1317	1	274	ochwoto	ochwoto	PROPN
ajlm-1317	1	275	innovation	innovation	NOUN
ajlm-1317	1	276	technology	technology	NOUN
ajlm-1317	1	277	transfer	transfer	NOUN
ajlm-1317	1	278	division	division	NOUN
ajlm-1317	1	279	,	,	PUNCT
ajlm-1317	1	280	kenya	kenya	PROPN
ajlm-1317	1	281	medical	medical	PROPN
ajlm-1317	1	282	research	research	PROPN
ajlm-1317	1	283	institute	institute	PROPN
ajlm-1317	1	284	,	,	PUNCT
ajlm-1317	1	285	nairobi	nairobi	PROPN
ajlm-1317	1	286	,	,	PUNCT
ajlm-1317	1	287	kenya	kenya	PROPN
ajlm-1317	1	288	citation	citation	PROPN
ajlm-1317	1	289	kimotho	kimotho	PROPN
ajlm-1317	1	290	jh	jh	PROPN
ajlm-1317	1	291	,	,	PUNCT
ajlm-1317	1	292	gosar	gosar	VERB
ajlm-1317	1	293	aa	aa	NOUN
ajlm-1317	1	294	,	,	PUNCT
ajlm-1317	1	295	inyangala	inyangala	NOUN
ajlm-1317	1	296	r	r	NOUN
ajlm-1317	1	297	,	,	PUNCT
ajlm-1317	1	298	et	et	PROPN
ajlm-1317	1	299	al	al	PROPN
ajlm-1317	1	300	.	.	PUNCT
ajlm-1317	2	1	pre	pre	ADJ
ajlm-1317	2	2	-	-	ADJ
ajlm-1317	2	3	evaluation	evaluation	ADJ
ajlm-1317	2	4	assessment	assessment	NOUN
ajlm-1317	2	5	of	of	ADP
ajlm-1317	2	6	serological	serological	NOUN
ajlm-1317	2	7	-	-	PUNCT
ajlm-1317	2	8	based	base	VERB
ajlm-1317	2	9	covid-19	covid-19	PROPN
ajlm-1317	2	10	point	point	NOUN
ajlm-1317	2	11	-	-	PUNCT
ajlm-1317	2	12	of	of	ADP
ajlm-1317	2	13	-	-	PUNCT
ajlm-1317	2	14	care	care	NOUN
ajlm-1317	2	15	lateral	lateral	ADJ
ajlm-1317	2	16	flow	flow	NOUN
ajlm-1317	2	17	assays	assay	NOUN
ajlm-1317	2	18	in	in	ADP
ajlm-1317	2	19	kenya	kenya	PROPN
ajlm-1317	2	20	.	.	PUNCT
ajlm-1317	3	1	afr	afr	PROPN
ajlm-1317	3	2	j	j	PROPN
ajlm-1317	3	3	lab	lab	PROPN
ajlm-1317	3	4	med	med	PROPN
ajlm-1317	3	5	.	.	PUNCT
ajlm-1317	4	1	2021;10(1	2021;10(1	NUM
ajlm-1317	4	2	)	)	PUNCT
ajlm-1317	4	3	,	,	PUNCT
ajlm-1317	4	4	a1317	a1317	PROPN
ajlm-1317	4	5	.	.	NOUN
ajlm-1317	4	6	https://doi.org/10.4102/ajlm.v10i1.1317	https://doi.org/10.4102/ajlm.v10i1.1317	NUM
ajlm-1317	4	7	original	original	ADJ
ajlm-1317	4	8	research	research	NOUN
ajlm-1317	4	9	pre	pre	ADJ
ajlm-1317	4	10	-	-	NOUN
ajlm-1317	4	11	evaluation	evaluation	ADJ
ajlm-1317	4	12	assessment	assessment	NOUN
ajlm-1317	4	13	of	of	ADP
ajlm-1317	4	14	serological	serological	NOUN
ajlm-1317	4	15	-	-	PUNCT
ajlm-1317	4	16	based	base	VERB
ajlm-1317	4	17	covid-19	covid-19	PROPN
ajlm-1317	4	18	point	point	NOUN
ajlm-1317	4	19	-	-	PUNCT
ajlm-1317	4	20	of	of	ADP
ajlm-1317	4	21	-	-	PUNCT
ajlm-1317	4	22	care	care	NOUN
ajlm-1317	4	23	lateral	lateral	ADJ
ajlm-1317	4	24	flow	flow	NOUN
ajlm-1317	4	25	assays	assay	NOUN
ajlm-1317	4	26	in	in	ADP
ajlm-1317	4	27	kenya	kenya	PROPN
ajlm-1317	4	28	james	james	PROPN
ajlm-1317	4	29	h.	h.	PROPN
ajlm-1317	4	30	kimotho	kimotho	PROPN
ajlm-1317	4	31	,	,	PUNCT
ajlm-1317	4	32	abdiaziz	abdiaziz	PROPN
ajlm-1317	4	33	a.	a.	NOUN
ajlm-1317	4	34	gosar	gosar	PROPN
ajlm-1317	4	35	,	,	PUNCT
ajlm-1317	4	36	ronald	ronald	PROPN
ajlm-1317	4	37	inyangala	inyangala	PROPN
ajlm-1317	4	38	,	,	PUNCT
ajlm-1317	4	39	paulyne	paulyne	PROPN
ajlm-1317	4	40	wairimu	wairimu	PROPN
ajlm-1317	4	41	,	,	PUNCT
ajlm-1317	4	42	fred	fred	PROPN
ajlm-1317	4	43	siyoi	siyoi	PROPN
ajlm-1317	4	44	,	,	PUNCT
ajlm-1317	4	45	damaris	damaris	PROPN
ajlm-1317	4	46	matoke	matoke	NOUN
ajlm-1317	4	47	-	-	PUNCT
ajlm-1317	4	48	muhia	muhia	NOUN
ajlm-1317	4	49	,	,	PUNCT
ajlm-1317	4	50	cecilia	cecilia	PROPN
ajlm-1317	4	51	wanjala	wanjala	PROPN
ajlm-1317	4	52	,	,	PUNCT
ajlm-1317	4	53	jeremiah	jeremiah	PROPN
ajlm-1317	4	54	zablon	zablon	PROPN
ajlm-1317	4	55	,	,	PUNCT
ajlm-1317	4	56	moses	moses	PROPN
ajlm-1317	4	57	orina	orina	PROPN
ajlm-1317	4	58	,	,	PUNCT
ajlm-1317	4	59	lucy	lucy	PROPN
ajlm-1317	4	60	muita	muita	PROPN
ajlm-1317	4	61	,	,	PUNCT
ajlm-1317	4	62	jacqueline	jacqueline	PROPN
ajlm-1317	4	63	thiga	thiga	PROPN
ajlm-1317	4	64	,	,	PUNCT
ajlm-1317	4	65	lameck	lameck	PROPN
ajlm-1317	4	66	nyabuti	nyabuti	PROPN
ajlm-1317	4	67	,	,	PUNCT
ajlm-1317	4	68	eunice	eunice	PROPN
ajlm-1317	4	69	wainaina	wainaina	PROPN
ajlm-1317	4	70	,	,	PUNCT
ajlm-1317	4	71	joseph	joseph	PROPN
ajlm-1317	4	72	mwangi	mwangi	PROPN
ajlm-1317	4	73	,	,	PUNCT
ajlm-1317	4	74	alice	alice	PROPN
ajlm-1317	4	75	mumbi	mumbi	PROPN
ajlm-1317	4	76	,	,	PUNCT
ajlm-1317	4	77	samuel	samuel	PROPN
ajlm-1317	4	78	omari	omari	PROPN
ajlm-1317	4	79	,	,	PUNCT
ajlm-1317	4	80	ann	ann	PROPN
ajlm-1317	4	81	wanjiru	wanjiru	PROPN
ajlm-1317	4	82	,	,	PUNCT
ajlm-1317	4	83	samson	samson	PROPN
ajlm-1317	4	84	m.	m.	PROPN
ajlm-1317	4	85	nzou	nzou	PROPN
ajlm-1317	4	86	,	,	PUNCT
ajlm-1317	4	87	missiani	missiani	PROPN
ajlm-1317	4	88	ochwoto	ochwoto	PROPN
ajlm-1317	4	89	received	receive	VERB
ajlm-1317	4	90	:	:	PUNCT
ajlm-1317	4	91	25	25	NUM
ajlm-1317	4	92	june	june	PROPN
ajlm-1317	4	93	2020	2020	NUM
ajlm-1317	4	94	;	;	PUNCT
ajlm-1317	4	95	accepted	accept	VERB
ajlm-1317	4	96	:	:	PUNCT
ajlm-1317	4	97	23	23	NUM
ajlm-1317	4	98	june	june	PROPN
ajlm-1317	4	99	2021	2021	NUM
ajlm-1317	4	100	;	;	PUNCT
ajlm-1317	4	101	published	publish	VERB
ajlm-1317	4	102	:	:	PUNCT
ajlm-1317	5	1	17	17	NUM
ajlm-1317	5	2	sept	sept	PROPN
ajlm-1317	5	3	.	.	PROPN
ajlm-1317	5	4	2021	2021	NUM
ajlm-1317	5	5	copyright	copyright	NOUN
ajlm-1317	5	6	:	:	PUNCT
ajlm-1317	5	7	©	©	PROPN
ajlm-1317	5	8	2021	2021	NUM
ajlm-1317	5	9	.	.	PUNCT
ajlm-1317	6	1	the	the	DET
ajlm-1317	6	2	author(s	author(s	PROPN
ajlm-1317	6	3	)	)	PUNCT
ajlm-1317	6	4	.	.	PUNCT
ajlm-1317	7	1	licensee	licensee	NOUN
ajlm-1317	7	2	:	:	PUNCT
ajlm-1317	7	3	aosis	aosis	NOUN
ajlm-1317	7	4	.	.	PUNCT
ajlm-1317	8	1	this	this	PRON
ajlm-1317	8	2	is	be	AUX
ajlm-1317	8	3	an	an	DET
ajlm-1317	8	4	open	open	ADJ
ajlm-1317	8	5	access	access	NOUN
ajlm-1317	8	6	article	article	NOUN
ajlm-1317	8	7	distributed	distribute	VERB
ajlm-1317	8	8	under	under	ADP
ajlm-1317	8	9	the	the	DET
ajlm-1317	8	10	terms	term	NOUN
ajlm-1317	8	11	of	of	ADP
ajlm-1317	8	12	the	the	DET
ajlm-1317	8	13	creative	creative	ADJ
ajlm-1317	8	14	commons	common	NOUN
ajlm-1317	8	15	attribution	attribution	NOUN
ajlm-1317	8	16	license	license	NOUN
ajlm-1317	8	17	,	,	PUNCT
ajlm-1317	8	18	which	which	PRON
ajlm-1317	8	19	permits	permit	VERB
ajlm-1317	8	20	unrestricted	unrestricted	ADJ
ajlm-1317	8	21	use	use	NOUN
ajlm-1317	8	22	,	,	PUNCT
ajlm-1317	8	23	distribution	distribution	NOUN
ajlm-1317	8	24	,	,	PUNCT
ajlm-1317	8	25	and	and	CCONJ
ajlm-1317	8	26	reproduction	reproduction	NOUN
ajlm-1317	8	27	in	in	ADP
ajlm-1317	8	28	any	any	DET
ajlm-1317	8	29	medium	medium	NOUN
ajlm-1317	8	30	,	,	PUNCT
ajlm-1317	8	31	provided	provide	VERB
ajlm-1317	8	32	the	the	DET
ajlm-1317	8	33	original	original	ADJ
ajlm-1317	8	34	work	work	NOUN
ajlm-1317	8	35	is	be	AUX
ajlm-1317	8	36	properly	properly	ADV
ajlm-1317	8	37	cited	cite	VERB
ajlm-1317	8	38	.	.	PUNCT
ajlm-1317	9	1	abstract	abstract	ADJ
ajlm-1317	9	2	background	background	NOUN
ajlm-1317	9	3	:	:	PUNCT
ajlm-1317	9	4	timely	timely	ADJ
ajlm-1317	9	5	testing	testing	NOUN
ajlm-1317	9	6	is	be	AUX
ajlm-1317	9	7	a	a	DET
ajlm-1317	9	8	key	key	ADJ
ajlm-1317	9	9	determinant	determinant	NOUN
ajlm-1317	9	10	of	of	ADP
ajlm-1317	9	11	management	management	NOUN
ajlm-1317	9	12	outcomes	outcome	NOUN
ajlm-1317	9	13	of	of	ADP
ajlm-1317	9	14	coronavirus	coronavirus	NOUN
ajlm-1317	9	15	disease	disease	NOUN
ajlm-1317	9	16	2019	2019	NUM
ajlm-1317	9	17	(	(	PUNCT
ajlm-1317	9	18	covid-19	covid-19	PROPN
ajlm-1317	9	19	)	)	PUNCT
ajlm-1317	9	20	.	.	PUNCT
ajlm-1317	10	1	real	real	ADJ
ajlm-1317	10	2	-	-	PUNCT
ajlm-1317	10	3	time	time	NOUN
ajlm-1317	10	4	reverse	reverse	NOUN
ajlm-1317	10	5	transcription	transcription	NOUN
ajlm-1317	10	6	polymerase	polymerase	NOUN
ajlm-1317	10	7	chain	chain	NOUN
ajlm-1317	10	8	reaction	reaction	NOUN
ajlm-1317	10	9	tests	test	NOUN
ajlm-1317	10	10	are	be	AUX
ajlm-1317	10	11	currently	currently	ADV
ajlm-1317	10	12	the	the	DET
ajlm-1317	10	13	mainstay	mainstay	NOUN
ajlm-1317	10	14	for	for	ADP
ajlm-1317	10	15	covid-19	covid-19	PROPN
ajlm-1317	10	16	testing	testing	NOUN
ajlm-1317	10	17	.	.	PUNCT
ajlm-1317	11	1	however	however	ADV
ajlm-1317	11	2	,	,	PUNCT
ajlm-1317	11	3	serological	serological	ADJ
ajlm-1317	11	4	point	point	NOUN
ajlm-1317	11	5	-	-	PUNCT
ajlm-1317	11	6	of	of	ADP
ajlm-1317	11	7	-	-	PUNCT
ajlm-1317	11	8	care	care	NOUN
ajlm-1317	11	9	tests	test	NOUN
ajlm-1317	11	10	(	(	PUNCT
ajlm-1317	11	11	pocts	poct	NOUN
ajlm-1317	11	12	)	)	PUNCT
ajlm-1317	11	13	can	can	AUX
ajlm-1317	11	14	be	be	AUX
ajlm-1317	11	15	useful	useful	ADJ
ajlm-1317	11	16	in	in	ADP
ajlm-1317	11	17	identifying	identify	VERB
ajlm-1317	11	18	asymptomatic	asymptomatic	ADJ
ajlm-1317	11	19	and	and	CCONJ
ajlm-1317	11	20	recovered	recovered	ADJ
ajlm-1317	11	21	cases	case	NOUN
ajlm-1317	11	22	,	,	PUNCT
ajlm-1317	11	23	as	as	ADV
ajlm-1317	11	24	well	well	ADV
ajlm-1317	11	25	as	as	ADP
ajlm-1317	11	26	herd	herd	NOUN
ajlm-1317	11	27	immunity	immunity	NOUN
ajlm-1317	11	28	.	.	PUNCT
ajlm-1317	12	1	objective	objective	NOUN
ajlm-1317	12	2	:	:	PUNCT
ajlm-1317	12	3	the	the	DET
ajlm-1317	12	4	aim	aim	NOUN
ajlm-1317	12	5	of	of	ADP
ajlm-1317	12	6	this	this	DET
ajlm-1317	12	7	study	study	NOUN
ajlm-1317	12	8	was	be	AUX
ajlm-1317	12	9	to	to	PART
ajlm-1317	12	10	assess	assess	VERB
ajlm-1317	12	11	covid-19	covid-19	PROPN
ajlm-1317	12	12	pocts	poct	NOUN
ajlm-1317	12	13	in	in	ADP
ajlm-1317	12	14	kenya	kenya	PROPN
ajlm-1317	12	15	to	to	PART
ajlm-1317	12	16	support	support	VERB
ajlm-1317	12	17	the	the	DET
ajlm-1317	12	18	emergency	emergency	NOUN
ajlm-1317	12	19	use	use	VERB
ajlm-1317	12	20	authorisation	authorisation	NOUN
ajlm-1317	12	21	of	of	ADP
ajlm-1317	12	22	these	these	DET
ajlm-1317	12	23	tests	test	NOUN
ajlm-1317	12	24	.	.	PUNCT
ajlm-1317	13	1	methods	method	NOUN
ajlm-1317	13	2	:	:	PUNCT
ajlm-1317	13	3	between	between	ADP
ajlm-1317	13	4	march	march	PROPN
ajlm-1317	13	5	2020	2020	NUM
ajlm-1317	13	6	and	and	CCONJ
ajlm-1317	13	7	may	may	PROPN
ajlm-1317	13	8	2020	2020	NUM
ajlm-1317	13	9	,	,	PUNCT
ajlm-1317	13	10	18	18	NUM
ajlm-1317	13	11	firms	firm	NOUN
ajlm-1317	13	12	,	,	PUNCT
ajlm-1317	13	13	of	of	ADP
ajlm-1317	13	14	which	which	PRON
ajlm-1317	13	15	13	13	NUM
ajlm-1317	13	16	were	be	AUX
ajlm-1317	13	17	from	from	ADP
ajlm-1317	13	18	china	china	PROPN
ajlm-1317	13	19	,	,	PUNCT
ajlm-1317	13	20	submitted	submit	VERB
ajlm-1317	13	21	their	their	PRON
ajlm-1317	13	22	pocts	poct	NOUN
ajlm-1317	13	23	to	to	ADP
ajlm-1317	13	24	the	the	DET
ajlm-1317	13	25	national	national	ADJ
ajlm-1317	13	26	regulatory	regulatory	ADJ
ajlm-1317	13	27	authority	authority	NOUN
ajlm-1317	13	28	,	,	PUNCT
ajlm-1317	13	29	the	the	DET
ajlm-1317	13	30	pharmacy	pharmacy	NOUN
ajlm-1317	13	31	and	and	CCONJ
ajlm-1317	13	32	poison	poison	NOUN
ajlm-1317	13	33	board	board	NOUN
ajlm-1317	13	34	,	,	PUNCT
ajlm-1317	13	35	who	who	PRON
ajlm-1317	13	36	in	in	ADP
ajlm-1317	13	37	turn	turn	NOUN
ajlm-1317	13	38	forwarded	forward	VERB
ajlm-1317	13	39	them	they	PRON
ajlm-1317	13	40	to	to	ADP
ajlm-1317	13	41	the	the	DET
ajlm-1317	13	42	kenya	kenya	PROPN
ajlm-1317	13	43	medical	medical	PROPN
ajlm-1317	13	44	research	research	PROPN
ajlm-1317	13	45	institute	institute	PROPN
ajlm-1317	13	46	for	for	ADP
ajlm-1317	13	47	pre	pre	ADJ
ajlm-1317	13	48	-	-	ADJ
ajlm-1317	13	49	evaluation	evaluation	ADJ
ajlm-1317	13	50	assessment	assessment	NOUN
ajlm-1317	13	51	.	.	PUNCT
ajlm-1317	14	1	the	the	DET
ajlm-1317	14	2	tests	test	NOUN
ajlm-1317	14	3	were	be	AUX
ajlm-1317	14	4	run	run	VERB
ajlm-1317	14	5	with	with	ADP
ajlm-1317	14	6	real	real	ADJ
ajlm-1317	14	7	-	-	PUNCT
ajlm-1317	14	8	time	time	NOUN
ajlm-1317	14	9	reverse	reverse	NOUN
ajlm-1317	14	10	transcription	transcription	NOUN
ajlm-1317	14	11	polymerase	polymerase	NOUN
ajlm-1317	14	12	chain	chain	NOUN
ajlm-1317	14	13	reaction	reaction	NOUN
ajlm-1317	14	14	covid-19	covid-19	PROPN
ajlm-1317	14	15	-	-	PUNCT
ajlm-1317	14	16	positive	positive	ADJ
ajlm-1317	14	17	samples	sample	NOUN
ajlm-1317	14	18	.	.	PUNCT
ajlm-1317	15	1	pre	pre	ADJ
ajlm-1317	15	2	-	-	ADJ
ajlm-1317	15	3	covid-19	covid-19	ADJ
ajlm-1317	15	4	plasma	plasma	NOUN
ajlm-1317	15	5	samples	sample	NOUN
ajlm-1317	15	6	that	that	PRON
ajlm-1317	15	7	were	be	AUX
ajlm-1317	15	8	collected	collect	VERB
ajlm-1317	15	9	in	in	ADP
ajlm-1317	15	10	june	june	PROPN
ajlm-1317	15	11	2019	2019	NUM
ajlm-1317	15	12	were	be	AUX
ajlm-1317	15	13	used	use	VERB
ajlm-1317	15	14	as	as	ADP
ajlm-1317	15	15	negative	negative	ADJ
ajlm-1317	15	16	samples	sample	NOUN
ajlm-1317	15	17	.	.	PUNCT
ajlm-1317	16	1	the	the	DET
ajlm-1317	16	2	shelf	shelf	NOUN
ajlm-1317	16	3	lives	live	VERB
ajlm-1317	16	4	of	of	ADP
ajlm-1317	16	5	the	the	DET
ajlm-1317	16	6	pocts	poct	NOUN
ajlm-1317	16	7	ranged	range	VERB
ajlm-1317	16	8	from	from	ADP
ajlm-1317	16	9	6	6	NUM
ajlm-1317	16	10	to	to	PART
ajlm-1317	16	11	24	24	NUM
ajlm-1317	16	12	months	month	NOUN
ajlm-1317	16	13	.	.	PUNCT
ajlm-1317	17	1	results	result	NOUN
ajlm-1317	17	2	:	:	PUNCT
ajlm-1317	17	3	only	only	ADV
ajlm-1317	17	4	nine	nine	NUM
ajlm-1317	17	5	(	(	PUNCT
ajlm-1317	17	6	50	50	NUM
ajlm-1317	17	7	%	%	NOUN
ajlm-1317	17	8	)	)	PUNCT
ajlm-1317	17	9	tests	test	NOUN
ajlm-1317	17	10	had	have	AUX
ajlm-1317	17	11	sensitivities	sensitivity	NOUN
ajlm-1317	17	12	≥	≥	NUM
ajlm-1317	17	13	40	40	NUM
ajlm-1317	17	14	%	%	NOUN
ajlm-1317	17	15	(	(	PUNCT
ajlm-1317	17	16	range	range	NOUN
ajlm-1317	17	17	:	:	PUNCT
ajlm-1317	17	18	40	40	NUM
ajlm-1317	17	19	%	%	NOUN
ajlm-1317	17	20	–	–	PUNCT
ajlm-1317	17	21	60	60	NUM
ajlm-1317	17	22	%	%	NOUN
ajlm-1317	17	23	)	)	PUNCT
ajlm-1317	17	24	and	and	CCONJ
ajlm-1317	17	25	the	the	DET
ajlm-1317	17	26	ability	ability	NOUN
ajlm-1317	17	27	of	of	ADP
ajlm-1317	17	28	these	these	DET
ajlm-1317	17	29	tests	test	NOUN
ajlm-1317	17	30	to	to	PART
ajlm-1317	17	31	detect	detect	VERB
ajlm-1317	17	32	igm	igm	NOUN
ajlm-1317	17	33	ranged	range	VERB
ajlm-1317	17	34	from	from	ADP
ajlm-1317	17	35	0	0	NUM
ajlm-1317	17	36	%	%	NOUN
ajlm-1317	17	37	to	to	PART
ajlm-1317	17	38	50	50	NUM
ajlm-1317	17	39	%	%	NOUN
ajlm-1317	17	40	.	.	PUNCT
ajlm-1317	18	1	many	many	ADJ
ajlm-1317	18	2	(	(	PUNCT
ajlm-1317	18	3	7/18	7/18	NUM
ajlm-1317	18	4	;	;	PUNCT
ajlm-1317	18	5	38.9	38.9	NUM
ajlm-1317	18	6	%	%	NOUN
ajlm-1317	18	7	)	)	PUNCT
ajlm-1317	18	8	of	of	ADP
ajlm-1317	18	9	the	the	DET
ajlm-1317	18	10	kits	kit	NOUN
ajlm-1317	18	11	had	have	VERB
ajlm-1317	18	12	very	very	ADV
ajlm-1317	18	13	weak	weak	ADJ
ajlm-1317	18	14	igm	igm	NOUN
ajlm-1317	18	15	and	and	CCONJ
ajlm-1317	18	16	igg	igg	PROPN
ajlm-1317	18	17	band	band	NOUN
ajlm-1317	18	18	intensities	intensity	NOUN
ajlm-1317	18	19	(	(	PUNCT
ajlm-1317	18	20	range	range	NOUN
ajlm-1317	18	21	:	:	PUNCT
ajlm-1317	18	22	2–3	2–3	NUM
ajlm-1317	18	23	)	)	PUNCT
ajlm-1317	18	24	.	.	PUNCT
ajlm-1317	19	1	conclusion	conclusion	NOUN
ajlm-1317	19	2	:	:	PUNCT
ajlm-1317	19	3	serological	serological	NOUN
ajlm-1317	19	4	-	-	PUNCT
ajlm-1317	19	5	based	base	VERB
ajlm-1317	19	6	pocts	poct	NOUN
ajlm-1317	19	7	available	available	ADJ
ajlm-1317	19	8	in	in	ADP
ajlm-1317	19	9	kenya	kenya	PROPN
ajlm-1317	19	10	can	can	AUX
ajlm-1317	19	11	only	only	ADV
ajlm-1317	19	12	detect	detect	VERB
ajlm-1317	19	13	covid-19	covid-19	PROPN
ajlm-1317	19	14	in	in	ADP
ajlm-1317	19	15	up	up	ADP
ajlm-1317	19	16	to	to	PART
ajlm-1317	19	17	60	60	NUM
ajlm-1317	19	18	%	%	NOUN
ajlm-1317	19	19	of	of	ADP
ajlm-1317	19	20	the	the	DET
ajlm-1317	19	21	infected	infected	ADJ
ajlm-1317	19	22	population	population	NOUN
ajlm-1317	19	23	.	.	PUNCT
ajlm-1317	20	1	keywords	keyword	NOUN
ajlm-1317	20	2	:	:	PUNCT
ajlm-1317	20	3	covid-19	covid-19	PROPN
ajlm-1317	20	4	;	;	PUNCT
ajlm-1317	20	5	point	point	NOUN
ajlm-1317	20	6	-	-	PUNCT
ajlm-1317	20	7	of	of	ADP
ajlm-1317	20	8	-	-	PUNCT
ajlm-1317	20	9	care	care	NOUN
ajlm-1317	20	10	;	;	PUNCT
ajlm-1317	20	11	igm	igm	PROPN
ajlm-1317	20	12	;	;	PUNCT
ajlm-1317	20	13	igg	igg	PROPN
ajlm-1317	20	14	;	;	PUNCT
ajlm-1317	20	15	sensitivity	sensitivity	NOUN
ajlm-1317	20	16	;	;	PUNCT
ajlm-1317	20	17	specificity	specificity	NOUN
ajlm-1317	20	18	;	;	PUNCT
ajlm-1317	20	19	sars	sar	NOUN
ajlm-1317	20	20	-	-	PUNCT
ajlm-1317	20	21	cov-2	cov-2	NOUN
ajlm-1317	20	22	.	.	PUNCT
ajlm-1317	21	1	introduction	introduction	NOUN
ajlm-1317	21	2	the	the	DET
ajlm-1317	21	3	world	world	NOUN
ajlm-1317	21	4	is	be	AUX
ajlm-1317	21	5	grappling	grapple	VERB
ajlm-1317	21	6	with	with	ADP
ajlm-1317	21	7	one	one	NUM
ajlm-1317	21	8	of	of	ADP
ajlm-1317	21	9	the	the	DET
ajlm-1317	21	10	worst	bad	ADJ
ajlm-1317	21	11	disease	disease	NOUN
ajlm-1317	21	12	pandemics	pandemic	NOUN
ajlm-1317	21	13	ever	ever	ADV
ajlm-1317	21	14	experienced	experience	VERB
ajlm-1317	21	15	in	in	ADP
ajlm-1317	21	16	over	over	ADP
ajlm-1317	21	17	100	100	NUM
ajlm-1317	21	18	years	year	NOUN
ajlm-1317	21	19	,	,	PUNCT
ajlm-1317	21	20	the	the	DET
ajlm-1317	21	21	coronavirus	coronavirus	NOUN
ajlm-1317	21	22	disease	disease	NOUN
ajlm-1317	21	23	2019	2019	NUM
ajlm-1317	21	24	(	(	PUNCT
ajlm-1317	21	25	covid-19	covid-19	PROPN
ajlm-1317	21	26	)	)	PUNCT
ajlm-1317	21	27	.	.	PUNCT
ajlm-1317	22	1	according	accord	VERB
ajlm-1317	22	2	to	to	ADP
ajlm-1317	22	3	a	a	DET
ajlm-1317	22	4	world	world	NOUN
ajlm-1317	22	5	health	health	NOUN
ajlm-1317	22	6	organization	organization	NOUN
ajlm-1317	22	7	situation	situation	NOUN
ajlm-1317	22	8	report	report	NOUN
ajlm-1317	22	9	,	,	PUNCT
ajlm-1317	22	10	as	as	ADP
ajlm-1317	22	11	of	of	ADP
ajlm-1317	22	12	07	07	NUM
ajlm-1317	22	13	june	june	PROPN
ajlm-1317	22	14	2020	2020	NUM
ajlm-1317	22	15	,	,	PUNCT
ajlm-1317	22	16	the	the	DET
ajlm-1317	22	17	number	number	NOUN
ajlm-1317	22	18	of	of	ADP
ajlm-1317	22	19	covid-19	covid-19	PROPN
ajlm-1317	22	20	cases	case	NOUN
ajlm-1317	22	21	had	have	AUX
ajlm-1317	22	22	reached	reach	VERB
ajlm-1317	22	23	6	6	NUM
ajlm-1317	22	24	931	931	NUM
ajlm-1317	22	25	000	000	NUM
ajlm-1317	22	26	people	people	NOUN
ajlm-1317	22	27	globally	globally	ADV
ajlm-1317	22	28	,	,	PUNCT
ajlm-1317	22	29	with	with	ADP
ajlm-1317	22	30	more	more	ADJ
ajlm-1317	22	31	than	than	ADP
ajlm-1317	22	32	400	400	NUM
ajlm-1317	22	33	121	121	NUM
ajlm-1317	22	34	deaths	death	NOUN
ajlm-1317	22	35	.	.	PUNCT
ajlm-1317	23	1	in	in	ADP
ajlm-1317	23	2	kenya	kenya	PROPN
ajlm-1317	23	3	,	,	PUNCT
ajlm-1317	23	4	the	the	DET
ajlm-1317	23	5	number	number	NOUN
ajlm-1317	23	6	of	of	ADP
ajlm-1317	23	7	reported	report	VERB
ajlm-1317	23	8	cases	case	NOUN
ajlm-1317	23	9	as	as	ADP
ajlm-1317	23	10	of	of	ADP
ajlm-1317	23	11	06	06	NUM
ajlm-1317	23	12	june	june	PROPN
ajlm-1317	23	13	2020	2020	NUM
ajlm-1317	23	14	was	be	AUX
ajlm-1317	23	15	2600	2600	NUM
ajlm-1317	23	16	with	with	ADP
ajlm-1317	23	17	83	83	NUM
ajlm-1317	23	18	deaths.1	deaths.1	PROPN
ajlm-1317	23	19	real	real	ADJ
ajlm-1317	23	20	-	-	PUNCT
ajlm-1317	23	21	time	time	NOUN
ajlm-1317	23	22	reverse	reverse	NOUN
ajlm-1317	23	23	transcription	transcription	NOUN
ajlm-1317	23	24	polymerase	polymerase	NOUN
ajlm-1317	23	25	chain	chain	NOUN
ajlm-1317	23	26	reaction	reaction	NOUN
ajlm-1317	23	27	(	(	PUNCT
ajlm-1317	23	28	rrt	rrt	NOUN
ajlm-1317	23	29	-	-	ADJ
ajlm-1317	23	30	pcr	pcr	NOUN
ajlm-1317	23	31	)	)	PUNCT
ajlm-1317	23	32	is	be	AUX
ajlm-1317	23	33	currently	currently	ADV
ajlm-1317	23	34	the	the	DET
ajlm-1317	23	35	gold	gold	ADJ
ajlm-1317	23	36	standard	standard	NOUN
ajlm-1317	23	37	for	for	ADP
ajlm-1317	23	38	severe	severe	ADJ
ajlm-1317	23	39	acute	acute	ADJ
ajlm-1317	23	40	respiratory	respiratory	ADJ
ajlm-1317	23	41	syndrome	syndrome	NOUN
ajlm-1317	23	42	coronavirus	coronavirus	NOUN
ajlm-1317	23	43	2	2	NUM
ajlm-1317	23	44	(	(	PUNCT
ajlm-1317	23	45	sars	sar	NOUN
ajlm-1317	23	46	-	-	PUNCT
ajlm-1317	23	47	cov-2	cov-2	NOUN
ajlm-1317	23	48	)	)	PUNCT
ajlm-1317	23	49	diagnosis	diagnosis	NOUN
ajlm-1317	23	50	as	as	SCONJ
ajlm-1317	23	51	it	it	PRON
ajlm-1317	23	52	is	be	AUX
ajlm-1317	23	53	highly	highly	ADV
ajlm-1317	23	54	sensitive	sensitive	ADJ
ajlm-1317	23	55	and	and	CCONJ
ajlm-1317	23	56	relatively	relatively	ADV
ajlm-1317	23	57	easy	easy	ADJ
ajlm-1317	23	58	to	to	ADP
ajlm-1317	23	59	develop.2	develop.2	PROPN
ajlm-1317	23	60	however	however	ADV
ajlm-1317	23	61	,	,	PUNCT
ajlm-1317	23	62	rrt	rrt	ADJ
ajlm-1317	23	63	-	-	ADJ
ajlm-1317	23	64	pcr	pcr	ADJ
ajlm-1317	23	65	test	test	NOUN
ajlm-1317	23	66	protocols	protocol	NOUN
ajlm-1317	23	67	are	be	AUX
ajlm-1317	23	68	complex	complex	ADJ
ajlm-1317	23	69	,	,	PUNCT
ajlm-1317	23	70	expensive	expensive	ADJ
ajlm-1317	23	71	,	,	PUNCT
ajlm-1317	23	72	mainly	mainly	ADV
ajlm-1317	23	73	suited	suit	VERB
ajlm-1317	23	74	to	to	ADP
ajlm-1317	23	75	advanced	advanced	ADJ
ajlm-1317	23	76	laboratories	laboratory	NOUN
ajlm-1317	23	77	,	,	PUNCT
ajlm-1317	23	78	and	and	CCONJ
ajlm-1317	23	79	typically	typically	ADV
ajlm-1317	23	80	take	take	VERB
ajlm-1317	23	81	4–6	4–6	NUM
ajlm-1317	23	82	h	h	NOUN
ajlm-1317	23	83	to	to	PART
ajlm-1317	23	84	complete	complete	VERB
ajlm-1317	23	85	.	.	PUNCT
ajlm-1317	24	1	moreover	moreover	ADV
ajlm-1317	24	2	,	,	PUNCT
ajlm-1317	24	3	these	these	DET
ajlm-1317	24	4	tests	test	NOUN
ajlm-1317	24	5	are	be	AUX
ajlm-1317	24	6	manufactured	manufacture	VERB
ajlm-1317	24	7	by	by	ADP
ajlm-1317	24	8	predominantly	predominantly	ADV
ajlm-1317	24	9	european	european	ADJ
ajlm-1317	24	10	and	and	CCONJ
ajlm-1317	24	11	american	american	ADJ
ajlm-1317	24	12	companies	company	NOUN
ajlm-1317	24	13	that	that	PRON
ajlm-1317	24	14	have	have	AUX
ajlm-1317	24	15	adopted	adopt	VERB
ajlm-1317	24	16	a	a	DET
ajlm-1317	24	17	‘	'	PUNCT
ajlm-1317	24	18	me	i	PRON
ajlm-1317	24	19	first	first	ADJ
ajlm-1317	24	20	’	'	PUNCT
ajlm-1317	24	21	policy	policy	NOUN
ajlm-1317	24	22	due	due	ADP
ajlm-1317	24	23	to	to	ADP
ajlm-1317	24	24	the	the	DET
ajlm-1317	24	25	high	high	ADJ
ajlm-1317	24	26	numbers	number	NOUN
ajlm-1317	24	27	of	of	ADP
ajlm-1317	24	28	covid-19	covid-19	PROPN
ajlm-1317	24	29	-	-	PUNCT
ajlm-1317	24	30	related	relate	VERB
ajlm-1317	24	31	deaths	death	NOUN
ajlm-1317	24	32	in	in	ADP
ajlm-1317	24	33	their	their	PRON
ajlm-1317	24	34	own	own	ADJ
ajlm-1317	24	35	countries	country	NOUN
ajlm-1317	24	36	,	,	PUNCT
ajlm-1317	24	37	thereby	thereby	ADV
ajlm-1317	24	38	successfully	successfully	ADV
ajlm-1317	24	39	eliminating	eliminate	VERB
ajlm-1317	24	40	the	the	DET
ajlm-1317	24	41	chances	chance	NOUN
ajlm-1317	24	42	of	of	ADP
ajlm-1317	24	43	these	these	DET
ajlm-1317	24	44	test	test	NOUN
ajlm-1317	24	45	kits	kit	NOUN
ajlm-1317	24	46	flowing	flow	VERB
ajlm-1317	24	47	to	to	ADP
ajlm-1317	24	48	africa	africa	PROPN
ajlm-1317	24	49	and	and	CCONJ
ajlm-1317	24	50	kenya	kenya	PROPN
ajlm-1317	24	51	in	in	ADP
ajlm-1317	24	52	quantities	quantity	NOUN
ajlm-1317	24	53	sufficient	sufficient	ADJ
ajlm-1317	24	54	for	for	ADP
ajlm-1317	24	55	use.3,4	use.3,4	ADJ
ajlm-1317	24	56	on	on	ADP
ajlm-1317	24	57	the	the	DET
ajlm-1317	24	58	other	other	ADJ
ajlm-1317	24	59	hand	hand	NOUN
ajlm-1317	24	60	,	,	PUNCT
ajlm-1317	24	61	serological	serological	NOUN
ajlm-1317	24	62	-	-	PUNCT
ajlm-1317	24	63	based	base	VERB
ajlm-1317	24	64	point	point	NOUN
ajlm-1317	24	65	-	-	PUNCT
ajlm-1317	24	66	of	of	ADP
ajlm-1317	24	67	-	-	PUNCT
ajlm-1317	24	68	care	care	NOUN
ajlm-1317	24	69	tests	test	NOUN
ajlm-1317	24	70	(	(	PUNCT
ajlm-1317	24	71	pocts	poct	NOUN
ajlm-1317	24	72	)	)	PUNCT
ajlm-1317	24	73	that	that	PRON
ajlm-1317	24	74	take	take	VERB
ajlm-1317	24	75	5–15	5–15	PROPN
ajlm-1317	24	76	min	min	NOUN
ajlm-1317	24	77	to	to	PART
ajlm-1317	24	78	complete	complete	VERB
ajlm-1317	24	79	can	can	AUX
ajlm-1317	24	80	pick	pick	VERB
ajlm-1317	24	81	up	up	ADP
ajlm-1317	24	82	asymptomatic	asymptomatic	ADJ
ajlm-1317	24	83	or	or	CCONJ
ajlm-1317	24	84	recovered	recovered	ADJ
ajlm-1317	24	85	cases	case	NOUN
ajlm-1317	24	86	of	of	ADP
ajlm-1317	24	87	covid-19	covid-19	PROPN
ajlm-1317	24	88	,	,	PUNCT
ajlm-1317	24	89	making	make	VERB
ajlm-1317	24	90	them	they	PRON
ajlm-1317	24	91	suitable	suitable	ADJ
ajlm-1317	24	92	to	to	PART
ajlm-1317	24	93	support	support	VERB
ajlm-1317	24	94	disease	disease	NOUN
ajlm-1317	24	95	surveillance	surveillance	NOUN
ajlm-1317	24	96	and	and	CCONJ
ajlm-1317	24	97	the	the	DET
ajlm-1317	24	98	determination	determination	NOUN
ajlm-1317	24	99	of	of	ADP
ajlm-1317	24	100	herd	herd	NOUN
ajlm-1317	24	101	immunity.5	immunity.5	PROPN
ajlm-1317	24	102	however	however	ADV
ajlm-1317	24	103	,	,	PUNCT
ajlm-1317	24	104	these	these	DET
ajlm-1317	24	105	pocts	poct	NOUN
ajlm-1317	24	106	have	have	VERB
ajlm-1317	24	107	low	low	ADJ
ajlm-1317	24	108	overall	overall	ADJ
ajlm-1317	24	109	sensitivities	sensitivity	NOUN
ajlm-1317	24	110	(	(	PUNCT
ajlm-1317	24	111	34	34	NUM
ajlm-1317	24	112	%	%	NOUN
ajlm-1317	24	113	–	–	PUNCT
ajlm-1317	24	114	80	80	NUM
ajlm-1317	24	115	%	%	NOUN
ajlm-1317	24	116	)	)	PUNCT
ajlm-1317	24	117	and	and	CCONJ
ajlm-1317	24	118	specificities	specificity	NOUN
ajlm-1317	24	119	(	(	PUNCT
ajlm-1317	24	120	70	70	NUM
ajlm-1317	24	121	%	%	NOUN
ajlm-1317	24	122	–	–	PUNCT
ajlm-1317	24	123	100	100	NUM
ajlm-1317	24	124	%	%	NOUN
ajlm-1317	24	125	)	)	PUNCT
ajlm-1317	24	126	compared	compare	VERB
ajlm-1317	24	127	to	to	ADP
ajlm-1317	24	128	covid-19	covid-19	PROPN
ajlm-1317	24	129	rrt	rrt	NOUN
ajlm-1317	24	130	-	-	NOUN
ajlm-1317	24	131	pcr	pcr	NOUN
ajlm-1317	24	132	as	as	ADP
ajlm-1317	24	133	the	the	DET
ajlm-1317	24	134	gold	gold	NOUN
ajlm-1317	24	135	standard.6	standard.6	PROPN
ajlm-1317	24	136	serological	serological	NOUN
ajlm-1317	24	137	-	-	PUNCT
ajlm-1317	24	138	based	base	VERB
ajlm-1317	24	139	pocts	poct	NOUN
ajlm-1317	24	140	detect	detect	VERB
ajlm-1317	24	141	plasma	plasma	NOUN
ajlm-1317	24	142	levels	level	NOUN
ajlm-1317	24	143	of	of	ADP
ajlm-1317	24	144	immunoglobin	immunoglobin	PROPN
ajlm-1317	24	145	g	g	PROPN
ajlm-1317	24	146	(	(	PUNCT
ajlm-1317	24	147	igg	igg	PROPN
ajlm-1317	24	148	)	)	PUNCT
ajlm-1317	24	149	,	,	PUNCT
ajlm-1317	24	150	immunoglobin	immunoglobin	PROPN
ajlm-1317	24	151	m	m	PROPN
ajlm-1317	24	152	(	(	PUNCT
ajlm-1317	24	153	igm	igm	PROPN
ajlm-1317	24	154	)	)	PUNCT
ajlm-1317	24	155	,	,	PUNCT
ajlm-1317	24	156	and	and	CCONJ
ajlm-1317	24	157	,	,	PUNCT
ajlm-1317	24	158	sometimes	sometimes	ADV
ajlm-1317	24	159	,	,	PUNCT
ajlm-1317	24	160	iga	iga	PROPN
ajlm-1317	24	161	against	against	ADP
ajlm-1317	24	162	sars	sar	NOUN
ajlm-1317	24	163	-	-	PUNCT
ajlm-1317	24	164	cov-2	cov-2	NOUN
ajlm-1317	24	165	.	.	PUNCT
ajlm-1317	25	1	the	the	DET
ajlm-1317	25	2	levels	level	NOUN
ajlm-1317	25	3	of	of	ADP
ajlm-1317	25	4	igm	igm	PROPN
ajlm-1317	25	5	are	be	AUX
ajlm-1317	25	6	elevated	elevate	VERB
ajlm-1317	25	7	during	during	ADP
ajlm-1317	25	8	the	the	DET
ajlm-1317	25	9	first	first	ADJ
ajlm-1317	25	10	week	week	NOUN
ajlm-1317	25	11	after	after	SCONJ
ajlm-1317	25	12	sars	sar	NOUN
ajlm-1317	25	13	-	-	PUNCT
ajlm-1317	25	14	cov-2	cov-2	PART
ajlm-1317	25	15	infection	infection	NOUN
ajlm-1317	25	16	,	,	PUNCT
ajlm-1317	25	17	peak	peak	NOUN
ajlm-1317	25	18	at	at	ADP
ajlm-1317	25	19	2	2	NUM
ajlm-1317	25	20	weeks	week	NOUN
ajlm-1317	25	21	,	,	PUNCT
ajlm-1317	25	22	and	and	CCONJ
ajlm-1317	25	23	then	then	ADV
ajlm-1317	25	24	reduce	reduce	VERB
ajlm-1317	25	25	to	to	ADP
ajlm-1317	25	26	baseline	baseline	VERB
ajlm-1317	25	27	levels	level	NOUN
ajlm-1317	25	28	in	in	ADP
ajlm-1317	25	29	most	most	ADJ
ajlm-1317	25	30	patients	patient	NOUN
ajlm-1317	25	31	.	.	PUNCT
ajlm-1317	26	1	on	on	ADP
ajlm-1317	26	2	the	the	DET
ajlm-1317	26	3	other	other	ADJ
ajlm-1317	26	4	hand	hand	NOUN
ajlm-1317	26	5	,	,	PUNCT
ajlm-1317	26	6	igg	igg	PROPN
ajlm-1317	26	7	is	be	AUX
ajlm-1317	26	8	detectable	detectable	ADJ
ajlm-1317	26	9	after	after	ADP
ajlm-1317	26	10	1	1	NUM
ajlm-1317	26	11	week	week	NOUN
ajlm-1317	26	12	and	and	CCONJ
ajlm-1317	26	13	is	be	AUX
ajlm-1317	26	14	sustained	sustain	VERB
ajlm-1317	26	15	at	at	ADP
ajlm-1317	26	16	a	a	DET
ajlm-1317	26	17	high	high	ADJ
ajlm-1317	26	18	level	level	NOUN
ajlm-1317	26	19	for	for	ADP
ajlm-1317	26	20	a	a	DET
ajlm-1317	26	21	long	long	ADJ
ajlm-1317	26	22	period.7,8,9	period.7,8,9	NOUN
ajlm-1317	26	23	currently	currently	ADV
ajlm-1317	26	24	,	,	PUNCT
ajlm-1317	26	25	the	the	DET
ajlm-1317	26	26	world	world	PROPN
ajlm-1317	26	27	health	health	NOUN
ajlm-1317	26	28	organization	organization	NOUN
ajlm-1317	26	29	does	do	AUX
ajlm-1317	26	30	not	not	PART
ajlm-1317	26	31	recommend	recommend	VERB
ajlm-1317	26	32	the	the	DET
ajlm-1317	26	33	use	use	NOUN
ajlm-1317	26	34	of	of	ADP
ajlm-1317	26	35	covid-19	covid-19	PROPN
ajlm-1317	26	36	serological	serological	ADJ
ajlm-1317	26	37	tests	test	NOUN
ajlm-1317	26	38	in	in	ADP
ajlm-1317	26	39	the	the	DET
ajlm-1317	26	40	clinical	clinical	ADJ
ajlm-1317	26	41	setting	setting	NOUN
ajlm-1317	26	42	.	.	PUNCT
ajlm-1317	27	1	however	however	ADV
ajlm-1317	27	2	,	,	PUNCT
ajlm-1317	27	3	the	the	DET
ajlm-1317	27	4	potential	potential	NOUN
ajlm-1317	27	5	of	of	ADP
ajlm-1317	27	6	the	the	DET
ajlm-1317	27	7	use	use	NOUN
ajlm-1317	27	8	of	of	ADP
ajlm-1317	27	9	antigen	antigen	NOUN
ajlm-1317	27	10	-	-	PUNCT
ajlm-1317	27	11	based	base	VERB
ajlm-1317	27	12	pocts	poct	NOUN
ajlm-1317	27	13	at	at	ADP
ajlm-1317	27	14	triage	triage	NOUN
ajlm-1317	27	15	to	to	PART
ajlm-1317	27	16	rapidly	rapidly	ADV
ajlm-1317	27	17	detect	detect	VERB
ajlm-1317	27	18	cases	case	NOUN
ajlm-1317	27	19	is	be	AUX
ajlm-1317	27	20	acknowledged.10	acknowledged.10	ADJ
ajlm-1317	27	21	to	to	PART
ajlm-1317	27	22	evaluate	evaluate	VERB
ajlm-1317	27	23	in	in	ADP
ajlm-1317	27	24	vitro	vitro	X
ajlm-1317	27	25	serological	serological	NOUN
ajlm-1317	27	26	-	-	PUNCT
ajlm-1317	27	27	based	base	VERB
ajlm-1317	27	28	pocts	poct	NOUN
ajlm-1317	27	29	,	,	PUNCT
ajlm-1317	27	30	the	the	DET
ajlm-1317	27	31	world	world	PROPN
ajlm-1317	27	32	health	health	NOUN
ajlm-1317	27	33	organization	organization	NOUN
ajlm-1317	27	34	recommends	recommend	VERB
ajlm-1317	27	35	the	the	DET
ajlm-1317	27	36	use	use	NOUN
ajlm-1317	27	37	of	of	ADP
ajlm-1317	27	38	a	a	DET
ajlm-1317	27	39	minimum	minimum	NOUN
ajlm-1317	27	40	of	of	ADP
ajlm-1317	27	41	200	200	NUM
ajlm-1317	27	42	prospective	prospective	ADJ
ajlm-1317	27	43	covid-19	covid-19	PROPN
ajlm-1317	27	44	specimens	specimen	NOUN
ajlm-1317	27	45	(	(	PUNCT
ajlm-1317	27	46	100	100	NUM
ajlm-1317	27	47	confirmed	confirm	VERB
ajlm-1317	27	48	rrt	rrt	ADJ
ajlm-1317	27	49	-	-	ADJ
ajlm-1317	27	50	pcr	pcr	ADJ
ajlm-1317	27	51	positive	positive	ADJ
ajlm-1317	27	52	samples	sample	NOUN
ajlm-1317	27	53	and	and	CCONJ
ajlm-1317	27	54	100	100	NUM
ajlm-1317	27	55	prospective	prospective	ADJ
ajlm-1317	27	56	specimens	specimen	NOUN
ajlm-1317	27	57	from	from	ADP
ajlm-1317	27	58	patients	patient	NOUN
ajlm-1317	27	59	with	with	ADP
ajlm-1317	27	60	signs	sign	NOUN
ajlm-1317	27	61	and	and	CCONJ
ajlm-1317	27	62	symptoms	symptom	NOUN
ajlm-1317	27	63	suggestive	suggestive	ADJ
ajlm-1317	27	64	of	of	ADP
ajlm-1317	27	65	covid-19	covid-19	PROPN
ajlm-1317	27	66	)	)	PUNCT
ajlm-1317	27	67	.	.	PUNCT
ajlm-1317	28	1	at	at	ADV
ajlm-1317	28	2	least	least	ADV
ajlm-1317	28	3	30	30	NUM
ajlm-1317	28	4	specimens	specimen	NOUN
ajlm-1317	28	5	should	should	AUX
ajlm-1317	28	6	be	be	AUX
ajlm-1317	28	7	rrt	rrt	ADJ
ajlm-1317	28	8	-	-	ADJ
ajlm-1317	28	9	pcr	pcr	ADJ
ajlm-1317	28	10	positive	positive	ADJ
ajlm-1317	28	11	at	at	ADP
ajlm-1317	28	12	the	the	DET
ajlm-1317	28	13	time	time	NOUN
ajlm-1317	28	14	of	of	ADP
ajlm-1317	28	15	specimen	speciman	NOUN
ajlm-1317	28	16	collection	collection	NOUN
ajlm-1317	28	17	and	and	CCONJ
ajlm-1317	28	18	within	within	ADP
ajlm-1317	28	19	a	a	DET
ajlm-1317	28	20	week	week	NOUN
ajlm-1317	28	21	of	of	ADP
ajlm-1317	28	22	symptom	symptom	NOUN
ajlm-1317	28	23	onset	onset	VERB
ajlm-1317	28	24	.	.	PUNCT
ajlm-1317	29	1	the	the	DET
ajlm-1317	29	2	remaining	remain	VERB
ajlm-1317	29	3	data	datum	NOUN
ajlm-1317	29	4	may	may	AUX
ajlm-1317	29	5	be	be	AUX
ajlm-1317	29	6	supplemented	supplement	VERB
ajlm-1317	29	7	during	during	ADP
ajlm-1317	29	8	the	the	DET
ajlm-1317	29	9	review	review	NOUN
ajlm-1317	29	10	process	process	NOUN
ajlm-1317	29	11	.	.	PUNCT
ajlm-1317	30	1	for	for	ADP
ajlm-1317	30	2	diagnostic	diagnostic	ADJ
ajlm-1317	30	3	specificity	specificity	NOUN
ajlm-1317	30	4	,	,	PUNCT
ajlm-1317	30	5	200	200	NUM
ajlm-1317	30	6	individual	individual	ADJ
ajlm-1317	30	7	specimens	specimen	NOUN
ajlm-1317	30	8	from	from	ADP
ajlm-1317	30	9	symptomatic	symptomatic	ADJ
ajlm-1317	30	10	patients	patient	NOUN
ajlm-1317	30	11	that	that	PRON
ajlm-1317	30	12	tested	test	VERB
ajlm-1317	30	13	negative	negative	ADJ
ajlm-1317	30	14	to	to	ADP
ajlm-1317	30	15	covid-19	covid-19	PROPN
ajlm-1317	30	16	by	by	ADP
ajlm-1317	30	17	rrt	rrt	ADJ
ajlm-1317	30	18	-	-	ADJ
ajlm-1317	30	19	pcr	pcr	ADJ
ajlm-1317	30	20	and	and	CCONJ
ajlm-1317	30	21	at	at	ADP
ajlm-1317	30	22	least	least	ADJ
ajlm-1317	30	23	1000	1000	NUM
ajlm-1317	30	24	specimens	specimen	NOUN
ajlm-1317	30	25	from	from	ADP
ajlm-1317	30	26	the	the	DET
ajlm-1317	30	27	general	general	ADJ
ajlm-1317	30	28	population	population	NOUN
ajlm-1317	30	29	collected	collect	VERB
ajlm-1317	30	30	before	before	ADP
ajlm-1317	30	31	november	november	PROPN
ajlm-1317	30	32	2019	2019	NUM
ajlm-1317	30	33	are	be	AUX
ajlm-1317	30	34	used	use	VERB
ajlm-1317	30	35	.	.	PUNCT
ajlm-1317	31	1	at	at	ADV
ajlm-1317	31	2	least	least	ADV
ajlm-1317	31	3	50	50	NUM
ajlm-1317	31	4	%	%	NOUN
ajlm-1317	31	5	of	of	ADP
ajlm-1317	31	6	data	datum	NOUN
ajlm-1317	31	7	are	be	AUX
ajlm-1317	31	8	requested	request	VERB
ajlm-1317	31	9	for	for	ADP
ajlm-1317	31	10	submission.11	submission.11	ADJ
ajlm-1317	31	11	manufacturers	manufacturer	NOUN
ajlm-1317	31	12	of	of	ADP
ajlm-1317	31	13	commercial	commercial	ADJ
ajlm-1317	31	14	covid-19	covid-19	PROPN
ajlm-1317	31	15	pocts	poct	NOUN
ajlm-1317	31	16	submit	submit	VERB
ajlm-1317	31	17	their	their	PRON
ajlm-1317	31	18	pocts	poct	NOUN
ajlm-1317	31	19	to	to	ADP
ajlm-1317	31	20	the	the	DET
ajlm-1317	31	21	pharmacy	pharmacy	NOUN
ajlm-1317	31	22	and	and	CCONJ
ajlm-1317	31	23	poisons	poison	NOUN
ajlm-1317	31	24	board	board	NOUN
ajlm-1317	31	25	(	(	PUNCT
ajlm-1317	31	26	ppb	ppb	NOUN
ajlm-1317	31	27	)	)	PUNCT
ajlm-1317	31	28	,	,	PUNCT
ajlm-1317	31	29	nairobi	nairobi	PROPN
ajlm-1317	31	30	,	,	PUNCT
ajlm-1317	31	31	kenya	kenya	PROPN
ajlm-1317	31	32	,	,	PUNCT
ajlm-1317	31	33	for	for	SCONJ
ajlm-1317	31	34	evaluation	evaluation	NOUN
ajlm-1317	31	35	to	to	PART
ajlm-1317	31	36	facilitate	facilitate	VERB
ajlm-1317	31	37	and	and	CCONJ
ajlm-1317	31	38	enhance	enhance	VERB
ajlm-1317	31	39	the	the	DET
ajlm-1317	31	40	issuance	issuance	NOUN
ajlm-1317	31	41	of	of	ADP
ajlm-1317	31	42	emergency	emergency	NOUN
ajlm-1317	31	43	use	use	NOUN
ajlm-1317	31	44	authorisation	authorisation	NOUN
ajlm-1317	31	45	(	(	PUNCT
ajlm-1317	31	46	eua	eua	PROPN
ajlm-1317	31	47	)	)	PUNCT
ajlm-1317	31	48	.	.	PUNCT
ajlm-1317	32	1	upon	upon	SCONJ
ajlm-1317	32	2	receiving	receive	VERB
ajlm-1317	32	3	the	the	DET
ajlm-1317	32	4	eua	eua	PROPN
ajlm-1317	32	5	,	,	PUNCT
ajlm-1317	32	6	the	the	DET
ajlm-1317	32	7	supplier	supplier	NOUN
ajlm-1317	32	8	of	of	ADP
ajlm-1317	32	9	a	a	DET
ajlm-1317	32	10	poct	poct	NOUN
ajlm-1317	32	11	may	may	AUX
ajlm-1317	32	12	opt	opt	VERB
ajlm-1317	32	13	to	to	PART
ajlm-1317	32	14	submit	submit	VERB
ajlm-1317	32	15	it	it	PRON
ajlm-1317	32	16	for	for	ADP
ajlm-1317	32	17	the	the	DET
ajlm-1317	32	18	full	full	ADJ
ajlm-1317	32	19	evaluation	evaluation	NOUN
ajlm-1317	32	20	.	.	PUNCT
ajlm-1317	33	1	in	in	ADP
ajlm-1317	33	2	the	the	DET
ajlm-1317	33	3	face	face	NOUN
ajlm-1317	33	4	of	of	ADP
ajlm-1317	33	5	the	the	DET
ajlm-1317	33	6	pandemic	pandemic	NOUN
ajlm-1317	33	7	,	,	PUNCT
ajlm-1317	33	8	the	the	DET
ajlm-1317	33	9	regulatory	regulatory	ADJ
ajlm-1317	33	10	pathway	pathway	NOUN
ajlm-1317	33	11	of	of	ADP
ajlm-1317	33	12	eua	eua	PROPN
ajlm-1317	33	13	bypasses	bypass	VERB
ajlm-1317	33	14	the	the	DET
ajlm-1317	33	15	often	often	ADV
ajlm-1317	33	16	longer	long	ADV
ajlm-1317	33	17	,	,	PUNCT
ajlm-1317	33	18	data	datum	NOUN
ajlm-1317	33	19	scrutinising	scrutinise	VERB
ajlm-1317	33	20	pre	pre	ADJ
ajlm-1317	33	21	-	-	ADJ
ajlm-1317	33	22	evaluation	evaluation	NOUN
ajlm-1317	33	23	process	process	NOUN
ajlm-1317	33	24	conducted	conduct	VERB
ajlm-1317	33	25	by	by	ADP
ajlm-1317	33	26	the	the	DET
ajlm-1317	33	27	regulator	regulator	NOUN
ajlm-1317	33	28	(	(	PUNCT
ajlm-1317	33	29	the	the	DET
ajlm-1317	33	30	ppb	ppb	NOUN
ajlm-1317	33	31	)	)	PUNCT
ajlm-1317	33	32	before	before	ADP
ajlm-1317	33	33	allowing	allow	VERB
ajlm-1317	33	34	market	market	NOUN
ajlm-1317	33	35	authorisation	authorisation	NOUN
ajlm-1317	33	36	to	to	ADP
ajlm-1317	33	37	a	a	DET
ajlm-1317	33	38	manufacturer	manufacturer	NOUN
ajlm-1317	33	39	.	.	PUNCT
ajlm-1317	34	1	owing	owe	VERB
ajlm-1317	34	2	to	to	ADP
ajlm-1317	34	3	the	the	DET
ajlm-1317	34	4	novelty	novelty	NOUN
ajlm-1317	34	5	of	of	ADP
ajlm-1317	34	6	the	the	DET
ajlm-1317	34	7	coronavirus	coronavirus	NOUN
ajlm-1317	34	8	and	and	CCONJ
ajlm-1317	34	9	the	the	DET
ajlm-1317	34	10	devastating	devastating	ADJ
ajlm-1317	34	11	risk	risk	NOUN
ajlm-1317	34	12	of	of	ADP
ajlm-1317	34	13	death	death	NOUN
ajlm-1317	34	14	of	of	ADP
ajlm-1317	34	15	infected	infected	ADJ
ajlm-1317	34	16	persons	person	NOUN
ajlm-1317	34	17	,	,	PUNCT
ajlm-1317	34	18	the	the	DET
ajlm-1317	34	19	need	need	NOUN
ajlm-1317	34	20	to	to	PART
ajlm-1317	34	21	avail	avail	VERB
ajlm-1317	34	22	the	the	DET
ajlm-1317	34	23	pocts	poct	NOUN
ajlm-1317	34	24	and	and	CCONJ
ajlm-1317	34	25	rrt	rrt	NOUN
ajlm-1317	34	26	-	-	ADJ
ajlm-1317	34	27	pcr	pcr	NOUN
ajlm-1317	34	28	to	to	ADP
ajlm-1317	34	29	the	the	DET
ajlm-1317	34	30	general	general	ADJ
ajlm-1317	34	31	population	population	NOUN
ajlm-1317	34	32	was	be	AUX
ajlm-1317	34	33	paramount	paramount	ADJ
ajlm-1317	34	34	.	.	PUNCT
ajlm-1317	35	1	the	the	DET
ajlm-1317	35	2	need	need	NOUN
ajlm-1317	35	3	for	for	SCONJ
ajlm-1317	35	4	laboratory	laboratory	NOUN
ajlm-1317	35	5	performance	performance	NOUN
ajlm-1317	35	6	pre	pre	NOUN
ajlm-1317	35	7	-	-	NOUN
ajlm-1317	35	8	evaluation	evaluation	NOUN
ajlm-1317	35	9	was	be	AUX
ajlm-1317	35	10	identified	identify	VERB
ajlm-1317	35	11	as	as	ADP
ajlm-1317	35	12	a	a	DET
ajlm-1317	35	13	key	key	ADJ
ajlm-1317	35	14	component	component	NOUN
ajlm-1317	35	15	required	require	VERB
ajlm-1317	35	16	in	in	ADP
ajlm-1317	35	17	ascertaining	ascertain	VERB
ajlm-1317	35	18	the	the	DET
ajlm-1317	35	19	quality	quality	NOUN
ajlm-1317	35	20	of	of	ADP
ajlm-1317	35	21	the	the	DET
ajlm-1317	35	22	pocts	poct	NOUN
ajlm-1317	35	23	,	,	PUNCT
ajlm-1317	35	24	thus	thus	ADV
ajlm-1317	35	25	helping	help	VERB
ajlm-1317	35	26	to	to	PART
ajlm-1317	35	27	ensure	ensure	VERB
ajlm-1317	35	28	that	that	SCONJ
ajlm-1317	35	29	in	in	ADP
ajlm-1317	35	30	the	the	DET
ajlm-1317	35	31	interim	interim	ADJ
ajlm-1317	35	32	period	period	NOUN
ajlm-1317	35	33	of	of	ADP
ajlm-1317	35	34	use	use	NOUN
ajlm-1317	35	35	of	of	ADP
ajlm-1317	35	36	the	the	DET
ajlm-1317	35	37	pocts	poct	NOUN
ajlm-1317	35	38	,	,	PUNCT
ajlm-1317	35	39	performance	performance	NOUN
ajlm-1317	35	40	,	,	PUNCT
ajlm-1317	35	41	efficacy	efficacy	NOUN
ajlm-1317	35	42	and	and	CCONJ
ajlm-1317	35	43	safety	safety	NOUN
ajlm-1317	35	44	standards	standard	NOUN
ajlm-1317	35	45	are	be	AUX
ajlm-1317	35	46	met	meet	VERB
ajlm-1317	35	47	.	.	PUNCT
ajlm-1317	36	1	this	this	DET
ajlm-1317	36	2	study	study	NOUN
ajlm-1317	36	3	aimed	aim	VERB
ajlm-1317	36	4	to	to	PART
ajlm-1317	36	5	conduct	conduct	VERB
ajlm-1317	36	6	a	a	DET
ajlm-1317	36	7	preliminary	preliminary	ADJ
ajlm-1317	36	8	evaluation	evaluation	NOUN
ajlm-1317	36	9	of	of	ADP
ajlm-1317	36	10	commercial	commercial	ADJ
ajlm-1317	36	11	pocts	poct	NOUN
ajlm-1317	36	12	that	that	PRON
ajlm-1317	36	13	had	have	AUX
ajlm-1317	36	14	been	be	AUX
ajlm-1317	36	15	presented	present	VERB
ajlm-1317	36	16	to	to	ADP
ajlm-1317	36	17	the	the	DET
ajlm-1317	36	18	kenya	kenya	PROPN
ajlm-1317	36	19	medical	medical	PROPN
ajlm-1317	36	20	research	research	PROPN
ajlm-1317	36	21	institute	institute	PROPN
ajlm-1317	36	22	(	(	PUNCT
ajlm-1317	36	23	kemri	kemri	PROPN
ajlm-1317	36	24	)	)	PUNCT
ajlm-1317	36	25	,	,	PUNCT
ajlm-1317	36	26	nairobi	nairobi	PROPN
ajlm-1317	36	27	,	,	PUNCT
ajlm-1317	36	28	kenya	kenya	PROPN
ajlm-1317	36	29	,	,	PUNCT
ajlm-1317	36	30	by	by	ADP
ajlm-1317	36	31	the	the	DET
ajlm-1317	36	32	ppb	ppb	NOUN
ajlm-1317	36	33	.	.	PUNCT
ajlm-1317	37	1	methods	method	NOUN
ajlm-1317	37	2	ethical	ethical	ADJ
ajlm-1317	37	3	considerations	consideration	NOUN
ajlm-1317	37	4	this	this	DET
ajlm-1317	37	5	study	study	NOUN
ajlm-1317	37	6	was	be	AUX
ajlm-1317	37	7	initially	initially	ADV
ajlm-1317	37	8	approved	approve	VERB
ajlm-1317	37	9	by	by	ADP
ajlm-1317	37	10	the	the	DET
ajlm-1317	37	11	scientific	scientific	ADJ
ajlm-1317	37	12	ethical	ethical	ADJ
ajlm-1317	37	13	review	review	NOUN
ajlm-1317	37	14	unit	unit	NOUN
ajlm-1317	37	15	at	at	ADP
ajlm-1317	37	16	kemri	kemri	PROPN
ajlm-1317	37	17	under	under	ADP
ajlm-1317	37	18	protocol	protocol	PROPN
ajlm-1317	37	19	kemri	kemri	PROPN
ajlm-1317	37	20	/	/	SYM
ajlm-1317	37	21	seru	seru	PROPN
ajlm-1317	37	22	/	/	PROPN
ajlm-1317	37	23	cbrd/209/4008	cbrd/209/4008	NOUN
ajlm-1317	37	24	.	.	PUNCT
ajlm-1317	38	1	it	it	PRON
ajlm-1317	38	2	was	be	AUX
ajlm-1317	38	3	also	also	ADV
ajlm-1317	38	4	reviewed	review	VERB
ajlm-1317	38	5	and	and	CCONJ
ajlm-1317	38	6	approved	approve	VERB
ajlm-1317	38	7	by	by	ADP
ajlm-1317	38	8	the	the	DET
ajlm-1317	38	9	kenyatta	kenyatta	PROPN
ajlm-1317	38	10	national	national	PROPN
ajlm-1317	38	11	hospital	hospital	PROPN
ajlm-1317	38	12	ethical	ethical	PROPN
ajlm-1317	38	13	review	review	PROPN
ajlm-1317	38	14	committee	committee	NOUN
ajlm-1317	38	15	under	under	ADP
ajlm-1317	38	16	protocol	protocol	NOUN
ajlm-1317	38	17	number	number	NOUN
ajlm-1317	38	18	p274/05/2020	p274/05/2020	PROPN
ajlm-1317	38	19	.	.	PUNCT
ajlm-1317	39	1	covid-19	covid-19	PROPN
ajlm-1317	39	2	patients	patient	NOUN
ajlm-1317	39	3	or	or	CCONJ
ajlm-1317	39	4	subjects	subject	NOUN
ajlm-1317	39	5	had	have	VERB
ajlm-1317	39	6	to	to	PART
ajlm-1317	39	7	provide	provide	VERB
ajlm-1317	39	8	written	write	VERB
ajlm-1317	39	9	informed	inform	VERB
ajlm-1317	39	10	consent	consent	NOUN
ajlm-1317	39	11	before	before	ADP
ajlm-1317	39	12	blood	blood	NOUN
ajlm-1317	39	13	sample	sample	NOUN
ajlm-1317	39	14	collection	collection	NOUN
ajlm-1317	39	15	.	.	PUNCT
ajlm-1317	40	1	all	all	DET
ajlm-1317	40	2	samples	sample	NOUN
ajlm-1317	40	3	were	be	AUX
ajlm-1317	40	4	anonymised	anonymise	VERB
ajlm-1317	40	5	.	.	PUNCT
ajlm-1317	41	1	sample	sample	NOUN
ajlm-1317	41	2	collection	collection	NOUN
ajlm-1317	41	3	a	a	DET
ajlm-1317	41	4	total	total	NOUN
ajlm-1317	41	5	of	of	ADP
ajlm-1317	41	6	50	50	NUM
ajlm-1317	41	7	anonymised	anonymise	VERB
ajlm-1317	41	8	blood	blood	NOUN
ajlm-1317	41	9	samples	sample	NOUN
ajlm-1317	41	10	were	be	AUX
ajlm-1317	41	11	collected	collect	VERB
ajlm-1317	41	12	through	through	ADP
ajlm-1317	41	13	purposive	purposive	ADJ
ajlm-1317	41	14	sampling	sampling	NOUN
ajlm-1317	41	15	from	from	ADP
ajlm-1317	41	16	patients	patient	NOUN
ajlm-1317	41	17	(	(	PUNCT
ajlm-1317	41	18	male	male	ADJ
ajlm-1317	41	19	and	and	CCONJ
ajlm-1317	41	20	female	female	NOUN
ajlm-1317	41	21	)	)	PUNCT
ajlm-1317	41	22	of	of	ADP
ajlm-1317	41	23	all	all	DET
ajlm-1317	41	24	ages	age	NOUN
ajlm-1317	41	25	with	with	ADP
ajlm-1317	41	26	active	active	ADJ
ajlm-1317	41	27	infection	infection	NOUN
ajlm-1317	41	28	as	as	SCONJ
ajlm-1317	41	29	determined	determine	VERB
ajlm-1317	41	30	by	by	ADP
ajlm-1317	41	31	covid-19	covid-19	PROPN
ajlm-1317	41	32	rrt	rrt	NOUN
ajlm-1317	41	33	-	-	PUNCT
ajlm-1317	41	34	pcr	pcr	NOUN
ajlm-1317	41	35	.	.	PUNCT
ajlm-1317	42	1	the	the	DET
ajlm-1317	42	2	study	study	NOUN
ajlm-1317	42	3	subjects	subject	NOUN
ajlm-1317	42	4	were	be	AUX
ajlm-1317	42	5	from	from	ADP
ajlm-1317	42	6	the	the	DET
ajlm-1317	42	7	isolation	isolation	NOUN
ajlm-1317	42	8	and	and	CCONJ
ajlm-1317	42	9	quarantine	quarantine	NOUN
ajlm-1317	42	10	centre	centre	NOUN
ajlm-1317	42	11	at	at	ADP
ajlm-1317	42	12	the	the	DET
ajlm-1317	42	13	kenyatta	kenyatta	PROPN
ajlm-1317	42	14	national	national	PROPN
ajlm-1317	42	15	hospital	hospital	PROPN
ajlm-1317	42	16	infectious	infectious	ADJ
ajlm-1317	42	17	diseases	disease	NOUN
ajlm-1317	42	18	unit	unit	NOUN
ajlm-1317	42	19	.	.	PUNCT
ajlm-1317	43	1	after	after	ADP
ajlm-1317	43	2	consenting	consent	VERB
ajlm-1317	43	3	,	,	PUNCT
ajlm-1317	43	4	5	5	NUM
ajlm-1317	43	5	ml	ml	NOUN
ajlm-1317	43	6	blood	blood	NOUN
ajlm-1317	43	7	samples	sample	NOUN
ajlm-1317	43	8	were	be	AUX
ajlm-1317	43	9	drawn	draw	VERB
ajlm-1317	43	10	from	from	ADP
ajlm-1317	43	11	the	the	DET
ajlm-1317	43	12	subjects	subject	NOUN
ajlm-1317	43	13	and	and	CCONJ
ajlm-1317	43	14	transported	transport	VERB
ajlm-1317	43	15	to	to	ADP
ajlm-1317	43	16	the	the	DET
ajlm-1317	43	17	kemri	kemri	PROPN
ajlm-1317	43	18	innovation	innovation	NOUN
ajlm-1317	43	19	and	and	CCONJ
ajlm-1317	43	20	technology	technology	NOUN
ajlm-1317	43	21	division	division	NOUN
ajlm-1317	43	22	.	.	PUNCT
ajlm-1317	44	1	the	the	DET
ajlm-1317	44	2	serum	serum	NOUN
ajlm-1317	44	3	was	be	AUX
ajlm-1317	44	4	separated	separate	VERB
ajlm-1317	44	5	and	and	CCONJ
ajlm-1317	44	6	stored	store	VERB
ajlm-1317	44	7	at	at	ADP
ajlm-1317	44	8	–	–	PUNCT
ajlm-1317	44	9	20	20	NUM
ajlm-1317	44	10	°	°	NUM
ajlm-1317	44	11	c	c	NOUN
ajlm-1317	44	12	until	until	ADP
ajlm-1317	44	13	the	the	DET
ajlm-1317	44	14	day	day	NOUN
ajlm-1317	44	15	of	of	ADP
ajlm-1317	44	16	the	the	DET
ajlm-1317	44	17	pre	pre	ADJ
ajlm-1317	44	18	-	-	NOUN
ajlm-1317	44	19	evaluation	evaluation	ADJ
ajlm-1317	44	20	assessment	assessment	NOUN
ajlm-1317	44	21	.	.	PUNCT
ajlm-1317	45	1	eighteen	eighteen	NUM
ajlm-1317	45	2	covid-19	covid-19	PROPN
ajlm-1317	45	3	pocts	poct	NOUN
ajlm-1317	45	4	were	be	AUX
ajlm-1317	45	5	received	receive	VERB
ajlm-1317	45	6	from	from	ADP
ajlm-1317	45	7	the	the	DET
ajlm-1317	45	8	ppb	ppb	NOUN
ajlm-1317	45	9	,	,	PUNCT
ajlm-1317	45	10	the	the	DET
ajlm-1317	45	11	kenyan	kenyan	ADJ
ajlm-1317	45	12	drug	drug	NOUN
ajlm-1317	45	13	regulatory	regulatory	ADJ
ajlm-1317	45	14	authority	authority	NOUN
ajlm-1317	45	15	,	,	PUNCT
ajlm-1317	45	16	who	who	PRON
ajlm-1317	45	17	had	have	AUX
ajlm-1317	45	18	received	receive	VERB
ajlm-1317	45	19	the	the	DET
ajlm-1317	45	20	tests	test	NOUN
ajlm-1317	45	21	from	from	ADP
ajlm-1317	45	22	various	various	ADJ
ajlm-1317	45	23	clients	client	NOUN
ajlm-1317	45	24	for	for	ADP
ajlm-1317	45	25	pre	pre	ADJ
ajlm-1317	45	26	-	-	ADJ
ajlm-1317	45	27	evaluation	evaluation	ADJ
ajlm-1317	45	28	assessment	assessment	NOUN
ajlm-1317	45	29	and	and	CCONJ
ajlm-1317	45	30	subsequent	subsequent	ADJ
ajlm-1317	45	31	registration	registration	NOUN
ajlm-1317	45	32	for	for	ADP
ajlm-1317	45	33	eua	eua	PROPN
ajlm-1317	45	34	.	.	PUNCT
ajlm-1317	46	1	the	the	DET
ajlm-1317	46	2	kits	kit	NOUN
ajlm-1317	46	3	included	include	VERB
ajlm-1317	46	4	in	in	ADP
ajlm-1317	46	5	the	the	DET
ajlm-1317	46	6	study	study	NOUN
ajlm-1317	46	7	were	be	AUX
ajlm-1317	46	8	rapid	rapid	ADJ
ajlm-1317	46	9	-	-	PUNCT
ajlm-1317	46	10	format	format	NOUN
ajlm-1317	46	11	antibody	antibody	NOUN
ajlm-1317	46	12	-	-	PUNCT
ajlm-1317	46	13	based	base	VERB
ajlm-1317	46	14	pocts	poct	NOUN
ajlm-1317	46	15	that	that	PRON
ajlm-1317	46	16	were	be	AUX
ajlm-1317	46	17	meant	mean	VERB
ajlm-1317	46	18	to	to	PART
ajlm-1317	46	19	detect	detect	VERB
ajlm-1317	46	20	igm	igm	PROPN
ajlm-1317	46	21	or	or	CCONJ
ajlm-1317	46	22	igm	igm	PROPN
ajlm-1317	46	23	/	/	SYM
ajlm-1317	46	24	igg	igg	PROPN
ajlm-1317	46	25	antibodies	antibodie	VERB
ajlm-1317	46	26	to	to	ADP
ajlm-1317	46	27	sars	sar	NOUN
ajlm-1317	46	28	-	-	PUNCT
ajlm-1317	46	29	cov-2	cov-2	NOUN
ajlm-1317	46	30	nucleocapsid	nucleocapsid	NOUN
ajlm-1317	46	31	or	or	CCONJ
ajlm-1317	46	32	spike	spike	ADJ
ajlm-1317	46	33	1	1	NUM
ajlm-1317	46	34	or	or	CCONJ
ajlm-1317	46	35	2	2	NUM
ajlm-1317	46	36	proteins	protein	NOUN
ajlm-1317	46	37	.	.	PUNCT
ajlm-1317	47	1	pre	pre	ADJ
ajlm-1317	47	2	-	-	ADJ
ajlm-1317	47	3	covid	covid	ADJ
ajlm-1317	47	4	human	human	PROPN
ajlm-1317	47	5	de	de	PROPN
ajlm-1317	47	6	-	-	ADJ
ajlm-1317	47	7	identified	identify	VERB
ajlm-1317	47	8	archived	archive	VERB
ajlm-1317	47	9	blood	blood	NOUN
ajlm-1317	47	10	samples	sample	NOUN
ajlm-1317	47	11	were	be	AUX
ajlm-1317	47	12	collected	collect	VERB
ajlm-1317	47	13	from	from	ADP
ajlm-1317	47	14	national	national	ADJ
ajlm-1317	47	15	blood	blood	NOUN
ajlm-1317	47	16	transfusion	transfusion	NOUN
ajlm-1317	47	17	centres	centre	NOUN
ajlm-1317	47	18	and	and	CCONJ
ajlm-1317	47	19	were	be	AUX
ajlm-1317	47	20	randomly	randomly	ADV
ajlm-1317	47	21	selected	select	VERB
ajlm-1317	47	22	for	for	ADP
ajlm-1317	47	23	the	the	DET
ajlm-1317	47	24	pre	pre	NOUN
ajlm-1317	47	25	-	-	NOUN
ajlm-1317	47	26	evaluation	evaluation	NOUN
ajlm-1317	47	27	of	of	ADP
ajlm-1317	47	28	kits	kit	NOUN
ajlm-1317	47	29	.	.	PUNCT
ajlm-1317	48	1	they	they	PRON
ajlm-1317	48	2	were	be	AUX
ajlm-1317	48	3	stored	store	VERB
ajlm-1317	48	4	at	at	ADP
ajlm-1317	48	5	–	–	PUNCT
ajlm-1317	48	6	80	80	NUM
ajlm-1317	48	7	°	°	NUM
ajlm-1317	48	8	c	c	NOUN
ajlm-1317	48	9	at	at	ADP
ajlm-1317	48	10	the	the	DET
ajlm-1317	48	11	kemri	kemri	PROPN
ajlm-1317	48	12	innovation	innovation	NOUN
ajlm-1317	48	13	and	and	CCONJ
ajlm-1317	48	14	technology	technology	NOUN
ajlm-1317	48	15	division	division	NOUN
ajlm-1317	48	16	to	to	PART
ajlm-1317	48	17	serve	serve	VERB
ajlm-1317	48	18	as	as	ADP
ajlm-1317	48	19	covid	covid	ADJ
ajlm-1317	48	20	-	-	PUNCT
ajlm-1317	48	21	negative	negative	ADJ
ajlm-1317	48	22	samples	sample	NOUN
ajlm-1317	48	23	.	.	PUNCT
ajlm-1317	49	1	test	test	NOUN
ajlm-1317	49	2	evaluation	evaluation	NOUN
ajlm-1317	49	3	the	the	DET
ajlm-1317	49	4	tests	test	NOUN
ajlm-1317	49	5	were	be	AUX
ajlm-1317	49	6	run	run	VERB
ajlm-1317	49	7	according	accord	VERB
ajlm-1317	49	8	to	to	ADP
ajlm-1317	49	9	the	the	DET
ajlm-1317	49	10	manufacturers	manufacturer	NOUN
ajlm-1317	49	11	’	’	PART
ajlm-1317	49	12	instructions	instruction	NOUN
ajlm-1317	49	13	under	under	ADP
ajlm-1317	49	14	a	a	DET
ajlm-1317	49	15	biosafety	biosafety	NOUN
ajlm-1317	49	16	cabinet	cabinet	NOUN
ajlm-1317	49	17	.	.	PUNCT
ajlm-1317	50	1	briefly	briefly	ADV
ajlm-1317	50	2	,	,	PUNCT
ajlm-1317	50	3	for	for	ADP
ajlm-1317	50	4	lateral	lateral	ADJ
ajlm-1317	50	5	flow	flow	NOUN
ajlm-1317	50	6	assays	assay	NOUN
ajlm-1317	50	7	,	,	PUNCT
ajlm-1317	50	8	the	the	DET
ajlm-1317	50	9	procedure	procedure	NOUN
ajlm-1317	50	10	was	be	AUX
ajlm-1317	50	11	as	as	SCONJ
ajlm-1317	50	12	follows	follow	VERB
ajlm-1317	50	13	:	:	PUNCT
ajlm-1317	50	14	blood	blood	NOUN
ajlm-1317	50	15	samples	sample	NOUN
ajlm-1317	50	16	were	be	AUX
ajlm-1317	50	17	spun	spin	VERB
ajlm-1317	50	18	in	in	ADP
ajlm-1317	50	19	a	a	DET
ajlm-1317	50	20	centrifuge	centrifuge	NOUN
ajlm-1317	50	21	and	and	CCONJ
ajlm-1317	50	22	the	the	DET
ajlm-1317	50	23	serum	serum	NOUN
ajlm-1317	50	24	and	and	CCONJ
ajlm-1317	50	25	plasma	plasma	NOUN
ajlm-1317	50	26	were	be	AUX
ajlm-1317	50	27	separated	separate	VERB
ajlm-1317	50	28	.	.	PUNCT
ajlm-1317	51	1	the	the	DET
ajlm-1317	51	2	test	test	NOUN
ajlm-1317	51	3	cassette	cassette	NOUN
ajlm-1317	51	4	was	be	AUX
ajlm-1317	51	5	removed	remove	VERB
ajlm-1317	51	6	from	from	ADP
ajlm-1317	51	7	foil	foil	NOUN
ajlm-1317	51	8	and	and	CCONJ
ajlm-1317	51	9	allowed	allow	VERB
ajlm-1317	51	10	to	to	PART
ajlm-1317	51	11	equilibrate	equilibrate	VERB
ajlm-1317	51	12	to	to	ADP
ajlm-1317	51	13	room	room	NOUN
ajlm-1317	51	14	temperature	temperature	NOUN
ajlm-1317	51	15	.	.	PUNCT
ajlm-1317	52	1	one	one	NUM
ajlm-1317	52	2	drop	drop	NOUN
ajlm-1317	52	3	(	(	PUNCT
ajlm-1317	52	4	about	about	ADV
ajlm-1317	52	5	10	10	NUM
ajlm-1317	52	6	μl	μl	NUM
ajlm-1317	52	7	)	)	PUNCT
ajlm-1317	52	8	of	of	ADP
ajlm-1317	52	9	plasma	plasma	NOUN
ajlm-1317	52	10	sample	sample	NOUN
ajlm-1317	52	11	was	be	AUX
ajlm-1317	52	12	loaded	load	VERB
ajlm-1317	52	13	using	use	VERB
ajlm-1317	52	14	a	a	DET
ajlm-1317	52	15	micropipette	micropipette	NOUN
ajlm-1317	52	16	into	into	ADP
ajlm-1317	52	17	the	the	DET
ajlm-1317	52	18	sample	sample	NOUN
ajlm-1317	52	19	well	well	ADV
ajlm-1317	52	20	in	in	ADP
ajlm-1317	52	21	the	the	DET
ajlm-1317	52	22	cassette	cassette	NOUN
ajlm-1317	52	23	.	.	PUNCT
ajlm-1317	53	1	thereafter	thereafter	ADV
ajlm-1317	53	2	,	,	PUNCT
ajlm-1317	53	3	about	about	ADV
ajlm-1317	53	4	60	60	NUM
ajlm-1317	53	5	μl	μl	INTJ
ajlm-1317	53	6	(	(	PUNCT
ajlm-1317	53	7	2–3	2–3	NUM
ajlm-1317	53	8	drops	drop	NOUN
ajlm-1317	53	9	)	)	PUNCT
ajlm-1317	53	10	of	of	ADP
ajlm-1317	53	11	the	the	DET
ajlm-1317	53	12	assay	assay	NOUN
ajlm-1317	53	13	solution	solution	NOUN
ajlm-1317	53	14	(	(	PUNCT
ajlm-1317	53	15	chase	chase	NOUN
ajlm-1317	53	16	buffer	buffer	NOUN
ajlm-1317	53	17	)	)	PUNCT
ajlm-1317	53	18	was	be	AUX
ajlm-1317	53	19	pipetted	pipette	VERB
ajlm-1317	53	20	into	into	ADP
ajlm-1317	53	21	the	the	DET
ajlm-1317	53	22	sample	sample	NOUN
ajlm-1317	53	23	well	well	ADV
ajlm-1317	53	24	in	in	ADP
ajlm-1317	53	25	the	the	DET
ajlm-1317	53	26	device	device	NOUN
ajlm-1317	53	27	.	.	PUNCT
ajlm-1317	54	1	after	after	ADP
ajlm-1317	54	2	about	about	ADV
ajlm-1317	54	3	10	10	NUM
ajlm-1317	54	4	min	min	NOUN
ajlm-1317	54	5	,	,	PUNCT
ajlm-1317	54	6	the	the	DET
ajlm-1317	54	7	results	result	NOUN
ajlm-1317	54	8	were	be	AUX
ajlm-1317	54	9	interpreted	interpret	VERB
ajlm-1317	54	10	.	.	PUNCT
ajlm-1317	55	1	only	only	ADV
ajlm-1317	55	2	tests	test	NOUN
ajlm-1317	55	3	in	in	ADP
ajlm-1317	55	4	which	which	PRON
ajlm-1317	55	5	the	the	DET
ajlm-1317	55	6	colour	colour	NOUN
ajlm-1317	55	7	of	of	ADP
ajlm-1317	55	8	the	the	DET
ajlm-1317	55	9	control	control	NOUN
ajlm-1317	55	10	line	line	NOUN
ajlm-1317	55	11	changed	change	VERB
ajlm-1317	55	12	were	be	AUX
ajlm-1317	55	13	considered	consider	VERB
ajlm-1317	55	14	valid	valid	ADJ
ajlm-1317	55	15	,	,	PUNCT
ajlm-1317	55	16	and	and	CCONJ
ajlm-1317	55	17	if	if	SCONJ
ajlm-1317	55	18	a	a	DET
ajlm-1317	55	19	coloured	coloured	ADJ
ajlm-1317	55	20	line	line	NOUN
ajlm-1317	55	21	was	be	AUX
ajlm-1317	55	22	observed	observe	VERB
ajlm-1317	55	23	for	for	ADP
ajlm-1317	55	24	igm	igm	NOUN
ajlm-1317	55	25	or	or	CCONJ
ajlm-1317	55	26	igg	igg	PROPN
ajlm-1317	55	27	,	,	PUNCT
ajlm-1317	55	28	the	the	DET
ajlm-1317	55	29	test	test	NOUN
ajlm-1317	55	30	was	be	AUX
ajlm-1317	55	31	considered	consider	VERB
ajlm-1317	55	32	positive	positive	ADJ
ajlm-1317	55	33	.	.	PUNCT
ajlm-1317	56	1	the	the	DET
ajlm-1317	56	2	intensity	intensity	NOUN
ajlm-1317	56	3	of	of	ADP
ajlm-1317	56	4	the	the	DET
ajlm-1317	56	5	colour	colour	NOUN
ajlm-1317	56	6	was	be	AUX
ajlm-1317	56	7	compared	compare	VERB
ajlm-1317	56	8	with	with	ADP
ajlm-1317	56	9	that	that	PRON
ajlm-1317	56	10	of	of	ADP
ajlm-1317	56	11	the	the	DET
ajlm-1317	56	12	colour	colour	NOUN
ajlm-1317	56	13	reference	reference	NOUN
ajlm-1317	56	14	card	card	NOUN
ajlm-1317	56	15	and	and	CCONJ
ajlm-1317	56	16	semi	semi	ADJ
ajlm-1317	56	17	-	-	ADJ
ajlm-1317	56	18	quantified	quantified	ADJ
ajlm-1317	56	19	.	.	PUNCT
ajlm-1317	57	1	the	the	DET
ajlm-1317	57	2	immunofluorescent	immunofluorescent	NOUN
ajlm-1317	57	3	protocol	protocol	NOUN
ajlm-1317	57	4	was	be	AUX
ajlm-1317	57	5	as	as	SCONJ
ajlm-1317	57	6	follows	follow	VERB
ajlm-1317	57	7	:	:	PUNCT
ajlm-1317	57	8	150	150	NUM
ajlm-1317	57	9	μl	μl	NOUN
ajlm-1317	57	10	of	of	ADP
ajlm-1317	57	11	detector	detector	NOUN
ajlm-1317	57	12	diluent	diluent	NOUN
ajlm-1317	57	13	was	be	AUX
ajlm-1317	57	14	transferred	transfer	VERB
ajlm-1317	57	15	into	into	ADP
ajlm-1317	57	16	a	a	DET
ajlm-1317	57	17	vial	vial	ADJ
ajlm-1317	57	18	containing	contain	VERB
ajlm-1317	57	19	detector	detector	NOUN
ajlm-1317	57	20	crystal	crystal	NOUN
ajlm-1317	57	21	.	.	PUNCT
ajlm-1317	58	1	10	10	NUM
ajlm-1317	58	2	μl	μl	ADP
ajlm-1317	58	3	of	of	ADP
ajlm-1317	58	4	plasma	plasma	NOUN
ajlm-1317	58	5	sample	sample	NOUN
ajlm-1317	58	6	was	be	AUX
ajlm-1317	58	7	then	then	ADV
ajlm-1317	58	8	added	add	VERB
ajlm-1317	58	9	,	,	PUNCT
ajlm-1317	58	10	mixed	mixed	ADJ
ajlm-1317	58	11	,	,	PUNCT
ajlm-1317	58	12	and	and	CCONJ
ajlm-1317	58	13	,	,	PUNCT
ajlm-1317	58	14	using	use	VERB
ajlm-1317	58	15	a	a	DET
ajlm-1317	58	16	micropipette	micropipette	NOUN
ajlm-1317	58	17	,	,	PUNCT
ajlm-1317	58	18	75	75	NUM
ajlm-1317	58	19	μl	μl	NUM
ajlm-1317	58	20	of	of	ADP
ajlm-1317	58	21	the	the	DET
ajlm-1317	58	22	mixture	mixture	NOUN
ajlm-1317	58	23	was	be	AUX
ajlm-1317	58	24	pipetted	pipette	VERB
ajlm-1317	58	25	into	into	ADP
ajlm-1317	58	26	the	the	DET
ajlm-1317	58	27	sample	sample	NOUN
ajlm-1317	58	28	well	well	ADV
ajlm-1317	58	29	in	in	ADP
ajlm-1317	58	30	the	the	DET
ajlm-1317	58	31	cartridge	cartridge	NOUN
ajlm-1317	58	32	.	.	PUNCT
ajlm-1317	59	1	after	after	ADP
ajlm-1317	59	2	10	10	NUM
ajlm-1317	59	3	min	min	NOUN
ajlm-1317	59	4	,	,	PUNCT
ajlm-1317	59	5	the	the	DET
ajlm-1317	59	6	cartridge	cartridge	NOUN
ajlm-1317	59	7	was	be	AUX
ajlm-1317	59	8	placed	place	VERB
ajlm-1317	59	9	into	into	ADP
ajlm-1317	59	10	the	the	DET
ajlm-1317	59	11	immunofluorescent	immunofluorescent	NOUN
ajlm-1317	59	12	reader	reader	NOUN
ajlm-1317	59	13	and	and	CCONJ
ajlm-1317	59	14	the	the	DET
ajlm-1317	59	15	results	result	NOUN
ajlm-1317	59	16	were	be	AUX
ajlm-1317	59	17	read	read	VERB
ajlm-1317	59	18	and	and	CCONJ
ajlm-1317	59	19	interpreted	interpret	VERB
ajlm-1317	59	20	.	.	PUNCT
ajlm-1317	60	1	determination	determination	NOUN
ajlm-1317	60	2	of	of	ADP
ajlm-1317	60	3	sensitivity	sensitivity	NOUN
ajlm-1317	60	4	and	and	CCONJ
ajlm-1317	60	5	specificity	specificity	NOUN
ajlm-1317	60	6	of	of	ADP
ajlm-1317	60	7	the	the	DET
ajlm-1317	60	8	assays	assay	NOUN
ajlm-1317	60	9	data	datum	NOUN
ajlm-1317	60	10	generated	generate	VERB
ajlm-1317	60	11	were	be	AUX
ajlm-1317	60	12	recorded	record	VERB
ajlm-1317	60	13	and	and	CCONJ
ajlm-1317	60	14	analysed	analyse	VERB
ajlm-1317	60	15	using	use	VERB
ajlm-1317	60	16	microsoft	microsoft	PROPN
ajlm-1317	60	17	excel	excel	PROPN
ajlm-1317	60	18	2010	2010	NUM
ajlm-1317	60	19	(	(	PUNCT
ajlm-1317	60	20	microsoft	microsoft	PROPN
ajlm-1317	60	21	corporation	corporation	PROPN
ajlm-1317	60	22	,	,	PUNCT
ajlm-1317	60	23	redmond	redmond	PROPN
ajlm-1317	60	24	,	,	PUNCT
ajlm-1317	60	25	washington	washington	PROPN
ajlm-1317	60	26	,	,	PUNCT
ajlm-1317	60	27	united	united	PROPN
ajlm-1317	60	28	states	states	PROPN
ajlm-1317	60	29	)	)	PUNCT
ajlm-1317	60	30	and	and	CCONJ
ajlm-1317	60	31	stata	stata	VERB
ajlm-1317	60	32	version	version	NOUN
ajlm-1317	60	33	14.1	14.1	NUM
ajlm-1317	60	34	(	(	PUNCT
ajlm-1317	60	35	statacorp	statacorp	PROPN
ajlm-1317	60	36	llc	llc	PROPN
ajlm-1317	60	37	,	,	PUNCT
ajlm-1317	60	38	brownsville	brownsville	PROPN
ajlm-1317	60	39	,	,	PUNCT
ajlm-1317	60	40	texas	texas	PROPN
ajlm-1317	60	41	,	,	PUNCT
ajlm-1317	60	42	unites	unite	VERB
ajlm-1317	60	43	states	state	NOUN
ajlm-1317	60	44	)	)	PUNCT
ajlm-1317	60	45	.	.	PUNCT
ajlm-1317	61	1	the	the	DET
ajlm-1317	61	2	specificity	specificity	NOUN
ajlm-1317	61	3	of	of	ADP
ajlm-1317	61	4	the	the	DET
ajlm-1317	61	5	assays	assay	NOUN
ajlm-1317	61	6	was	be	AUX
ajlm-1317	61	7	determined	determine	VERB
ajlm-1317	61	8	using	use	VERB
ajlm-1317	61	9	a	a	DET
ajlm-1317	61	10	panel	panel	NOUN
ajlm-1317	61	11	of	of	ADP
ajlm-1317	61	12	50	50	NUM
ajlm-1317	61	13	pre	pre	ADJ
ajlm-1317	61	14	-	-	ADJ
ajlm-1317	61	15	covid-19	covid-19	ADJ
ajlm-1317	61	16	pandemic	pandemic	ADJ
ajlm-1317	61	17	serum	serum	NOUN
ajlm-1317	61	18	samples	sample	NOUN
ajlm-1317	61	19	from	from	ADP
ajlm-1317	61	20	june	june	PROPN
ajlm-1317	61	21	2019	2019	NUM
ajlm-1317	61	22	.	.	PUNCT
ajlm-1317	62	1	sensitivity	sensitivity	NOUN
ajlm-1317	62	2	was	be	AUX
ajlm-1317	62	3	determined	determine	VERB
ajlm-1317	62	4	for	for	ADP
ajlm-1317	62	5	each	each	DET
ajlm-1317	62	6	assay	assay	NOUN
ajlm-1317	62	7	using	use	VERB
ajlm-1317	62	8	50	50	NUM
ajlm-1317	62	9	rrt	rrt	ADJ
ajlm-1317	62	10	-	-	PUNCT
ajlm-1317	62	11	pcr	pcr	ADJ
ajlm-1317	62	12	sars	sar	NOUN
ajlm-1317	62	13	-	-	PUNCT
ajlm-1317	62	14	cov-2	cov-2	NOUN
ajlm-1317	62	15	-	-	ADJ
ajlm-1317	62	16	positive	positive	ADJ
ajlm-1317	62	17	samples	sample	NOUN
ajlm-1317	62	18	.	.	PUNCT
ajlm-1317	63	1	the	the	DET
ajlm-1317	63	2	rna	rna	NOUN
ajlm-1317	63	3	for	for	ADP
ajlm-1317	63	4	confirmatory	confirmatory	NOUN
ajlm-1317	63	5	tests	test	NOUN
ajlm-1317	63	6	were	be	AUX
ajlm-1317	63	7	extracted	extract	VERB
ajlm-1317	63	8	using	use	VERB
ajlm-1317	63	9	a	a	DET
ajlm-1317	63	10	qiaamp	qiaamp	ADJ
ajlm-1317	63	11	viral	viral	ADJ
ajlm-1317	63	12	rna	rna	NOUN
ajlm-1317	63	13	mini	mini	NOUN
ajlm-1317	63	14	kit	kit	NOUN
ajlm-1317	63	15	(	(	PUNCT
ajlm-1317	63	16	qiagen	qiagen	PROPN
ajlm-1317	63	17	,	,	PUNCT
ajlm-1317	63	18	germantown	germantown	PROPN
ajlm-1317	63	19	,	,	PUNCT
ajlm-1317	63	20	maryland	maryland	PROPN
ajlm-1317	63	21	,	,	PUNCT
ajlm-1317	63	22	united	united	PROPN
ajlm-1317	63	23	states	states	PROPN
ajlm-1317	63	24	)	)	PUNCT
ajlm-1317	63	25	.	.	PUNCT
ajlm-1317	64	1	the	the	DET
ajlm-1317	64	2	pcr	pcr	NOUN
ajlm-1317	64	3	was	be	AUX
ajlm-1317	64	4	done	do	VERB
ajlm-1317	64	5	on	on	ADP
ajlm-1317	64	6	an	an	DET
ajlm-1317	64	7	applied	apply	VERB
ajlm-1317	64	8	biosystems	biosystem	NOUN
ajlm-1317	64	9	quantstudio	quantstudio	PROPN
ajlm-1317	64	10	™	™	ADJ
ajlm-1317	64	11	5	5	NUM
ajlm-1317	64	12	(	(	PUNCT
ajlm-1317	64	13	thermofisher	thermofisher	PRON
ajlm-1317	64	14	scientific	scientific	PROPN
ajlm-1317	64	15	,	,	PUNCT
ajlm-1317	64	16	waltham	waltham	PROPN
ajlm-1317	64	17	,	,	PUNCT
ajlm-1317	64	18	massachusetts	massachusetts	PROPN
ajlm-1317	64	19	,	,	PUNCT
ajlm-1317	64	20	united	united	PROPN
ajlm-1317	64	21	states	states	PROPN
ajlm-1317	64	22	)	)	PUNCT
ajlm-1317	64	23	pcr	pcr	ADJ
ajlm-1317	64	24	machine	machine	NOUN
ajlm-1317	64	25	using	use	VERB
ajlm-1317	64	26	a	a	DET
ajlm-1317	64	27	sacace	sacace	NOUN
ajlm-1317	64	28	biotechnologies	biotechnology	NOUN
ajlm-1317	64	29	sars	sar	NOUN
ajlm-1317	64	30	-	-	PUNCT
ajlm-1317	64	31	cov-2	cov-2	NOUN
ajlm-1317	64	32	real	real	ADJ
ajlm-1317	64	33	-	-	PUNCT
ajlm-1317	64	34	tm	tm	NOUN
ajlm-1317	64	35	detection	detection	NOUN
ajlm-1317	64	36	kit	kit	NOUN
ajlm-1317	64	37	(	(	PUNCT
ajlm-1317	64	38	scalabrini	scalabrini	PROPN
ajlm-1317	64	39	,	,	PUNCT
ajlm-1317	64	40	como	como	PROPN
ajlm-1317	64	41	,	,	PUNCT
ajlm-1317	64	42	italy	italy	PROPN
ajlm-1317	64	43	)	)	PUNCT
ajlm-1317	64	44	with	with	ADP
ajlm-1317	64	45	their	their	PRON
ajlm-1317	64	46	recommended	recommend	VERB
ajlm-1317	64	47	cycling	cycling	NOUN
ajlm-1317	64	48	conditions	condition	NOUN
ajlm-1317	64	49	set	set	VERB
ajlm-1317	64	50	at	at	ADP
ajlm-1317	64	51	35	35	NUM
ajlm-1317	64	52	°	°	ADP
ajlm-1317	64	53	c	c	NOUN
ajlm-1317	64	54	for	for	ADP
ajlm-1317	64	55	20	20	NUM
ajlm-1317	64	56	min	min	NOUN
ajlm-1317	64	57	for	for	ADP
ajlm-1317	64	58	reverse	reverse	ADJ
ajlm-1317	64	59	transcription	transcription	NOUN
ajlm-1317	64	60	,	,	PUNCT
ajlm-1317	64	61	initial	initial	ADJ
ajlm-1317	64	62	pcr	pcr	ADJ
ajlm-1317	64	63	activation	activation	NOUN
ajlm-1317	64	64	at	at	ADP
ajlm-1317	64	65	94	94	NUM
ajlm-1317	64	66	°	°	ADP
ajlm-1317	64	67	c	c	NOUN
ajlm-1317	64	68	for	for	ADP
ajlm-1317	64	69	10	10	NUM
ajlm-1317	64	70	s	s	NOUN
ajlm-1317	64	71	,	,	PUNCT
ajlm-1317	64	72	and	and	CCONJ
ajlm-1317	64	73	five	five	NUM
ajlm-1317	64	74	cycles	cycle	NOUN
ajlm-1317	64	75	at	at	ADP
ajlm-1317	64	76	64	64	NUM
ajlm-1317	64	77	°	°	NOUN
ajlm-1317	64	78	c	c	NOUN
ajlm-1317	64	79	for	for	ADP
ajlm-1317	64	80	25	25	NUM
ajlm-1317	64	81	s.	s.	NOUN
ajlm-1317	64	82	the	the	DET
ajlm-1317	64	83	cycling	cycling	NOUN
ajlm-1317	64	84	step	step	NOUN
ajlm-1317	64	85	was	be	AUX
ajlm-1317	64	86	done	do	VERB
ajlm-1317	64	87	at	at	ADP
ajlm-1317	64	88	94	94	NUM
ajlm-1317	64	89	°	°	ADP
ajlm-1317	64	90	c	c	NOUN
ajlm-1317	64	91	for	for	ADP
ajlm-1317	64	92	10	10	NUM
ajlm-1317	64	93	s	s	VERB
ajlm-1317	64	94	followed	follow	VERB
ajlm-1317	64	95	by	by	ADP
ajlm-1317	64	96	64	64	NUM
ajlm-1317	64	97	°	°	NOUN
ajlm-1317	64	98	c	c	NOUN
ajlm-1317	64	99	for	for	ADP
ajlm-1317	64	100	25	25	NUM
ajlm-1317	64	101	s	s	NOUN
ajlm-1317	64	102	for	for	ADP
ajlm-1317	64	103	45	45	NUM
ajlm-1317	64	104	cycles	cycle	NOUN
ajlm-1317	64	105	.	.	PUNCT
ajlm-1317	65	1	analysis	analysis	NOUN
ajlm-1317	65	2	of	of	ADP
ajlm-1317	65	3	the	the	DET
ajlm-1317	65	4	results	result	NOUN
ajlm-1317	65	5	was	be	AUX
ajlm-1317	65	6	done	do	VERB
ajlm-1317	65	7	using	use	VERB
ajlm-1317	65	8	quantstudio	quantstudio	ADJ
ajlm-1317	65	9	design	design	NOUN
ajlm-1317	65	10	and	and	CCONJ
ajlm-1317	65	11	analysis	analysis	NOUN
ajlm-1317	65	12	software	software	NOUN
ajlm-1317	65	13	(	(	PUNCT
ajlm-1317	65	14	thermofisher	thermofisher	PROPN
ajlm-1317	65	15	scientific	scientific	PROPN
ajlm-1317	65	16	,	,	PUNCT
ajlm-1317	65	17	waltham	waltham	PROPN
ajlm-1317	65	18	,	,	PUNCT
ajlm-1317	65	19	massachusetts	massachusetts	PROPN
ajlm-1317	65	20	,	,	PUNCT
ajlm-1317	65	21	united	united	PROPN
ajlm-1317	65	22	states	states	PROPN
ajlm-1317	65	23	)	)	PUNCT
ajlm-1317	65	24	and	and	CCONJ
ajlm-1317	65	25	interpreted	interpret	VERB
ajlm-1317	65	26	using	use	VERB
ajlm-1317	65	27	the	the	DET
ajlm-1317	65	28	sacace	sacace	NOUN
ajlm-1317	65	29	sars	sar	NOUN
ajlm-1317	65	30	-	-	PUNCT
ajlm-1317	65	31	cov-2	cov-2	NOUN
ajlm-1317	65	32	real	real	ADJ
ajlm-1317	65	33	-	-	PUNCT
ajlm-1317	65	34	tm	tm	NOUN
ajlm-1317	65	35	result	result	NOUN
ajlm-1317	65	36	analysis	analysis	NOUN
ajlm-1317	65	37	guide	guide	NOUN
ajlm-1317	65	38	.	.	PUNCT
ajlm-1317	66	1	the	the	DET
ajlm-1317	66	2	antibody	antibody	NOUN
ajlm-1317	66	3	tests	test	NOUN
ajlm-1317	66	4	were	be	AUX
ajlm-1317	66	5	considered	consider	VERB
ajlm-1317	66	6	positive	positive	ADJ
ajlm-1317	66	7	when	when	SCONJ
ajlm-1317	66	8	the	the	DET
ajlm-1317	66	9	control	control	NOUN
ajlm-1317	66	10	band	band	NOUN
ajlm-1317	66	11	and	and	CCONJ
ajlm-1317	66	12	igm	igm	PROPN
ajlm-1317	66	13	,	,	PUNCT
ajlm-1317	66	14	igg	igg	PROPN
ajlm-1317	66	15	or	or	CCONJ
ajlm-1317	66	16	both	both	DET
ajlm-1317	66	17	bands	band	NOUN
ajlm-1317	66	18	were	be	AUX
ajlm-1317	66	19	visible	visible	ADJ
ajlm-1317	66	20	.	.	PUNCT
ajlm-1317	67	1	diagnostic	diagnostic	ADJ
ajlm-1317	67	2	sensitivity	sensitivity	NOUN
ajlm-1317	67	3	(	(	PUNCT
ajlm-1317	67	4	%	%	INTJ
ajlm-1317	67	5	)	)	PUNCT
ajlm-1317	67	6	was	be	AUX
ajlm-1317	67	7	calculated	calculate	VERB
ajlm-1317	67	8	as	as	ADP
ajlm-1317	67	9	a/(a	a/(a	ADJ
ajlm-1317	67	10	+	+	CCONJ
ajlm-1317	67	11	c	c	NOUN
ajlm-1317	67	12	)	)	PUNCT
ajlm-1317	67	13	×	×	NOUN
ajlm-1317	67	14	100	100	NUM
ajlm-1317	67	15	while	while	SCONJ
ajlm-1317	67	16	diagnostic	diagnostic	ADJ
ajlm-1317	67	17	specificity	specificity	NOUN
ajlm-1317	67	18	(	(	PUNCT
ajlm-1317	67	19	%	%	INTJ
ajlm-1317	67	20	)	)	PUNCT
ajlm-1317	67	21	was	be	AUX
ajlm-1317	67	22	calculated	calculate	VERB
ajlm-1317	67	23	as	as	ADP
ajlm-1317	67	24	d/(b	d/(b	NOUN
ajlm-1317	67	25	+	+	CCONJ
ajlm-1317	67	26	d	d	NOUN
ajlm-1317	67	27	)	)	PUNCT
ajlm-1317	67	28	×	×	NOUN
ajlm-1317	67	29	100	100	NUM
ajlm-1317	67	30	,	,	PUNCT
ajlm-1317	67	31	where	where	SCONJ
ajlm-1317	67	32	a	a	PRON
ajlm-1317	67	33	represents	represent	VERB
ajlm-1317	67	34	true	true	ADJ
ajlm-1317	67	35	positive	positive	ADJ
ajlm-1317	67	36	results	result	NOUN
ajlm-1317	67	37	,	,	PUNCT
ajlm-1317	67	38	c	c	PROPN
ajlm-1317	67	39	represents	represent	VERB
ajlm-1317	67	40	false	false	ADJ
ajlm-1317	67	41	negatives	negative	NOUN
ajlm-1317	67	42	,	,	PUNCT
ajlm-1317	67	43	b	b	PROPN
ajlm-1317	67	44	represents	represent	VERB
ajlm-1317	67	45	false	false	ADJ
ajlm-1317	67	46	positives	positive	NOUN
ajlm-1317	67	47	and	and	CCONJ
ajlm-1317	67	48	d	d	NOUN
ajlm-1317	67	49	represents	represent	VERB
ajlm-1317	67	50	true	true	ADJ
ajlm-1317	67	51	negatives	negative	NOUN
ajlm-1317	67	52	.	.	PUNCT
ajlm-1317	68	1	the	the	DET
ajlm-1317	68	2	pocts	poct	NOUN
ajlm-1317	68	3	were	be	AUX
ajlm-1317	68	4	considered	consider	VERB
ajlm-1317	68	5	to	to	PART
ajlm-1317	68	6	have	have	VERB
ajlm-1317	68	7	a	a	DET
ajlm-1317	68	8	high	high	ADJ
ajlm-1317	68	9	sensitivity	sensitivity	NOUN
ajlm-1317	68	10	when	when	SCONJ
ajlm-1317	68	11	able	able	ADJ
ajlm-1317	68	12	to	to	PART
ajlm-1317	68	13	correctly	correctly	ADV
ajlm-1317	68	14	identify	identify	VERB
ajlm-1317	68	15	all	all	DET
ajlm-1317	68	16	positive	positive	ADJ
ajlm-1317	68	17	samples	sample	NOUN
ajlm-1317	68	18	in	in	ADP
ajlm-1317	68	19	a	a	DET
ajlm-1317	68	20	panel	panel	NOUN
ajlm-1317	68	21	.	.	PUNCT
ajlm-1317	69	1	tests	test	VERB
ajlm-1317	69	2	that	that	PRON
ajlm-1317	69	3	only	only	ADV
ajlm-1317	69	4	detected	detect	VERB
ajlm-1317	69	5	40	40	NUM
ajlm-1317	69	6	%	%	NOUN
ajlm-1317	69	7	or	or	CCONJ
ajlm-1317	69	8	lower	low	ADJ
ajlm-1317	69	9	of	of	ADP
ajlm-1317	69	10	the	the	DET
ajlm-1317	69	11	positive	positive	ADJ
ajlm-1317	69	12	samples	sample	NOUN
ajlm-1317	69	13	in	in	ADP
ajlm-1317	69	14	the	the	DET
ajlm-1317	69	15	panel	panel	NOUN
ajlm-1317	69	16	were	be	AUX
ajlm-1317	69	17	deemed	deem	VERB
ajlm-1317	69	18	to	to	PART
ajlm-1317	69	19	have	have	VERB
ajlm-1317	69	20	lower	low	ADJ
ajlm-1317	69	21	sensitivity	sensitivity	NOUN
ajlm-1317	69	22	as	as	SCONJ
ajlm-1317	69	23	they	they	PRON
ajlm-1317	69	24	would	would	AUX
ajlm-1317	69	25	miss	miss	VERB
ajlm-1317	69	26	positives	positive	NOUN
ajlm-1317	69	27	and	and	CCONJ
ajlm-1317	69	28	give	give	VERB
ajlm-1317	69	29	higher	high	ADJ
ajlm-1317	69	30	false	false	ADJ
ajlm-1317	69	31	negative	negative	ADJ
ajlm-1317	69	32	rates	rate	NOUN
ajlm-1317	69	33	.	.	PUNCT
ajlm-1317	70	1	results	result	VERB
ajlm-1317	70	2	the	the	DET
ajlm-1317	70	3	study	study	NOUN
ajlm-1317	70	4	involved	involve	VERB
ajlm-1317	70	5	a	a	DET
ajlm-1317	70	6	total	total	NOUN
ajlm-1317	70	7	of	of	ADP
ajlm-1317	70	8	18	18	NUM
ajlm-1317	70	9	pocts	poct	NOUN
ajlm-1317	70	10	from	from	ADP
ajlm-1317	70	11	different	different	ADJ
ajlm-1317	70	12	manufacturers	manufacturer	NOUN
ajlm-1317	70	13	.	.	PUNCT
ajlm-1317	71	1	the	the	DET
ajlm-1317	71	2	number	number	NOUN
ajlm-1317	71	3	of	of	ADP
ajlm-1317	71	4	kits	kit	NOUN
ajlm-1317	71	5	submitted	submit	VERB
ajlm-1317	71	6	by	by	ADP
ajlm-1317	71	7	each	each	DET
ajlm-1317	71	8	manufacturer	manufacturer	NOUN
ajlm-1317	71	9	differed	differ	VERB
ajlm-1317	71	10	as	as	SCONJ
ajlm-1317	71	11	the	the	DET
ajlm-1317	71	12	national	national	ADJ
ajlm-1317	71	13	policy	policy	NOUN
ajlm-1317	71	14	on	on	ADP
ajlm-1317	71	15	the	the	DET
ajlm-1317	71	16	number	number	NOUN
ajlm-1317	71	17	of	of	ADP
ajlm-1317	71	18	kits	kit	NOUN
ajlm-1317	71	19	required	require	VERB
ajlm-1317	71	20	for	for	ADP
ajlm-1317	71	21	eua	eua	PROPN
ajlm-1317	71	22	pre	pre	PROPN
ajlm-1317	71	23	-	-	ADJ
ajlm-1317	71	24	evaluation	evaluation	ADJ
ajlm-1317	71	25	assessment	assessment	NOUN
ajlm-1317	71	26	had	have	AUX
ajlm-1317	71	27	not	not	PART
ajlm-1317	71	28	been	be	AUX
ajlm-1317	71	29	established	establish	VERB
ajlm-1317	71	30	at	at	ADP
ajlm-1317	71	31	the	the	DET
ajlm-1317	71	32	time	time	NOUN
ajlm-1317	71	33	.	.	PUNCT
ajlm-1317	72	1	the	the	DET
ajlm-1317	72	2	shelf	shelf	NOUN
ajlm-1317	72	3	lives	live	VERB
ajlm-1317	72	4	allocated	allocate	VERB
ajlm-1317	72	5	to	to	ADP
ajlm-1317	72	6	the	the	DET
ajlm-1317	72	7	kits	kit	NOUN
ajlm-1317	72	8	were	be	AUX
ajlm-1317	72	9	highly	highly	ADV
ajlm-1317	72	10	varied	varied	ADJ
ajlm-1317	72	11	:	:	PUNCT
ajlm-1317	72	12	6	6	NUM
ajlm-1317	72	13	months	month	NOUN
ajlm-1317	72	14	(	(	PUNCT
ajlm-1317	72	15	2/18	2/18	NUM
ajlm-1317	72	16	;	;	PUNCT
ajlm-1317	72	17	11.1	11.1	NUM
ajlm-1317	72	18	%	%	NOUN
ajlm-1317	72	19	)	)	PUNCT
ajlm-1317	72	20	,	,	PUNCT
ajlm-1317	72	21	12	12	NUM
ajlm-1317	72	22	months	month	NOUN
ajlm-1317	72	23	(	(	PUNCT
ajlm-1317	72	24	8/18	8/18	NUM
ajlm-1317	72	25	;	;	PUNCT
ajlm-1317	72	26	44.4	44.4	NUM
ajlm-1317	72	27	%	%	NOUN
ajlm-1317	72	28	)	)	PUNCT
ajlm-1317	72	29	,	,	PUNCT
ajlm-1317	72	30	18	18	NUM
ajlm-1317	72	31	months	month	NOUN
ajlm-1317	72	32	(	(	PUNCT
ajlm-1317	72	33	1/18	1/18	NUM
ajlm-1317	72	34	;	;	PUNCT
ajlm-1317	72	35	5.6	5.6	NUM
ajlm-1317	72	36	%	%	NOUN
ajlm-1317	72	37	)	)	PUNCT
ajlm-1317	72	38	,	,	PUNCT
ajlm-1317	72	39	and	and	CCONJ
ajlm-1317	72	40	24	24	NUM
ajlm-1317	72	41	months	month	NOUN
ajlm-1317	72	42	(	(	PUNCT
ajlm-1317	72	43	7/18	7/18	NUM
ajlm-1317	72	44	;	;	PUNCT
ajlm-1317	72	45	38.9	38.9	NUM
ajlm-1317	72	46	%	%	NOUN
ajlm-1317	72	47	)	)	PUNCT
ajlm-1317	72	48	(	(	PUNCT
ajlm-1317	72	49	table	table	NOUN
ajlm-1317	72	50	1	1	NUM
ajlm-1317	72	51	)	)	PUNCT
ajlm-1317	72	52	.	.	PUNCT
ajlm-1317	73	1	many	many	ADJ
ajlm-1317	73	2	(	(	PUNCT
ajlm-1317	73	3	7	7	NUM
ajlm-1317	73	4	;	;	PUNCT
ajlm-1317	73	5	38.9	38.9	NUM
ajlm-1317	73	6	%	%	NOUN
ajlm-1317	73	7	)	)	PUNCT
ajlm-1317	73	8	of	of	ADP
ajlm-1317	73	9	the	the	DET
ajlm-1317	73	10	kits	kit	NOUN
ajlm-1317	73	11	were	be	AUX
ajlm-1317	73	12	manufactured	manufacture	VERB
ajlm-1317	73	13	in	in	ADP
ajlm-1317	73	14	march	march	PROPN
ajlm-1317	73	15	2020	2020	NUM
ajlm-1317	73	16	(	(	PUNCT
ajlm-1317	73	17	and	and	CCONJ
ajlm-1317	73	18	the	the	DET
ajlm-1317	73	19	study	study	NOUN
ajlm-1317	73	20	commenced	commence	VERB
ajlm-1317	73	21	in	in	ADP
ajlm-1317	73	22	may	may	PROPN
ajlm-1317	73	23	2020	2020	NUM
ajlm-1317	73	24	)	)	PUNCT
ajlm-1317	73	25	.	.	PUNCT
ajlm-1317	74	1	thirteen	thirteen	NUM
ajlm-1317	74	2	(	(	PUNCT
ajlm-1317	74	3	72.2	72.2	NUM
ajlm-1317	74	4	%	%	NOUN
ajlm-1317	74	5	)	)	PUNCT
ajlm-1317	74	6	of	of	ADP
ajlm-1317	74	7	the	the	DET
ajlm-1317	74	8	kits	kit	NOUN
ajlm-1317	74	9	analysed	analyse	VERB
ajlm-1317	74	10	were	be	AUX
ajlm-1317	74	11	manufactured	manufacture	VERB
ajlm-1317	74	12	in	in	ADP
ajlm-1317	74	13	china	china	PROPN
ajlm-1317	74	14	,	,	PUNCT
ajlm-1317	74	15	2	2	NUM
ajlm-1317	74	16	(	(	PUNCT
ajlm-1317	74	17	11.1	11.1	NUM
ajlm-1317	74	18	%	%	NOUN
ajlm-1317	74	19	)	)	PUNCT
ajlm-1317	74	20	in	in	ADP
ajlm-1317	74	21	korea	korea	PROPN
ajlm-1317	74	22	,	,	PUNCT
ajlm-1317	74	23	1	1	NUM
ajlm-1317	74	24	(	(	PUNCT
ajlm-1317	74	25	5.6	5.6	NUM
ajlm-1317	74	26	%	%	NOUN
ajlm-1317	74	27	)	)	PUNCT
ajlm-1317	74	28	in	in	ADP
ajlm-1317	74	29	canada	canada	PROPN
ajlm-1317	74	30	,	,	PUNCT
ajlm-1317	74	31	1	1	NUM
ajlm-1317	74	32	(	(	PUNCT
ajlm-1317	74	33	5.6	5.6	NUM
ajlm-1317	74	34	%	%	NOUN
ajlm-1317	74	35	)	)	PUNCT
ajlm-1317	74	36	in	in	ADP
ajlm-1317	74	37	the	the	DET
ajlm-1317	74	38	united	united	PROPN
ajlm-1317	74	39	states	states	PROPN
ajlm-1317	74	40	,	,	PUNCT
ajlm-1317	74	41	and	and	CCONJ
ajlm-1317	74	42	1	1	NUM
ajlm-1317	74	43	(	(	PUNCT
ajlm-1317	74	44	5.6	5.6	NUM
ajlm-1317	74	45	%	%	NOUN
ajlm-1317	74	46	)	)	PUNCT
ajlm-1317	74	47	in	in	ADP
ajlm-1317	74	48	malaysia	malaysia	PROPN
ajlm-1317	74	49	.	.	PUNCT
ajlm-1317	75	1	table	table	NOUN
ajlm-1317	75	2	1	1	NUM
ajlm-1317	75	3	:	:	PUNCT
ajlm-1317	75	4	 	 	SPACE
ajlm-1317	75	5	characteristics	characteristic	NOUN
ajlm-1317	75	6	of	of	ADP
ajlm-1317	75	7	covid-19	covid-19	PROPN
ajlm-1317	75	8	point	point	NOUN
ajlm-1317	75	9	-	-	PUNCT
ajlm-1317	75	10	of	of	ADP
ajlm-1317	75	11	-	-	PUNCT
ajlm-1317	75	12	care	care	NOUN
ajlm-1317	75	13	test	test	NOUN
ajlm-1317	75	14	kits	kit	NOUN
ajlm-1317	75	15	submitted	submit	VERB
ajlm-1317	75	16	to	to	ADP
ajlm-1317	75	17	the	the	DET
ajlm-1317	75	18	kenya	kenya	PROPN
ajlm-1317	75	19	medical	medical	PROPN
ajlm-1317	75	20	research	research	PROPN
ajlm-1317	75	21	institute	institute	PROPN
ajlm-1317	75	22	by	by	ADP
ajlm-1317	75	23	the	the	DET
ajlm-1317	75	24	pharmacy	pharmacy	NOUN
ajlm-1317	75	25	and	and	CCONJ
ajlm-1317	75	26	poisons	poison	NOUN
ajlm-1317	75	27	board	board	PROPN
ajlm-1317	75	28	,	,	PUNCT
ajlm-1317	75	29	nairobi	nairobi	PROPN
ajlm-1317	75	30	,	,	PUNCT
ajlm-1317	75	31	kenya	kenya	PROPN
ajlm-1317	75	32	,	,	PUNCT
ajlm-1317	75	33	for	for	ADP
ajlm-1317	75	34	pre	pre	ADJ
ajlm-1317	75	35	-	-	ADJ
ajlm-1317	75	36	evaluation	evaluation	ADJ
ajlm-1317	75	37	assessment	assessment	NOUN
ajlm-1317	75	38	,	,	PUNCT
ajlm-1317	75	39	march	march	PROPN
ajlm-1317	75	40	–	–	PUNCT
ajlm-1317	75	41	may	may	NOUN
ajlm-1317	75	42	2020	2020	NUM
ajlm-1317	75	43	.	.	PUNCT
ajlm-1317	76	1	most	most	ADJ
ajlm-1317	76	2	of	of	ADP
ajlm-1317	76	3	the	the	DET
ajlm-1317	76	4	tests	test	NOUN
ajlm-1317	76	5	(	(	PUNCT
ajlm-1317	76	6	15/18	15/18	NUM
ajlm-1317	76	7	;	;	PUNCT
ajlm-1317	76	8	83	83	NUM
ajlm-1317	76	9	%	%	NOUN
ajlm-1317	76	10	)	)	PUNCT
ajlm-1317	76	11	were	be	AUX
ajlm-1317	76	12	based	base	VERB
ajlm-1317	76	13	on	on	ADP
ajlm-1317	76	14	covid-19	covid-19	PROPN
ajlm-1317	76	15	igg	igg	PROPN
ajlm-1317	76	16	or	or	CCONJ
ajlm-1317	76	17	igm	igm	PROPN
ajlm-1317	76	18	detection	detection	NOUN
ajlm-1317	76	19	on	on	ADP
ajlm-1317	76	20	separate	separate	ADJ
ajlm-1317	76	21	bands	band	NOUN
ajlm-1317	76	22	;	;	PUNCT
ajlm-1317	76	23	one	one	NUM
ajlm-1317	76	24	was	be	AUX
ajlm-1317	76	25	based	base	VERB
ajlm-1317	76	26	on	on	ADP
ajlm-1317	76	27	covid-19	covid-19	PROPN
ajlm-1317	76	28	igg	igg	PROPN
ajlm-1317	76	29	or	or	CCONJ
ajlm-1317	76	30	igm	igm	PROPN
ajlm-1317	76	31	detection	detection	NOUN
ajlm-1317	76	32	on	on	ADP
ajlm-1317	76	33	a	a	DET
ajlm-1317	76	34	combined	combine	VERB
ajlm-1317	76	35	band	band	NOUN
ajlm-1317	76	36	,	,	PUNCT
ajlm-1317	76	37	while	while	SCONJ
ajlm-1317	76	38	two	two	NUM
ajlm-1317	76	39	could	could	AUX
ajlm-1317	76	40	only	only	ADV
ajlm-1317	76	41	detect	detect	VERB
ajlm-1317	76	42	igm	igm	PROPN
ajlm-1317	76	43	.	.	PUNCT
ajlm-1317	77	1	the	the	DET
ajlm-1317	77	2	signal	signal	NOUN
ajlm-1317	77	3	from	from	ADP
ajlm-1317	77	4	17	17	NUM
ajlm-1317	77	5	tests	test	NOUN
ajlm-1317	77	6	could	could	AUX
ajlm-1317	77	7	be	be	AUX
ajlm-1317	77	8	detected	detect	VERB
ajlm-1317	77	9	by	by	ADP
ajlm-1317	77	10	the	the	DET
ajlm-1317	77	11	naked	naked	ADJ
ajlm-1317	77	12	eye	eye	NOUN
ajlm-1317	77	13	,	,	PUNCT
ajlm-1317	77	14	while	while	SCONJ
ajlm-1317	77	15	the	the	DET
ajlm-1317	77	16	signal	signal	NOUN
ajlm-1317	77	17	of	of	ADP
ajlm-1317	77	18	one	one	NUM
ajlm-1317	77	19	kit	kit	NOUN
ajlm-1317	77	20	(	(	PUNCT
ajlm-1317	77	21	i	i	NOUN
ajlm-1317	77	22	d	d	PROPN
ajlm-1317	77	23	11	11	NUM
ajlm-1317	77	24	)	)	PUNCT
ajlm-1317	77	25	could	could	AUX
ajlm-1317	77	26	be	be	AUX
ajlm-1317	77	27	detected	detect	VERB
ajlm-1317	77	28	only	only	ADV
ajlm-1317	77	29	using	use	VERB
ajlm-1317	77	30	a	a	DET
ajlm-1317	77	31	fluorometric	fluorometric	ADJ
ajlm-1317	77	32	machine	machine	NOUN
ajlm-1317	77	33	which	which	PRON
ajlm-1317	77	34	is	be	AUX
ajlm-1317	77	35	a	a	DET
ajlm-1317	77	36	semi	semi	ADJ
ajlm-1317	77	37	-	-	ADJ
ajlm-1317	77	38	automated	automated	ADJ
ajlm-1317	77	39	in	in	ADP
ajlm-1317	77	40	vitro	vitro	X
ajlm-1317	77	41	diagnostic	diagnostic	ADJ
ajlm-1317	77	42	device	device	NOUN
ajlm-1317	77	43	that	that	PRON
ajlm-1317	77	44	detects	detect	NOUN
ajlm-1317	77	45	analytes	analyte	VERB
ajlm-1317	77	46	through	through	ADP
ajlm-1317	77	47	fluorescent	fluorescent	NOUN
ajlm-1317	77	48	scanning	scanning	NOUN
ajlm-1317	77	49	.	.	PUNCT
ajlm-1317	78	1	diagnostic	diagnostic	ADJ
ajlm-1317	78	2	sensitivity	sensitivity	NOUN
ajlm-1317	78	3	of	of	ADP
ajlm-1317	78	4	the	the	DET
ajlm-1317	78	5	point	point	NOUN
ajlm-1317	78	6	-	-	PUNCT
ajlm-1317	78	7	of	of	ADP
ajlm-1317	78	8	-	-	PUNCT
ajlm-1317	78	9	care	care	NOUN
ajlm-1317	78	10	test	test	NOUN
ajlm-1317	78	11	kits	kit	NOUN
ajlm-1317	78	12	kit	kit	NOUN
ajlm-1317	78	13	2	2	NUM
ajlm-1317	78	14	(	(	PUNCT
ajlm-1317	78	15	igm	igm	PROPN
ajlm-1317	78	16	)	)	PUNCT
ajlm-1317	78	17	and	and	CCONJ
ajlm-1317	78	18	kit	kit	NOUN
ajlm-1317	78	19	14	14	NUM
ajlm-1317	78	20	showed	show	VERB
ajlm-1317	78	21	low	low	ADJ
ajlm-1317	78	22	sensitivities	sensitivity	NOUN
ajlm-1317	78	23	of	of	ADP
ajlm-1317	78	24	26.7	26.7	NUM
ajlm-1317	78	25	%	%	NOUN
ajlm-1317	78	26	and	and	CCONJ
ajlm-1317	78	27	11.1	11.1	NUM
ajlm-1317	78	28	%	%	NOUN
ajlm-1317	78	29	;	;	PUNCT
ajlm-1317	78	30	kit	kit	NOUN
ajlm-1317	78	31	5	5	NUM
ajlm-1317	78	32	showed	show	VERB
ajlm-1317	78	33	no	no	DET
ajlm-1317	78	34	activity	activity	NOUN
ajlm-1317	78	35	;	;	PUNCT
ajlm-1317	78	36	kit	kit	NOUN
ajlm-1317	78	37	11	11	NUM
ajlm-1317	78	38	,	,	PUNCT
ajlm-1317	78	39	which	which	PRON
ajlm-1317	78	40	was	be	AUX
ajlm-1317	78	41	the	the	DET
ajlm-1317	78	42	only	only	ADJ
ajlm-1317	78	43	kit	kit	NOUN
ajlm-1317	78	44	with	with	ADP
ajlm-1317	78	45	igg	igg	PROPN
ajlm-1317	78	46	and	and	CCONJ
ajlm-1317	78	47	igm	igm	PROPN
ajlm-1317	78	48	combined	combine	VERB
ajlm-1317	78	49	in	in	ADP
ajlm-1317	78	50	a	a	DET
ajlm-1317	78	51	single	single	ADJ
ajlm-1317	78	52	band	band	NOUN
ajlm-1317	78	53	test	test	NOUN
ajlm-1317	78	54	,	,	PUNCT
ajlm-1317	78	55	showed	show	VERB
ajlm-1317	78	56	high	high	ADJ
ajlm-1317	78	57	sensitivity	sensitivity	NOUN
ajlm-1317	78	58	(	(	PUNCT
ajlm-1317	78	59	figure	figure	NOUN
ajlm-1317	78	60	1	1	NUM
ajlm-1317	78	61	)	)	PUNCT
ajlm-1317	78	62	.	.	PUNCT
ajlm-1317	79	1	of	of	ADP
ajlm-1317	79	2	the	the	DET
ajlm-1317	79	3	total	total	ADJ
ajlm-1317	79	4	18	18	NUM
ajlm-1317	79	5	kits	kit	NOUN
ajlm-1317	79	6	,	,	PUNCT
ajlm-1317	79	7	6	6	NUM
ajlm-1317	79	8	(	(	PUNCT
ajlm-1317	79	9	33.3	33.3	NUM
ajlm-1317	79	10	%	%	NOUN
ajlm-1317	79	11	)	)	PUNCT
ajlm-1317	79	12	kits	kit	NOUN
ajlm-1317	79	13	had	have	VERB
ajlm-1317	79	14	sensitivities	sensitivity	NOUN
ajlm-1317	79	15	of	of	ADP
ajlm-1317	79	16	at	at	ADV
ajlm-1317	79	17	least	least	ADV
ajlm-1317	79	18	50	50	NUM
ajlm-1317	79	19	%	%	NOUN
ajlm-1317	79	20	:	:	PUNCT
ajlm-1317	79	21	kits	kit	NOUN
ajlm-1317	79	22	7	7	NUM
ajlm-1317	79	23	,	,	PUNCT
ajlm-1317	79	24	10	10	NUM
ajlm-1317	79	25	,	,	PUNCT
ajlm-1317	79	26	12	12	NUM
ajlm-1317	79	27	,	,	PUNCT
ajlm-1317	79	28	13	13	NUM
ajlm-1317	79	29	,	,	PUNCT
ajlm-1317	79	30	16	16	NUM
ajlm-1317	79	31	,	,	PUNCT
ajlm-1317	79	32	and	and	CCONJ
ajlm-1317	80	1	18	18	NUM
ajlm-1317	80	2	.	.	NOUN
ajlm-1317	80	3	five	five	NUM
ajlm-1317	80	4	kits	kit	NOUN
ajlm-1317	80	5	had	have	VERB
ajlm-1317	80	6	diagnostic	diagnostic	ADJ
ajlm-1317	80	7	sensitivities	sensitivity	NOUN
ajlm-1317	80	8	between	between	ADP
ajlm-1317	80	9	40	40	NUM
ajlm-1317	80	10	%	%	NOUN
ajlm-1317	80	11	and	and	CCONJ
ajlm-1317	80	12	50	50	NUM
ajlm-1317	80	13	%	%	NOUN
ajlm-1317	80	14	(	(	PUNCT
ajlm-1317	80	15	kits	kit	NOUN
ajlm-1317	80	16	3	3	NUM
ajlm-1317	80	17	,	,	PUNCT
ajlm-1317	80	18	4	4	NUM
ajlm-1317	80	19	,	,	PUNCT
ajlm-1317	80	20	6	6	NUM
ajlm-1317	80	21	,	,	PUNCT
ajlm-1317	80	22	8	8	NUM
ajlm-1317	80	23	and	and	CCONJ
ajlm-1317	80	24	17	17	NUM
ajlm-1317	80	25	)	)	PUNCT
ajlm-1317	80	26	,	,	PUNCT
ajlm-1317	80	27	while	while	SCONJ
ajlm-1317	80	28	kits	kit	NOUN
ajlm-1317	80	29	1	1	NUM
ajlm-1317	80	30	,	,	PUNCT
ajlm-1317	80	31	9	9	NUM
ajlm-1317	80	32	and	and	CCONJ
ajlm-1317	80	33	15	15	NUM
ajlm-1317	80	34	had	have	VERB
ajlm-1317	80	35	sensitivities	sensitivity	NOUN
ajlm-1317	80	36	between	between	ADP
ajlm-1317	80	37	30	30	NUM
ajlm-1317	80	38	%	%	NOUN
ajlm-1317	80	39	and	and	CCONJ
ajlm-1317	80	40	40	40	NUM
ajlm-1317	80	41	%	%	NOUN
ajlm-1317	80	42	.	.	PUNCT
ajlm-1317	81	1	only	only	ADV
ajlm-1317	81	2	kits	kit	NOUN
ajlm-1317	81	3	manufactured	manufacture	VERB
ajlm-1317	81	4	in	in	ADP
ajlm-1317	81	5	china	china	PROPN
ajlm-1317	81	6	and	and	CCONJ
ajlm-1317	81	7	the	the	DET
ajlm-1317	81	8	united	united	PROPN
ajlm-1317	81	9	states	states	PROPN
ajlm-1317	81	10	managed	manage	VERB
ajlm-1317	81	11	to	to	PART
ajlm-1317	81	12	score	score	VERB
ajlm-1317	81	13	more	more	ADJ
ajlm-1317	81	14	than	than	ADP
ajlm-1317	81	15	40	40	NUM
ajlm-1317	81	16	%	%	NOUN
ajlm-1317	81	17	diagnostic	diagnostic	ADJ
ajlm-1317	81	18	sensitivity	sensitivity	NOUN
ajlm-1317	81	19	.	.	PUNCT
ajlm-1317	82	1	figure	figure	NOUN
ajlm-1317	82	2	1	1	NUM
ajlm-1317	82	3	:	:	PUNCT
ajlm-1317	82	4	diagnostic	diagnostic	ADJ
ajlm-1317	82	5	sensitivity	sensitivity	NOUN
ajlm-1317	82	6	of	of	ADP
ajlm-1317	82	7	the	the	DET
ajlm-1317	82	8	pre	pre	ADJ
ajlm-1317	82	9	-	-	ADJ
ajlm-1317	82	10	assessed	assessed	ADJ
ajlm-1317	82	11	covid-19	covid-19	PROPN
ajlm-1317	82	12	point	point	NOUN
ajlm-1317	82	13	-	-	PUNCT
ajlm-1317	82	14	of	of	ADP
ajlm-1317	82	15	-	-	PUNCT
ajlm-1317	82	16	care	care	NOUN
ajlm-1317	82	17	tests	test	NOUN
ajlm-1317	82	18	submitted	submit	VERB
ajlm-1317	82	19	to	to	ADP
ajlm-1317	82	20	the	the	DET
ajlm-1317	82	21	kenya	kenya	PROPN
ajlm-1317	82	22	medical	medical	PROPN
ajlm-1317	82	23	research	research	PROPN
ajlm-1317	82	24	institute	institute	PROPN
ajlm-1317	82	25	by	by	ADP
ajlm-1317	82	26	the	the	DET
ajlm-1317	82	27	pharmacy	pharmacy	NOUN
ajlm-1317	82	28	and	and	CCONJ
ajlm-1317	82	29	poisons	poison	NOUN
ajlm-1317	82	30	board	board	PROPN
ajlm-1317	82	31	,	,	PUNCT
ajlm-1317	82	32	nairobi	nairobi	PROPN
ajlm-1317	82	33	,	,	PUNCT
ajlm-1317	82	34	kenya	kenya	PROPN
ajlm-1317	82	35	,	,	PUNCT
ajlm-1317	82	36	for	for	ADP
ajlm-1317	82	37	pre	pre	ADJ
ajlm-1317	82	38	-	-	ADJ
ajlm-1317	82	39	evaluation	evaluation	ADJ
ajlm-1317	82	40	assessment	assessment	NOUN
ajlm-1317	82	41	,	,	PUNCT
ajlm-1317	82	42	march	march	PROPN
ajlm-1317	82	43	–	–	PUNCT
ajlm-1317	82	44	may	may	PROPN
ajlm-1317	82	45	2020	2020	NUM
ajlm-1317	82	46	.	.	PUNCT
ajlm-1317	83	1	combined	combine	VERB
ajlm-1317	83	2	igg	igg	PROPN
ajlm-1317	83	3	and	and	CCONJ
ajlm-1317	83	4	igm	igm	PROPN
ajlm-1317	83	5	sensitivity	sensitivity	NOUN
ajlm-1317	83	6	was	be	AUX
ajlm-1317	83	7	assessed	assess	VERB
ajlm-1317	83	8	using	use	VERB
ajlm-1317	83	9	rrt	rrt	NOUN
ajlm-1317	83	10	-	-	NOUN
ajlm-1317	83	11	pcr	pcr	NOUN
ajlm-1317	83	12	as	as	ADP
ajlm-1317	83	13	standard	standard	NOUN
ajlm-1317	83	14	.	.	PUNCT
ajlm-1317	84	1	diagnostic	diagnostic	ADJ
ajlm-1317	84	2	sensitivity	sensitivity	NOUN
ajlm-1317	84	3	of	of	ADP
ajlm-1317	84	4	the	the	DET
ajlm-1317	84	5	igg	igg	PROPN
ajlm-1317	84	6	and	and	CCONJ
ajlm-1317	84	7	igm	igm	PROPN
ajlm-1317	84	8	separate	separate	ADJ
ajlm-1317	84	9	bands	band	NOUN
ajlm-1317	84	10	the	the	DET
ajlm-1317	84	11	diagnostic	diagnostic	ADJ
ajlm-1317	84	12	sensitivity	sensitivity	NOUN
ajlm-1317	84	13	of	of	ADP
ajlm-1317	84	14	the	the	DET
ajlm-1317	84	15	igg	igg	PROPN
ajlm-1317	84	16	and	and	CCONJ
ajlm-1317	84	17	igm	igm	PROPN
ajlm-1317	84	18	bands	band	NOUN
ajlm-1317	84	19	were	be	AUX
ajlm-1317	84	20	considered	consider	VERB
ajlm-1317	84	21	separately	separately	ADV
ajlm-1317	84	22	for	for	ADP
ajlm-1317	84	23	all	all	DET
ajlm-1317	84	24	the	the	DET
ajlm-1317	84	25	pocts	poct	NOUN
ajlm-1317	84	26	(	(	PUNCT
ajlm-1317	84	27	figure	figure	NOUN
ajlm-1317	84	28	2	2	NUM
ajlm-1317	84	29	)	)	PUNCT
ajlm-1317	84	30	.	.	PUNCT
ajlm-1317	85	1	the	the	DET
ajlm-1317	85	2	igm	igm	PROPN
ajlm-1317	85	3	band	band	NOUN
ajlm-1317	85	4	of	of	ADP
ajlm-1317	85	5	kit	kit	NOUN
ajlm-1317	85	6	1	1	NUM
ajlm-1317	85	7	did	do	AUX
ajlm-1317	85	8	not	not	PART
ajlm-1317	85	9	demonstrate	demonstrate	VERB
ajlm-1317	85	10	any	any	DET
ajlm-1317	85	11	capacity	capacity	NOUN
ajlm-1317	85	12	to	to	PART
ajlm-1317	85	13	detect	detect	VERB
ajlm-1317	85	14	igm	igm	PROPN
ajlm-1317	85	15	.	.	PUNCT
ajlm-1317	86	1	kit	kit	NOUN
ajlm-1317	86	2	2	2	NUM
ajlm-1317	86	3	,	,	PUNCT
ajlm-1317	86	4	an	an	DET
ajlm-1317	86	5	igm	igm	PROPN
ajlm-1317	86	6	-	-	PUNCT
ajlm-1317	86	7	only	only	ADV
ajlm-1317	86	8	kit	kit	NOUN
ajlm-1317	86	9	,	,	PUNCT
ajlm-1317	86	10	had	have	VERB
ajlm-1317	86	11	a	a	DET
ajlm-1317	86	12	low	low	ADJ
ajlm-1317	86	13	sensitivity	sensitivity	NOUN
ajlm-1317	86	14	of	of	ADP
ajlm-1317	86	15	19	19	NUM
ajlm-1317	86	16	%	%	NOUN
ajlm-1317	86	17	and	and	CCONJ
ajlm-1317	86	18	a	a	DET
ajlm-1317	86	19	specificity	specificity	NOUN
ajlm-1317	86	20	of	of	ADP
ajlm-1317	86	21	95	95	NUM
ajlm-1317	86	22	%	%	NOUN
ajlm-1317	86	23	.	.	PUNCT
ajlm-1317	87	1	the	the	DET
ajlm-1317	87	2	sensitivity	sensitivity	NOUN
ajlm-1317	87	3	of	of	ADP
ajlm-1317	87	4	kit	kit	NOUN
ajlm-1317	87	5	13	13	NUM
ajlm-1317	87	6	was	be	AUX
ajlm-1317	87	7	55	55	NUM
ajlm-1317	87	8	%	%	NOUN
ajlm-1317	87	9	for	for	ADP
ajlm-1317	87	10	igg	igg	PROPN
ajlm-1317	87	11	and	and	CCONJ
ajlm-1317	87	12	40	40	NUM
ajlm-1317	87	13	%	%	NOUN
ajlm-1317	87	14	for	for	ADP
ajlm-1317	87	15	igm	igm	PROPN
ajlm-1317	87	16	.	.	PUNCT
ajlm-1317	88	1	kit	kit	NOUN
ajlm-1317	88	2	12	12	NUM
ajlm-1317	88	3	showed	show	VERB
ajlm-1317	88	4	higher	high	ADJ
ajlm-1317	88	5	diagnostic	diagnostic	ADJ
ajlm-1317	88	6	sensitivity	sensitivity	NOUN
ajlm-1317	88	7	for	for	ADP
ajlm-1317	88	8	igg	igg	PROPN
ajlm-1317	88	9	(	(	PUNCT
ajlm-1317	88	10	40	40	NUM
ajlm-1317	88	11	%	%	NOUN
ajlm-1317	88	12	)	)	PUNCT
ajlm-1317	88	13	than	than	ADP
ajlm-1317	88	14	for	for	ADP
ajlm-1317	88	15	igm	igm	PROPN
ajlm-1317	88	16	(	(	PUNCT
ajlm-1317	88	17	5	5	NUM
ajlm-1317	88	18	%	%	NOUN
ajlm-1317	88	19	)	)	PUNCT
ajlm-1317	88	20	.	.	PUNCT
ajlm-1317	89	1	kit	kit	NOUN
ajlm-1317	89	2	3	3	NUM
ajlm-1317	89	3	was	be	AUX
ajlm-1317	89	4	the	the	DET
ajlm-1317	89	5	only	only	ADJ
ajlm-1317	89	6	kit	kit	NOUN
ajlm-1317	89	7	that	that	PRON
ajlm-1317	89	8	showed	show	VERB
ajlm-1317	89	9	higher	high	ADJ
ajlm-1317	89	10	diagnostic	diagnostic	ADJ
ajlm-1317	89	11	sensitivity	sensitivity	NOUN
ajlm-1317	89	12	for	for	ADP
ajlm-1317	89	13	igm	igm	PROPN
ajlm-1317	89	14	(	(	PUNCT
ajlm-1317	89	15	43	43	NUM
ajlm-1317	89	16	%	%	NOUN
ajlm-1317	89	17	)	)	PUNCT
ajlm-1317	89	18	than	than	ADP
ajlm-1317	89	19	igg	igg	PROPN
ajlm-1317	89	20	(	(	PUNCT
ajlm-1317	89	21	19	19	NUM
ajlm-1317	89	22	%	%	NOUN
ajlm-1317	89	23	)	)	PUNCT
ajlm-1317	89	24	.	.	PUNCT
ajlm-1317	90	1	interestingly	interestingly	ADV
ajlm-1317	90	2	,	,	PUNCT
ajlm-1317	90	3	five	five	NUM
ajlm-1317	90	4	kits	kit	NOUN
ajlm-1317	90	5	(	(	PUNCT
ajlm-1317	90	6	kits	kit	NOUN
ajlm-1317	90	7	4	4	NUM
ajlm-1317	90	8	,	,	PUNCT
ajlm-1317	90	9	6	6	NUM
ajlm-1317	90	10	,	,	PUNCT
ajlm-1317	90	11	8	8	NUM
ajlm-1317	90	12	,	,	PUNCT
ajlm-1317	90	13	10	10	NUM
ajlm-1317	90	14	,	,	PUNCT
ajlm-1317	90	15	and	and	CCONJ
ajlm-1317	90	16	18	18	NUM
ajlm-1317	90	17	)	)	PUNCT
ajlm-1317	90	18	showed	show	VERB
ajlm-1317	90	19	equal	equal	ADJ
ajlm-1317	90	20	diagnostic	diagnostic	ADJ
ajlm-1317	90	21	sensitivity	sensitivity	NOUN
ajlm-1317	90	22	for	for	ADP
ajlm-1317	90	23	igg	igg	PROPN
ajlm-1317	90	24	and	and	CCONJ
ajlm-1317	90	25	igm	igm	PROPN
ajlm-1317	90	26	.	.	PUNCT
ajlm-1317	91	1	there	there	PRON
ajlm-1317	91	2	was	be	VERB
ajlm-1317	91	3	a	a	DET
ajlm-1317	91	4	weak	weak	ADJ
ajlm-1317	91	5	positive	positive	ADJ
ajlm-1317	91	6	correlation	correlation	NOUN
ajlm-1317	91	7	between	between	ADP
ajlm-1317	91	8	the	the	DET
ajlm-1317	91	9	igm	igm	PROPN
ajlm-1317	91	10	and	and	CCONJ
ajlm-1317	91	11	igg	igg	PROPN
ajlm-1317	91	12	diagnostic	diagnostic	ADJ
ajlm-1317	91	13	sensitivities	sensitivity	NOUN
ajlm-1317	91	14	of	of	ADP
ajlm-1317	91	15	the	the	DET
ajlm-1317	91	16	kits	kit	NOUN
ajlm-1317	91	17	(	(	PUNCT
ajlm-1317	91	18	pearson	pearson	PROPN
ajlm-1317	91	19	’s	’s	PART
ajlm-1317	91	20	correlation	correlation	NOUN
ajlm-1317	91	21	coefficient	coefficient	NOUN
ajlm-1317	92	1	[	[	X
ajlm-1317	92	2	r	r	X
ajlm-1317	92	3	]	]	X
ajlm-1317	92	4	=	=	X
ajlm-1317	92	5	0.2527	0.2527	NUM
ajlm-1317	92	6	;	;	PUNCT
ajlm-1317	92	7	r2	r2	PROPN
ajlm-1317	92	8	=	=	SYM
ajlm-1317	92	9	0.0639	0.0639	PROPN
ajlm-1317	92	10	;	;	PUNCT
ajlm-1317	93	1	p	p	X
ajlm-1317	93	2	=	=	NOUN
ajlm-1317	93	3	0.45	0.45	NUM
ajlm-1317	93	4	)	)	PUNCT
ajlm-1317	93	5	.	.	PUNCT
ajlm-1317	94	1	figure	figure	VERB
ajlm-1317	94	2	2	2	NUM
ajlm-1317	94	3	:	:	PUNCT
ajlm-1317	94	4	diagnostic	diagnostic	ADJ
ajlm-1317	94	5	sensitivity	sensitivity	NOUN
ajlm-1317	94	6	of	of	ADP
ajlm-1317	94	7	the	the	DET
ajlm-1317	94	8	pre	pre	ADJ
ajlm-1317	94	9	-	-	ADJ
ajlm-1317	94	10	assessed	assessed	ADJ
ajlm-1317	94	11	covid-19	covid-19	PROPN
ajlm-1317	94	12	point	point	NOUN
ajlm-1317	94	13	-	-	PUNCT
ajlm-1317	94	14	of	of	ADP
ajlm-1317	94	15	-	-	PUNCT
ajlm-1317	94	16	care	care	NOUN
ajlm-1317	94	17	tests	test	NOUN
ajlm-1317	94	18	submitted	submit	VERB
ajlm-1317	94	19	to	to	ADP
ajlm-1317	94	20	the	the	DET
ajlm-1317	94	21	kenya	kenya	PROPN
ajlm-1317	94	22	medical	medical	PROPN
ajlm-1317	94	23	research	research	PROPN
ajlm-1317	94	24	institute	institute	PROPN
ajlm-1317	94	25	by	by	ADP
ajlm-1317	94	26	the	the	DET
ajlm-1317	94	27	pharmacy	pharmacy	NOUN
ajlm-1317	94	28	and	and	CCONJ
ajlm-1317	94	29	poisons	poison	NOUN
ajlm-1317	94	30	board	board	PROPN
ajlm-1317	94	31	,	,	PUNCT
ajlm-1317	94	32	nairobi	nairobi	PROPN
ajlm-1317	94	33	,	,	PUNCT
ajlm-1317	94	34	kenya	kenya	PROPN
ajlm-1317	94	35	,	,	PUNCT
ajlm-1317	94	36	for	for	ADP
ajlm-1317	94	37	pre	pre	ADJ
ajlm-1317	94	38	-	-	ADJ
ajlm-1317	94	39	evaluation	evaluation	ADJ
ajlm-1317	94	40	assessment	assessment	NOUN
ajlm-1317	94	41	,	,	PUNCT
ajlm-1317	94	42	march	march	PROPN
ajlm-1317	94	43	2020	2020	NUM
ajlm-1317	94	44	–	–	PUNCT
ajlm-1317	94	45	may	may	AUX
ajlm-1317	94	46	2020	2020	NUM
ajlm-1317	94	47	.	.	PUNCT
ajlm-1317	95	1	separate	separate	ADJ
ajlm-1317	95	2	igg	igg	PROPN
ajlm-1317	95	3	or	or	CCONJ
ajlm-1317	95	4	igm	igm	NOUN
ajlm-1317	95	5	sensitivities	sensitivity	NOUN
ajlm-1317	95	6	were	be	AUX
ajlm-1317	95	7	assessed	assess	VERB
ajlm-1317	95	8	using	use	VERB
ajlm-1317	95	9	rrt	rrt	NOUN
ajlm-1317	95	10	-	-	NOUN
ajlm-1317	95	11	pcr	pcr	NOUN
ajlm-1317	95	12	as	as	ADP
ajlm-1317	95	13	standard	standard	NOUN
ajlm-1317	95	14	.	.	PUNCT
ajlm-1317	96	1	diagnostic	diagnostic	ADJ
ajlm-1317	96	2	specificity	specificity	NOUN
ajlm-1317	96	3	of	of	ADP
ajlm-1317	96	4	the	the	DET
ajlm-1317	96	5	point	point	NOUN
ajlm-1317	96	6	-	-	PUNCT
ajlm-1317	96	7	of	of	ADP
ajlm-1317	96	8	-	-	PUNCT
ajlm-1317	96	9	care	care	NOUN
ajlm-1317	96	10	test	test	NOUN
ajlm-1317	96	11	kits	kit	NOUN
ajlm-1317	96	12	eight	eight	NUM
ajlm-1317	96	13	kits	kit	NOUN
ajlm-1317	96	14	(	(	PUNCT
ajlm-1317	96	15	kits	kit	NOUN
ajlm-1317	96	16	1	1	NUM
ajlm-1317	96	17	,	,	PUNCT
ajlm-1317	96	18	3	3	NUM
ajlm-1317	96	19	,	,	PUNCT
ajlm-1317	96	20	8	8	NUM
ajlm-1317	96	21	,	,	PUNCT
ajlm-1317	96	22	9	9	NUM
ajlm-1317	96	23	,	,	PUNCT
ajlm-1317	96	24	12	12	NUM
ajlm-1317	96	25	,	,	PUNCT
ajlm-1317	96	26	14	14	NUM
ajlm-1317	96	27	,	,	PUNCT
ajlm-1317	96	28	16	16	NUM
ajlm-1317	96	29	,	,	PUNCT
ajlm-1317	96	30	and	and	CCONJ
ajlm-1317	96	31	18	18	NUM
ajlm-1317	96	32	)	)	PUNCT
ajlm-1317	96	33	had	have	VERB
ajlm-1317	96	34	a	a	DET
ajlm-1317	96	35	diagnostic	diagnostic	ADJ
ajlm-1317	96	36	specificity	specificity	NOUN
ajlm-1317	96	37	of	of	ADP
ajlm-1317	96	38	100	100	NUM
ajlm-1317	96	39	%	%	NOUN
ajlm-1317	96	40	,	,	PUNCT
ajlm-1317	96	41	while	while	SCONJ
ajlm-1317	96	42	five	five	NUM
ajlm-1317	96	43	kits	kit	NOUN
ajlm-1317	96	44	had	have	VERB
ajlm-1317	96	45	low	low	ADJ
ajlm-1317	96	46	diagnostic	diagnostic	ADJ
ajlm-1317	96	47	specificities	specificity	NOUN
ajlm-1317	96	48	of	of	ADP
ajlm-1317	96	49	81	81	NUM
ajlm-1317	96	50	%	%	NOUN
ajlm-1317	96	51	(	(	PUNCT
ajlm-1317	96	52	kit	kit	NOUN
ajlm-1317	96	53	7	7	NUM
ajlm-1317	96	54	)	)	PUNCT
ajlm-1317	96	55	,	,	PUNCT
ajlm-1317	96	56	92	92	NUM
ajlm-1317	96	57	%	%	NOUN
ajlm-1317	96	58	(	(	PUNCT
ajlm-1317	96	59	kit	kit	NOUN
ajlm-1317	96	60	17	17	NUM
ajlm-1317	96	61	)	)	PUNCT
ajlm-1317	96	62	,	,	PUNCT
ajlm-1317	96	63	94	94	NUM
ajlm-1317	96	64	%	%	NOUN
ajlm-1317	96	65	(	(	PUNCT
ajlm-1317	96	66	kit	kit	NOUN
ajlm-1317	96	67	13	13	NUM
ajlm-1317	96	68	)	)	PUNCT
ajlm-1317	96	69	,	,	PUNCT
ajlm-1317	96	70	and	and	CCONJ
ajlm-1317	96	71	95	95	NUM
ajlm-1317	96	72	%	%	NOUN
ajlm-1317	96	73	(	(	PUNCT
ajlm-1317	96	74	kits	kit	NOUN
ajlm-1317	96	75	2	2	NUM
ajlm-1317	96	76	and	and	CCONJ
ajlm-1317	96	77	15	15	NUM
ajlm-1317	96	78	)	)	PUNCT
ajlm-1317	96	79	.	.	PUNCT
ajlm-1317	97	1	the	the	DET
ajlm-1317	97	2	remaining	remain	VERB
ajlm-1317	97	3	five	five	NUM
ajlm-1317	97	4	kits	kit	NOUN
ajlm-1317	97	5	were	be	AUX
ajlm-1317	97	6	not	not	PART
ajlm-1317	97	7	tested	test	VERB
ajlm-1317	97	8	for	for	ADP
ajlm-1317	97	9	diagnostic	diagnostic	ADJ
ajlm-1317	97	10	specificity	specificity	NOUN
ajlm-1317	97	11	as	as	SCONJ
ajlm-1317	97	12	they	they	PRON
ajlm-1317	97	13	had	have	AUX
ajlm-1317	97	14	run	run	VERB
ajlm-1317	97	15	out	out	ADP
ajlm-1317	97	16	of	of	ADP
ajlm-1317	97	17	stock	stock	NOUN
ajlm-1317	97	18	.	.	PUNCT
ajlm-1317	98	1	igm	igm	PROPN
ajlm-1317	98	2	and	and	CCONJ
ajlm-1317	98	3	igg	igg	PROPN
ajlm-1317	98	4	band	band	NOUN
ajlm-1317	98	5	signal	signal	PROPN
ajlm-1317	98	6	intensities	intensity	NOUN
ajlm-1317	98	7	of	of	ADP
ajlm-1317	98	8	the	the	DET
ajlm-1317	98	9	point	point	NOUN
ajlm-1317	98	10	-	-	PUNCT
ajlm-1317	98	11	of	of	ADP
ajlm-1317	98	12	-	-	PUNCT
ajlm-1317	98	13	care	care	NOUN
ajlm-1317	98	14	test	test	NOUN
ajlm-1317	98	15	kits	kit	VERB
ajlm-1317	98	16	the	the	DET
ajlm-1317	98	17	intensities	intensity	NOUN
ajlm-1317	98	18	of	of	ADP
ajlm-1317	98	19	the	the	DET
ajlm-1317	98	20	igm	igm	PROPN
ajlm-1317	98	21	and	and	CCONJ
ajlm-1317	98	22	igg	igg	PROPN
ajlm-1317	98	23	bands	band	NOUN
ajlm-1317	98	24	of	of	ADP
ajlm-1317	98	25	the	the	DET
ajlm-1317	98	26	pocts	poct	NOUN
ajlm-1317	98	27	were	be	AUX
ajlm-1317	98	28	analysed	analyse	VERB
ajlm-1317	98	29	with	with	ADP
ajlm-1317	98	30	the	the	DET
ajlm-1317	98	31	assistance	assistance	NOUN
ajlm-1317	98	32	of	of	ADP
ajlm-1317	98	33	a	a	DET
ajlm-1317	98	34	colour	colour	NOUN
ajlm-1317	98	35	reference	reference	NOUN
ajlm-1317	98	36	chart	chart	NOUN
ajlm-1317	98	37	(	(	PUNCT
ajlm-1317	98	38	figure	figure	NOUN
ajlm-1317	98	39	3	3	NUM
ajlm-1317	98	40	)	)	PUNCT
ajlm-1317	98	41	.	.	PUNCT
ajlm-1317	99	1	the	the	DET
ajlm-1317	99	2	average	average	ADJ
ajlm-1317	99	3	intensities	intensity	NOUN
ajlm-1317	99	4	of	of	ADP
ajlm-1317	99	5	the	the	DET
ajlm-1317	99	6	observed	observe	VERB
ajlm-1317	99	7	bands	band	NOUN
ajlm-1317	99	8	of	of	ADP
ajlm-1317	99	9	many	many	ADJ
ajlm-1317	99	10	(	(	PUNCT
ajlm-1317	99	11	7/18	7/18	NUM
ajlm-1317	99	12	;	;	PUNCT
ajlm-1317	99	13	38.8	38.8	NUM
ajlm-1317	99	14	%	%	NOUN
ajlm-1317	99	15	)	)	PUNCT
ajlm-1317	99	16	of	of	ADP
ajlm-1317	99	17	the	the	DET
ajlm-1317	99	18	kits	kit	NOUN
ajlm-1317	99	19	were	be	AUX
ajlm-1317	99	20	at	at	ADP
ajlm-1317	99	21	score	score	NOUN
ajlm-1317	99	22	3	3	NUM
ajlm-1317	99	23	on	on	ADP
ajlm-1317	99	24	the	the	DET
ajlm-1317	99	25	scale	scale	NOUN
ajlm-1317	99	26	(	(	PUNCT
ajlm-1317	99	27	figure	figure	NOUN
ajlm-1317	99	28	3	3	NUM
ajlm-1317	99	29	)	)	PUNCT
ajlm-1317	99	30	.	.	PUNCT
ajlm-1317	100	1	the	the	DET
ajlm-1317	100	2	intensities	intensity	NOUN
ajlm-1317	100	3	of	of	ADP
ajlm-1317	100	4	the	the	DET
ajlm-1317	100	5	igg	igg	PROPN
ajlm-1317	100	6	bands	band	NOUN
ajlm-1317	100	7	were	be	AUX
ajlm-1317	100	8	generally	generally	ADV
ajlm-1317	100	9	stronger	strong	ADJ
ajlm-1317	100	10	than	than	ADP
ajlm-1317	100	11	those	those	PRON
ajlm-1317	100	12	of	of	ADP
ajlm-1317	100	13	igm	igm	PROPN
ajlm-1317	100	14	.	.	PUNCT
ajlm-1317	100	15	kits	kits	PROPN
ajlm-1317	100	16	3	3	NUM
ajlm-1317	100	17	,	,	PUNCT
ajlm-1317	100	18	6	6	NUM
ajlm-1317	100	19	,	,	PUNCT
ajlm-1317	100	20	8	8	NUM
ajlm-1317	100	21	,	,	PUNCT
ajlm-1317	100	22	10	10	NUM
ajlm-1317	100	23	,	,	PUNCT
ajlm-1317	100	24	12	12	NUM
ajlm-1317	100	25	,	,	PUNCT
ajlm-1317	100	26	13	13	NUM
ajlm-1317	100	27	,	,	PUNCT
ajlm-1317	100	28	16	16	NUM
ajlm-1317	100	29	,	,	PUNCT
ajlm-1317	100	30	17	17	NUM
ajlm-1317	100	31	,	,	PUNCT
ajlm-1317	100	32	and	and	CCONJ
ajlm-1317	100	33	18	18	NUM
ajlm-1317	100	34	displayed	display	VERB
ajlm-1317	100	35	the	the	DET
ajlm-1317	100	36	strongest	strong	ADJ
ajlm-1317	100	37	intensities	intensity	NOUN
ajlm-1317	100	38	,	,	PUNCT
ajlm-1317	100	39	which	which	PRON
ajlm-1317	100	40	corresponded	correspond	VERB
ajlm-1317	100	41	with	with	ADP
ajlm-1317	100	42	their	their	PRON
ajlm-1317	100	43	higher	high	ADJ
ajlm-1317	100	44	diagnostic	diagnostic	ADJ
ajlm-1317	100	45	sensitivities	sensitivity	NOUN
ajlm-1317	100	46	compared	compare	VERB
ajlm-1317	100	47	to	to	ADP
ajlm-1317	100	48	the	the	DET
ajlm-1317	100	49	remaining	remain	VERB
ajlm-1317	100	50	kits	kit	NOUN
ajlm-1317	100	51	.	.	PUNCT
ajlm-1317	101	1	figure	figure	VERB
ajlm-1317	101	2	3	3	NUM
ajlm-1317	101	3	:	:	PUNCT
ajlm-1317	101	4	colour	colour	NOUN
ajlm-1317	101	5	intensity	intensity	NOUN
ajlm-1317	101	6	of	of	ADP
ajlm-1317	101	7	the	the	DET
ajlm-1317	101	8	positive	positive	ADJ
ajlm-1317	101	9	control	control	NOUN
ajlm-1317	101	10	signal	signal	NOUN
ajlm-1317	101	11	for	for	ADP
ajlm-1317	101	12	the	the	DET
ajlm-1317	101	13	igm	igm	PROPN
ajlm-1317	101	14	and	and	CCONJ
ajlm-1317	101	15	igg	igg	PROPN
ajlm-1317	101	16	bands	band	NOUN
ajlm-1317	101	17	of	of	ADP
ajlm-1317	101	18	point	point	NOUN
ajlm-1317	101	19	-	-	PUNCT
ajlm-1317	101	20	of	of	ADP
ajlm-1317	101	21	-	-	PUNCT
ajlm-1317	101	22	care	care	NOUN
ajlm-1317	101	23	tests	test	NOUN
ajlm-1317	101	24	assessed	assess	VERB
ajlm-1317	101	25	at	at	ADP
ajlm-1317	101	26	kenya	kenya	PROPN
ajlm-1317	101	27	medical	medical	PROPN
ajlm-1317	101	28	research	research	PROPN
ajlm-1317	101	29	institute	institute	PROPN
ajlm-1317	101	30	between	between	ADP
ajlm-1317	101	31	march	march	PROPN
ajlm-1317	101	32	2020	2020	NUM
ajlm-1317	101	33	and	and	CCONJ
ajlm-1317	101	34	may	may	PROPN
ajlm-1317	101	35	2020	2020	NUM
ajlm-1317	101	36	.	.	PUNCT
ajlm-1317	102	1	discussion	discussion	NOUN
ajlm-1317	102	2	this	this	DET
ajlm-1317	102	3	study	study	NOUN
ajlm-1317	102	4	carried	carry	VERB
ajlm-1317	102	5	out	out	ADP
ajlm-1317	102	6	a	a	DET
ajlm-1317	102	7	pre	pre	ADJ
ajlm-1317	102	8	-	-	ADJ
ajlm-1317	102	9	evaluation	evaluation	ADJ
ajlm-1317	102	10	assessment	assessment	NOUN
ajlm-1317	102	11	of	of	ADP
ajlm-1317	102	12	poct	poct	NOUN
ajlm-1317	102	13	kits	kit	NOUN
ajlm-1317	102	14	submitted	submit	VERB
ajlm-1317	102	15	by	by	ADP
ajlm-1317	102	16	manufacturers	manufacturer	NOUN
ajlm-1317	102	17	to	to	ADP
ajlm-1317	102	18	the	the	DET
ajlm-1317	102	19	ppb	ppb	NOUN
ajlm-1317	102	20	for	for	ADP
ajlm-1317	102	21	pre	pre	NOUN
ajlm-1317	102	22	-	-	NOUN
ajlm-1317	102	23	evaluation	evaluation	NOUN
ajlm-1317	102	24	.	.	PUNCT
ajlm-1317	103	1	out	out	ADP
ajlm-1317	103	2	of	of	ADP
ajlm-1317	103	3	the	the	DET
ajlm-1317	103	4	kits	kit	NOUN
ajlm-1317	103	5	evaluated	evaluate	VERB
ajlm-1317	103	6	,	,	PUNCT
ajlm-1317	103	7	50	50	NUM
ajlm-1317	103	8	%	%	NOUN
ajlm-1317	103	9	had	have	VERB
ajlm-1317	103	10	sensitivities	sensitivity	NOUN
ajlm-1317	103	11	of	of	ADP
ajlm-1317	103	12	≥	≥	NOUN
ajlm-1317	103	13	40	40	NUM
ajlm-1317	103	14	%	%	NOUN
ajlm-1317	103	15	,	,	PUNCT
ajlm-1317	103	16	and	and	CCONJ
ajlm-1317	103	17	most	most	ADJ
ajlm-1317	103	18	of	of	ADP
ajlm-1317	103	19	the	the	DET
ajlm-1317	103	20	kits	kit	NOUN
ajlm-1317	103	21	had	have	VERB
ajlm-1317	103	22	low	low	ADJ
ajlm-1317	103	23	band	band	NOUN
ajlm-1317	103	24	intensities	intensity	NOUN
ajlm-1317	103	25	.	.	PUNCT
ajlm-1317	104	1	the	the	DET
ajlm-1317	104	2	kits	kit	NOUN
ajlm-1317	104	3	with	with	ADP
ajlm-1317	104	4	sensitivities	sensitivity	NOUN
ajlm-1317	104	5	of	of	ADP
ajlm-1317	104	6	≥	≥	NOUN
ajlm-1317	104	7	40	40	NUM
ajlm-1317	104	8	%	%	NOUN
ajlm-1317	104	9	were	be	AUX
ajlm-1317	104	10	given	give	VERB
ajlm-1317	104	11	emergency	emergency	NOUN
ajlm-1317	104	12	approval	approval	NOUN
ajlm-1317	104	13	.	.	PUNCT
ajlm-1317	105	1	currently	currently	ADV
ajlm-1317	105	2	,	,	PUNCT
ajlm-1317	105	3	rrt	rrt	ADJ
ajlm-1317	105	4	-	-	ADJ
ajlm-1317	105	5	pcr	pcr	ADJ
ajlm-1317	105	6	tests	test	NOUN
ajlm-1317	105	7	are	be	AUX
ajlm-1317	105	8	the	the	DET
ajlm-1317	105	9	mainstay	mainstay	NOUN
ajlm-1317	105	10	of	of	ADP
ajlm-1317	105	11	sars	sar	NOUN
ajlm-1317	105	12	-	-	PUNCT
ajlm-1317	105	13	cov-2	cov-2	NOUN
ajlm-1317	105	14	diagnosis	diagnosis	NOUN
ajlm-1317	105	15	;	;	PUNCT
ajlm-1317	105	16	however	however	ADV
ajlm-1317	105	17	,	,	PUNCT
ajlm-1317	105	18	they	they	PRON
ajlm-1317	105	19	have	have	VERB
ajlm-1317	105	20	complex	complex	ADJ
ajlm-1317	105	21	protocols	protocol	NOUN
ajlm-1317	105	22	,	,	PUNCT
ajlm-1317	105	23	are	be	AUX
ajlm-1317	105	24	expensive	expensive	ADJ
ajlm-1317	105	25	,	,	PUNCT
ajlm-1317	105	26	and	and	CCONJ
ajlm-1317	105	27	require	require	VERB
ajlm-1317	105	28	advanced	advanced	ADJ
ajlm-1317	105	29	laboratory	laboratory	NOUN
ajlm-1317	105	30	equipment.2	equipment.2	VERB
ajlm-1317	105	31	the	the	DET
ajlm-1317	105	32	main	main	ADJ
ajlm-1317	105	33	goal	goal	NOUN
ajlm-1317	105	34	of	of	ADP
ajlm-1317	105	35	introducing	introduce	VERB
ajlm-1317	105	36	a	a	DET
ajlm-1317	105	37	poct	poct	NOUN
ajlm-1317	105	38	is	be	AUX
ajlm-1317	105	39	to	to	PART
ajlm-1317	105	40	avail	avail	VERB
ajlm-1317	105	41	quick	quick	ADJ
ajlm-1317	105	42	test	test	NOUN
ajlm-1317	105	43	results	result	NOUN
ajlm-1317	105	44	to	to	ADP
ajlm-1317	105	45	the	the	DET
ajlm-1317	105	46	healthcare	healthcare	NOUN
ajlm-1317	105	47	workers	worker	NOUN
ajlm-1317	105	48	or	or	CCONJ
ajlm-1317	105	49	the	the	DET
ajlm-1317	105	50	patient	patient	NOUN
ajlm-1317	105	51	to	to	PART
ajlm-1317	105	52	support	support	VERB
ajlm-1317	105	53	fast	fast	ADJ
ajlm-1317	105	54	clinical	clinical	ADJ
ajlm-1317	105	55	management	management	NOUN
ajlm-1317	105	56	decisions	decision	NOUN
ajlm-1317	105	57	and	and	CCONJ
ajlm-1317	105	58	,	,	PUNCT
ajlm-1317	105	59	ultimately	ultimately	ADV
ajlm-1317	105	60	,	,	PUNCT
ajlm-1317	105	61	improve	improve	VERB
ajlm-1317	105	62	patient	patient	ADJ
ajlm-1317	105	63	outcomes	outcome	NOUN
ajlm-1317	105	64	and	and	CCONJ
ajlm-1317	105	65	overall	overall	ADJ
ajlm-1317	105	66	public	public	ADJ
ajlm-1317	105	67	health	health	NOUN
ajlm-1317	105	68	.	.	PUNCT
ajlm-1317	106	1	it	it	PRON
ajlm-1317	106	2	is	be	AUX
ajlm-1317	106	3	hoped	hope	VERB
ajlm-1317	106	4	that	that	SCONJ
ajlm-1317	106	5	pocts	poct	NOUN
ajlm-1317	106	6	will	will	AUX
ajlm-1317	106	7	be	be	AUX
ajlm-1317	106	8	useful	useful	ADJ
ajlm-1317	106	9	in	in	ADP
ajlm-1317	106	10	identifying	identify	VERB
ajlm-1317	106	11	asymptomatic	asymptomatic	ADJ
ajlm-1317	106	12	and	and	CCONJ
ajlm-1317	106	13	recovered	recovered	ADJ
ajlm-1317	106	14	cases	case	NOUN
ajlm-1317	106	15	of	of	ADP
ajlm-1317	106	16	covid-19	covid-19	PROPN
ajlm-1317	106	17	as	as	ADV
ajlm-1317	106	18	well	well	ADV
ajlm-1317	106	19	as	as	ADP
ajlm-1317	106	20	herd	herd	NOUN
ajlm-1317	106	21	immunity.12	immunity.12	NOUN
ajlm-1317	106	22	the	the	DET
ajlm-1317	106	23	pre	pre	ADJ
ajlm-1317	106	24	-	-	ADJ
ajlm-1317	106	25	evaluation	evaluation	ADJ
ajlm-1317	106	26	assessment	assessment	NOUN
ajlm-1317	106	27	of	of	ADP
ajlm-1317	106	28	pocts	poct	NOUN
ajlm-1317	106	29	is	be	AUX
ajlm-1317	106	30	crucial	crucial	ADJ
ajlm-1317	106	31	to	to	ADP
ajlm-1317	106	32	mitigating	mitigate	VERB
ajlm-1317	106	33	the	the	DET
ajlm-1317	106	34	risks	risk	NOUN
ajlm-1317	106	35	associated	associate	VERB
ajlm-1317	106	36	with	with	ADP
ajlm-1317	106	37	the	the	DET
ajlm-1317	106	38	introduction	introduction	NOUN
ajlm-1317	106	39	of	of	ADP
ajlm-1317	106	40	kits	kit	NOUN
ajlm-1317	106	41	that	that	PRON
ajlm-1317	106	42	can	can	AUX
ajlm-1317	106	43	cause	cause	VERB
ajlm-1317	106	44	public	public	ADJ
ajlm-1317	106	45	anxiety	anxiety	NOUN
ajlm-1317	106	46	and	and	CCONJ
ajlm-1317	106	47	false	false	ADJ
ajlm-1317	106	48	alarm	alarm	NOUN
ajlm-1317	106	49	to	to	ADP
ajlm-1317	106	50	the	the	DET
ajlm-1317	106	51	market	market	NOUN
ajlm-1317	106	52	.	.	PUNCT
ajlm-1317	107	1	the	the	DET
ajlm-1317	107	2	regulatory	regulatory	ADJ
ajlm-1317	107	3	pathway	pathway	NOUN
ajlm-1317	107	4	for	for	ADP
ajlm-1317	107	5	the	the	DET
ajlm-1317	107	6	evaluation	evaluation	NOUN
ajlm-1317	107	7	and	and	CCONJ
ajlm-1317	107	8	assessment	assessment	NOUN
ajlm-1317	107	9	of	of	ADP
ajlm-1317	107	10	pocts	poct	NOUN
ajlm-1317	107	11	per	per	ADP
ajlm-1317	107	12	the	the	DET
ajlm-1317	107	13	stipulated	stipulate	VERB
ajlm-1317	107	14	turnaround	turnaround	NOUN
ajlm-1317	107	15	time	time	NOUN
ajlm-1317	107	16	for	for	ADP
ajlm-1317	107	17	in	in	ADP
ajlm-1317	107	18	vitro	vitro	X
ajlm-1317	107	19	diagnostics	diagnostic	NOUN
ajlm-1317	107	20	takes	take	VERB
ajlm-1317	107	21	1–3	1–3	NUM
ajlm-1317	107	22	years	year	NOUN
ajlm-1317	107	23	;	;	PUNCT
ajlm-1317	107	24	however	however	ADV
ajlm-1317	107	25	,	,	PUNCT
ajlm-1317	107	26	the	the	DET
ajlm-1317	107	27	covid-19	covid-19	PROPN
ajlm-1317	107	28	pandemic	pandemic	NOUN
ajlm-1317	107	29	presented	present	VERB
ajlm-1317	107	30	increased	increase	VERB
ajlm-1317	107	31	pressure	pressure	NOUN
ajlm-1317	107	32	and	and	CCONJ
ajlm-1317	107	33	the	the	DET
ajlm-1317	107	34	need	need	NOUN
ajlm-1317	107	35	to	to	PART
ajlm-1317	107	36	grant	grant	VERB
ajlm-1317	107	37	marketing	marketing	NOUN
ajlm-1317	107	38	authorisation	authorisation	NOUN
ajlm-1317	107	39	to	to	ADP
ajlm-1317	107	40	manufacturers	manufacturer	NOUN
ajlm-1317	107	41	,	,	PUNCT
ajlm-1317	107	42	necessitating	necessitate	VERB
ajlm-1317	107	43	the	the	DET
ajlm-1317	107	44	development	development	NOUN
ajlm-1317	107	45	of	of	ADP
ajlm-1317	107	46	a	a	DET
ajlm-1317	107	47	pre	pre	ADJ
ajlm-1317	107	48	-	-	ADJ
ajlm-1317	107	49	evaluation	evaluation	ADJ
ajlm-1317	107	50	assessment	assessment	NOUN
ajlm-1317	107	51	policy	policy	NOUN
ajlm-1317	107	52	.	.	PUNCT
ajlm-1317	108	1	according	accord	VERB
ajlm-1317	108	2	to	to	ADP
ajlm-1317	108	3	unpublished	unpublished	ADJ
ajlm-1317	108	4	reports	report	NOUN
ajlm-1317	108	5	from	from	ADP
ajlm-1317	108	6	the	the	DET
ajlm-1317	108	7	ppb	ppb	NOUN
ajlm-1317	108	8	,	,	PUNCT
ajlm-1317	108	9	and	and	CCONJ
ajlm-1317	108	10	as	as	ADP
ajlm-1317	108	11	a	a	DET
ajlm-1317	108	12	pre	pre	ADJ
ajlm-1317	108	13	-	-	ADJ
ajlm-1317	108	14	requisite	requisite	ADJ
ajlm-1317	108	15	measure	measure	NOUN
ajlm-1317	108	16	for	for	ADP
ajlm-1317	108	17	issuance	issuance	NOUN
ajlm-1317	108	18	of	of	ADP
ajlm-1317	108	19	the	the	DET
ajlm-1317	108	20	eua	eua	PROPN
ajlm-1317	108	21	,	,	PUNCT
ajlm-1317	108	22	those	those	DET
ajlm-1317	108	23	kits	kit	NOUN
ajlm-1317	108	24	without	without	ADP
ajlm-1317	108	25	satisfactory	satisfactory	ADJ
ajlm-1317	108	26	sensitivity	sensitivity	NOUN
ajlm-1317	108	27	and	and	CCONJ
ajlm-1317	108	28	specificity	specificity	NOUN
ajlm-1317	108	29	results	result	NOUN
ajlm-1317	108	30	must	must	AUX
ajlm-1317	108	31	be	be	AUX
ajlm-1317	108	32	subjected	subject	VERB
ajlm-1317	108	33	to	to	ADP
ajlm-1317	108	34	further	further	ADJ
ajlm-1317	108	35	evaluation	evaluation	NOUN
ajlm-1317	108	36	.	.	PUNCT
ajlm-1317	109	1	the	the	DET
ajlm-1317	109	2	shelf	shelf	NOUN
ajlm-1317	109	3	lives	live	VERB
ajlm-1317	109	4	of	of	ADP
ajlm-1317	109	5	the	the	DET
ajlm-1317	109	6	pocts	poct	NOUN
ajlm-1317	109	7	in	in	ADP
ajlm-1317	109	8	this	this	DET
ajlm-1317	109	9	study	study	NOUN
ajlm-1317	109	10	ranged	range	VERB
ajlm-1317	109	11	from	from	ADP
ajlm-1317	109	12	6	6	NUM
ajlm-1317	109	13	to	to	PART
ajlm-1317	109	14	24	24	NUM
ajlm-1317	109	15	months	month	NOUN
ajlm-1317	109	16	.	.	PUNCT
ajlm-1317	110	1	the	the	DET
ajlm-1317	110	2	manufacturers	manufacturer	NOUN
ajlm-1317	110	3	did	do	AUX
ajlm-1317	110	4	not	not	PART
ajlm-1317	110	5	provide	provide	VERB
ajlm-1317	110	6	reports	report	NOUN
ajlm-1317	110	7	of	of	ADP
ajlm-1317	110	8	their	their	PRON
ajlm-1317	110	9	stability	stability	NOUN
ajlm-1317	110	10	data	datum	NOUN
ajlm-1317	110	11	or	or	CCONJ
ajlm-1317	110	12	their	their	PRON
ajlm-1317	110	13	plans	plan	NOUN
ajlm-1317	110	14	for	for	ADP
ajlm-1317	110	15	generating	generate	VERB
ajlm-1317	110	16	such	such	ADJ
ajlm-1317	110	17	data.13	data.13	NOUN
ajlm-1317	110	18	the	the	DET
ajlm-1317	110	19	study	study	NOUN
ajlm-1317	110	20	showed	show	VERB
ajlm-1317	110	21	that	that	SCONJ
ajlm-1317	110	22	50	50	NUM
ajlm-1317	110	23	%	%	NOUN
ajlm-1317	110	24	of	of	ADP
ajlm-1317	110	25	the	the	DET
ajlm-1317	110	26	pocts	poct	NOUN
ajlm-1317	110	27	that	that	PRON
ajlm-1317	110	28	were	be	AUX
ajlm-1317	110	29	submitted	submit	VERB
ajlm-1317	110	30	for	for	ADP
ajlm-1317	110	31	pre	pre	ADJ
ajlm-1317	110	32	-	-	ADJ
ajlm-1317	110	33	evaluation	evaluation	ADJ
ajlm-1317	110	34	assessment	assessment	NOUN
ajlm-1317	110	35	did	do	AUX
ajlm-1317	110	36	not	not	PART
ajlm-1317	110	37	meet	meet	VERB
ajlm-1317	110	38	the	the	DET
ajlm-1317	110	39	criteria	criterion	NOUN
ajlm-1317	110	40	to	to	PART
ajlm-1317	110	41	proceed	proceed	VERB
ajlm-1317	110	42	to	to	ADP
ajlm-1317	110	43	full	full	ADJ
ajlm-1317	110	44	evaluation	evaluation	NOUN
ajlm-1317	110	45	as	as	SCONJ
ajlm-1317	110	46	they	they	PRON
ajlm-1317	110	47	were	be	AUX
ajlm-1317	110	48	unsatisfactory	unsatisfactory	ADJ
ajlm-1317	110	49	.	.	PUNCT
ajlm-1317	111	1	of	of	ADP
ajlm-1317	111	2	the	the	DET
ajlm-1317	111	3	18	18	NUM
ajlm-1317	111	4	pocts	poct	NOUN
ajlm-1317	111	5	,	,	PUNCT
ajlm-1317	111	6	one	one	NUM
ajlm-1317	111	7	had	have	VERB
ajlm-1317	111	8	no	no	DET
ajlm-1317	111	9	activity	activity	NOUN
ajlm-1317	111	10	at	at	ADV
ajlm-1317	111	11	all	all	ADV
ajlm-1317	111	12	,	,	PUNCT
ajlm-1317	111	13	two	two	NUM
ajlm-1317	111	14	igm	igm	NOUN
ajlm-1317	111	15	-	-	PUNCT
ajlm-1317	111	16	detecting	detect	VERB
ajlm-1317	111	17	tests	test	NOUN
ajlm-1317	111	18	had	have	VERB
ajlm-1317	111	19	both	both	CCONJ
ajlm-1317	111	20	low	low	ADJ
ajlm-1317	111	21	sensitivity	sensitivity	NOUN
ajlm-1317	111	22	and	and	CCONJ
ajlm-1317	111	23	low	low	ADJ
ajlm-1317	111	24	specificity	specificity	NOUN
ajlm-1317	111	25	,	,	PUNCT
ajlm-1317	111	26	and	and	CCONJ
ajlm-1317	111	27	three	three	NUM
ajlm-1317	111	28	tests	test	NOUN
ajlm-1317	111	29	displayed	display	VERB
ajlm-1317	111	30	high	high	ADJ
ajlm-1317	111	31	false	false	ADJ
ajlm-1317	111	32	-	-	PUNCT
ajlm-1317	111	33	positive	positive	ADJ
ajlm-1317	111	34	values	value	NOUN
ajlm-1317	111	35	.	.	PUNCT
ajlm-1317	112	1	only	only	ADV
ajlm-1317	112	2	nine	nine	NUM
ajlm-1317	112	3	(	(	PUNCT
ajlm-1317	112	4	50	50	NUM
ajlm-1317	112	5	%	%	NOUN
ajlm-1317	112	6	)	)	PUNCT
ajlm-1317	112	7	tests	test	NOUN
ajlm-1317	112	8	had	have	VERB
ajlm-1317	112	9	sensitivities	sensitivity	NOUN
ajlm-1317	112	10	of	of	ADP
ajlm-1317	112	11	≥	≥	NOUN
ajlm-1317	112	12	40	40	NUM
ajlm-1317	112	13	%	%	NOUN
ajlm-1317	112	14	(	(	PUNCT
ajlm-1317	112	15	range	range	NOUN
ajlm-1317	112	16	:	:	PUNCT
ajlm-1317	112	17	40	40	NUM
ajlm-1317	112	18	%	%	NOUN
ajlm-1317	112	19	–	–	PUNCT
ajlm-1317	112	20	60	60	NUM
ajlm-1317	112	21	%	%	NOUN
ajlm-1317	112	22	)	)	PUNCT
ajlm-1317	112	23	.	.	PUNCT
ajlm-1317	113	1	the	the	DET
ajlm-1317	113	2	capacity	capacity	NOUN
ajlm-1317	113	3	of	of	ADP
ajlm-1317	113	4	these	these	DET
ajlm-1317	113	5	nine	nine	NUM
ajlm-1317	113	6	tests	test	NOUN
ajlm-1317	113	7	to	to	PART
ajlm-1317	113	8	detect	detect	VERB
ajlm-1317	113	9	igm	igm	NOUN
ajlm-1317	113	10	ranged	range	VERB
ajlm-1317	113	11	from	from	ADP
ajlm-1317	113	12	0	0	NUM
ajlm-1317	113	13	%	%	NOUN
ajlm-1317	113	14	to	to	PART
ajlm-1317	113	15	50	50	NUM
ajlm-1317	113	16	%	%	NOUN
ajlm-1317	113	17	.	.	PUNCT
ajlm-1317	114	1	the	the	DET
ajlm-1317	114	2	majority	majority	NOUN
ajlm-1317	114	3	(	(	PUNCT
ajlm-1317	114	4	57.1	57.1	NUM
ajlm-1317	114	5	%	%	NOUN
ajlm-1317	114	6	)	)	PUNCT
ajlm-1317	114	7	of	of	ADP
ajlm-1317	114	8	the	the	DET
ajlm-1317	114	9	tests	test	NOUN
ajlm-1317	114	10	displayed	display	VERB
ajlm-1317	114	11	very	very	ADV
ajlm-1317	114	12	weak	weak	ADJ
ajlm-1317	114	13	visual	visual	ADJ
ajlm-1317	114	14	igm	igm	PROPN
ajlm-1317	114	15	band	band	NOUN
ajlm-1317	114	16	intensities	intensity	NOUN
ajlm-1317	114	17	(	(	PUNCT
ajlm-1317	114	18	scale	scale	NOUN
ajlm-1317	114	19	scores	score	NOUN
ajlm-1317	114	20	of	of	ADP
ajlm-1317	114	21	2–3	2–3	NUM
ajlm-1317	114	22	)	)	PUNCT
ajlm-1317	114	23	.	.	PUNCT
ajlm-1317	115	1	the	the	DET
ajlm-1317	115	2	sensitivities	sensitivity	NOUN
ajlm-1317	115	3	observed	observe	VERB
ajlm-1317	115	4	in	in	ADP
ajlm-1317	115	5	this	this	DET
ajlm-1317	115	6	evaluation	evaluation	NOUN
ajlm-1317	115	7	were	be	AUX
ajlm-1317	115	8	lower	low	ADJ
ajlm-1317	115	9	than	than	ADP
ajlm-1317	115	10	those	those	PRON
ajlm-1317	115	11	reported	report	VERB
ajlm-1317	115	12	elsewhere	elsewhere	ADV
ajlm-1317	115	13	,	,	PUNCT
ajlm-1317	115	14	and	and	CCONJ
ajlm-1317	115	15	the	the	DET
ajlm-1317	115	16	ability	ability	NOUN
ajlm-1317	115	17	of	of	ADP
ajlm-1317	115	18	the	the	DET
ajlm-1317	115	19	tests	test	NOUN
ajlm-1317	115	20	to	to	PART
ajlm-1317	115	21	detect	detect	VERB
ajlm-1317	115	22	igm	igm	NOUN
ajlm-1317	115	23	varied	varied	ADJ
ajlm-1317	115	24	,	,	PUNCT
ajlm-1317	115	25	with	with	ADP
ajlm-1317	115	26	one	one	NUM
ajlm-1317	115	27	test	test	NOUN
ajlm-1317	115	28	failing	fail	VERB
ajlm-1317	115	29	to	to	PART
ajlm-1317	115	30	capture	capture	VERB
ajlm-1317	115	31	any	any	DET
ajlm-1317	115	32	covid-19	covid-19	PROPN
ajlm-1317	115	33	igm	igm	PROPN
ajlm-1317	115	34	.	.	PUNCT
ajlm-1317	116	1	there	there	PRON
ajlm-1317	116	2	was	be	VERB
ajlm-1317	116	3	also	also	ADV
ajlm-1317	116	4	a	a	DET
ajlm-1317	116	5	weak	weak	ADJ
ajlm-1317	116	6	positive	positive	ADJ
ajlm-1317	116	7	correlation	correlation	NOUN
ajlm-1317	116	8	between	between	ADP
ajlm-1317	116	9	igm	igm	PROPN
ajlm-1317	116	10	and	and	CCONJ
ajlm-1317	116	11	igg	igg	PROPN
ajlm-1317	116	12	sensitivity	sensitivity	NOUN
ajlm-1317	116	13	for	for	ADP
ajlm-1317	116	14	the	the	DET
ajlm-1317	116	15	kits	kit	NOUN
ajlm-1317	116	16	.	.	PUNCT
ajlm-1317	117	1	the	the	DET
ajlm-1317	117	2	abbott	abbott	PROPN
ajlm-1317	117	3	i	i	PROPN
ajlm-1317	117	4	d	d	PROPN
ajlm-1317	117	5	now	now	ADV
ajlm-1317	117	6	covid-19	covid-19	PROPN
ajlm-1317	117	7	test	test	NOUN
ajlm-1317	117	8	(	(	PUNCT
ajlm-1317	117	9	abbott	abbott	PROPN
ajlm-1317	117	10	laboratories	laboratories	PROPN
ajlm-1317	117	11	,	,	PUNCT
ajlm-1317	117	12	abbott	abbott	PROPN
ajlm-1317	117	13	park	park	PROPN
ajlm-1317	117	14	,	,	PUNCT
ajlm-1317	117	15	illinois	illinois	PROPN
ajlm-1317	117	16	,	,	PUNCT
ajlm-1317	117	17	united	united	PROPN
ajlm-1317	117	18	states	states	PROPN
ajlm-1317	117	19	)	)	PUNCT
ajlm-1317	117	20	is	be	AUX
ajlm-1317	117	21	said	say	VERB
ajlm-1317	117	22	to	to	PART
ajlm-1317	117	23	be	be	AUX
ajlm-1317	117	24	the	the	DET
ajlm-1317	117	25	most	most	ADV
ajlm-1317	117	26	sensitive	sensitive	ADJ
ajlm-1317	117	27	and	and	CCONJ
ajlm-1317	117	28	specific	specific	ADJ
ajlm-1317	117	29	poct	poct	NOUN
ajlm-1317	117	30	on	on	ADP
ajlm-1317	117	31	the	the	DET
ajlm-1317	117	32	global	global	ADJ
ajlm-1317	117	33	market	market	NOUN
ajlm-1317	117	34	,	,	PUNCT
ajlm-1317	117	35	with	with	ADP
ajlm-1317	117	36	a	a	DET
ajlm-1317	117	37	sensitivity	sensitivity	NOUN
ajlm-1317	117	38	of	of	ADP
ajlm-1317	117	39	80.4	80.4	NUM
ajlm-1317	117	40	%	%	NOUN
ajlm-1317	117	41	and	and	CCONJ
ajlm-1317	117	42	specificity	specificity	NOUN
ajlm-1317	117	43	of	of	ADP
ajlm-1317	117	44	95.9	95.9	NUM
ajlm-1317	117	45	%	%	NOUN
ajlm-1317	117	46	with	with	ADP
ajlm-1317	117	47	rrt	rrt	NOUN
ajlm-1317	117	48	-	-	NOUN
ajlm-1317	117	49	pcr	pcr	NOUN
ajlm-1317	117	50	as	as	ADP
ajlm-1317	117	51	the	the	DET
ajlm-1317	117	52	standard.14,15	standard.14,15	NOUN
ajlm-1317	117	53	a	a	DET
ajlm-1317	117	54	study	study	NOUN
ajlm-1317	117	55	conducted	conduct	VERB
ajlm-1317	117	56	to	to	PART
ajlm-1317	117	57	assess	assess	VERB
ajlm-1317	117	58	the	the	DET
ajlm-1317	117	59	quality	quality	NOUN
ajlm-1317	117	60	of	of	ADP
ajlm-1317	117	61	a	a	DET
ajlm-1317	117	62	poct	poct	NOUN
ajlm-1317	117	63	based	base	VERB
ajlm-1317	117	64	solely	solely	ADV
ajlm-1317	117	65	on	on	ADP
ajlm-1317	117	66	pcr	pcr	NOUN
ajlm-1317	117	67	-	-	PUNCT
ajlm-1317	117	68	positivity	positivity	NOUN
ajlm-1317	117	69	among	among	ADP
ajlm-1317	117	70	anonymous	anonymous	ADJ
ajlm-1317	117	71	blood	blood	NOUN
ajlm-1317	117	72	donors	donor	NOUN
ajlm-1317	117	73	in	in	ADP
ajlm-1317	117	74	uppsala	uppsala	PROPN
ajlm-1317	117	75	university	university	PROPN
ajlm-1317	117	76	,	,	PUNCT
ajlm-1317	117	77	uppsala	uppsala	PROPN
ajlm-1317	117	78	,	,	PUNCT
ajlm-1317	117	79	sweden	sweden	PROPN
ajlm-1317	117	80	,	,	PUNCT
ajlm-1317	117	81	reported	report	VERB
ajlm-1317	117	82	a	a	DET
ajlm-1317	117	83	high	high	ADJ
ajlm-1317	117	84	performance	performance	NOUN
ajlm-1317	117	85	,	,	PUNCT
ajlm-1317	117	86	with	with	ADP
ajlm-1317	117	87	sensitivities	sensitivity	NOUN
ajlm-1317	117	88	of	of	ADP
ajlm-1317	117	89	69	69	NUM
ajlm-1317	117	90	%	%	NOUN
ajlm-1317	117	91	for	for	ADP
ajlm-1317	117	92	igm	igm	NOUN
ajlm-1317	117	93	and	and	CCONJ
ajlm-1317	117	94	93.1	93.1	NUM
ajlm-1317	117	95	%	%	NOUN
ajlm-1317	117	96	for	for	ADP
ajlm-1317	117	97	igg	igg	PROPN
ajlm-1317	117	98	,	,	PUNCT
ajlm-1317	117	99	and	and	CCONJ
ajlm-1317	117	100	specificities	specificity	NOUN
ajlm-1317	117	101	of	of	ADP
ajlm-1317	117	102	100	100	NUM
ajlm-1317	117	103	%	%	NOUN
ajlm-1317	117	104	for	for	ADP
ajlm-1317	117	105	igm	igm	NOUN
ajlm-1317	117	106	and	and	CCONJ
ajlm-1317	117	107	99.2	99.2	NUM
ajlm-1317	117	108	%	%	NOUN
ajlm-1317	117	109	for	for	ADP
ajlm-1317	117	110	igg.16	igg.16	PROPN
ajlm-1317	117	111	another	another	DET
ajlm-1317	117	112	study	study	NOUN
ajlm-1317	117	113	conducted	conduct	VERB
ajlm-1317	117	114	in	in	ADP
ajlm-1317	117	115	china	china	PROPN
ajlm-1317	117	116	among	among	ADP
ajlm-1317	117	117	covid-19	covid-19	PROPN
ajlm-1317	117	118	-	-	PUNCT
ajlm-1317	117	119	positive	positive	ADJ
ajlm-1317	117	120	patients	patient	NOUN
ajlm-1317	117	121	established	establish	VERB
ajlm-1317	117	122	the	the	DET
ajlm-1317	117	123	sensitivity	sensitivity	NOUN
ajlm-1317	117	124	and	and	CCONJ
ajlm-1317	117	125	specificity	specificity	NOUN
ajlm-1317	117	126	of	of	ADP
ajlm-1317	117	127	the	the	DET
ajlm-1317	117	128	test	test	NOUN
ajlm-1317	117	129	they	they	PRON
ajlm-1317	117	130	assessed	assess	VERB
ajlm-1317	117	131	to	to	PART
ajlm-1317	117	132	be	be	AUX
ajlm-1317	117	133	88.66	88.66	NUM
ajlm-1317	117	134	%	%	NOUN
ajlm-1317	117	135	and	and	CCONJ
ajlm-1317	117	136	90.63%.17	90.63%.17	PRON
ajlm-1317	117	137	a	a	DET
ajlm-1317	117	138	study	study	NOUN
ajlm-1317	117	139	done	do	VERB
ajlm-1317	117	140	at	at	ADP
ajlm-1317	117	141	guangzhou	guangzhou	PROPN
ajlm-1317	117	142	eighth	eighth	PROPN
ajlm-1317	117	143	people	people	PROPN
ajlm-1317	117	144	’s	’s	PART
ajlm-1317	117	145	hospital	hospital	NOUN
ajlm-1317	117	146	,	,	PUNCT
ajlm-1317	117	147	china	china	PROPN
ajlm-1317	117	148	,	,	PUNCT
ajlm-1317	117	149	among	among	ADP
ajlm-1317	117	150	patients	patient	NOUN
ajlm-1317	117	151	with	with	ADP
ajlm-1317	117	152	confirmed	confirm	VERB
ajlm-1317	117	153	sars	sar	NOUN
ajlm-1317	117	154	-	-	PUNCT
ajlm-1317	117	155	cov-2	cov-2	PART
ajlm-1317	117	156	infection	infection	NOUN
ajlm-1317	117	157	found	find	VERB
ajlm-1317	117	158	that	that	SCONJ
ajlm-1317	117	159	the	the	DET
ajlm-1317	117	160	combined	combined	ADJ
ajlm-1317	117	161	detection	detection	NOUN
ajlm-1317	117	162	of	of	ADP
ajlm-1317	117	163	nucleocapsid	nucleocapsid	NOUN
ajlm-1317	117	164	-	-	PUNCT
ajlm-1317	117	165	specific	specific	ADJ
ajlm-1317	117	166	and	and	CCONJ
ajlm-1317	117	167	spike	spike	ADJ
ajlm-1317	117	168	-	-	PUNCT
ajlm-1317	117	169	specific	specific	ADJ
ajlm-1317	117	170	igm	igm	NOUN
ajlm-1317	117	171	and	and	CCONJ
ajlm-1317	117	172	igg	igg	PROPN
ajlm-1317	117	173	could	could	AUX
ajlm-1317	117	174	identify	identify	VERB
ajlm-1317	117	175	up	up	ADP
ajlm-1317	117	176	to	to	PART
ajlm-1317	117	177	75	75	NUM
ajlm-1317	117	178	%	%	NOUN
ajlm-1317	117	179	of	of	ADP
ajlm-1317	117	180	sars	sar	NOUN
ajlm-1317	117	181	-	-	PUNCT
ajlm-1317	117	182	cov-2	cov-2	ADP
ajlm-1317	117	183	-	-	ADJ
ajlm-1317	117	184	positive	positive	ADJ
ajlm-1317	117	185	cases	case	NOUN
ajlm-1317	117	186	in	in	ADP
ajlm-1317	117	187	the	the	DET
ajlm-1317	117	188	first	first	ADJ
ajlm-1317	117	189	week	week	NOUN
ajlm-1317	117	190	using	use	VERB
ajlm-1317	117	191	an	an	DET
ajlm-1317	117	192	enzyme	enzyme	NOUN
ajlm-1317	117	193	-	-	PUNCT
ajlm-1317	117	194	linked	link	VERB
ajlm-1317	117	195	immunosorbent	immunosorbent	NOUN
ajlm-1317	117	196	assay	assay	NOUN
ajlm-1317	117	197	test	test	NOUN
ajlm-1317	117	198	kit.18	kit.18	VERB
ajlm-1317	117	199	in	in	ADP
ajlm-1317	117	200	consonance	consonance	NOUN
ajlm-1317	117	201	with	with	ADP
ajlm-1317	117	202	the	the	DET
ajlm-1317	117	203	findings	finding	NOUN
ajlm-1317	117	204	of	of	ADP
ajlm-1317	117	205	this	this	DET
ajlm-1317	117	206	study	study	NOUN
ajlm-1317	117	207	,	,	PUNCT
ajlm-1317	117	208	the	the	DET
ajlm-1317	117	209	organization	organization	NOUN
ajlm-1317	117	210	for	for	ADP
ajlm-1317	117	211	economic	economic	ADJ
ajlm-1317	117	212	co	co	NOUN
ajlm-1317	117	213	-	-	NOUN
ajlm-1317	117	214	operation	operation	NOUN
ajlm-1317	117	215	and	and	CCONJ
ajlm-1317	117	216	development	development	NOUN
ajlm-1317	117	217	has	have	AUX
ajlm-1317	117	218	emphasised	emphasise	VERB
ajlm-1317	117	219	the	the	DET
ajlm-1317	117	220	need	need	NOUN
ajlm-1317	117	221	to	to	PART
ajlm-1317	117	222	recognise	recognise	VERB
ajlm-1317	117	223	that	that	SCONJ
ajlm-1317	117	224	pocts	poct	NOUN
ajlm-1317	117	225	have	have	AUX
ajlm-1317	117	226	not	not	PART
ajlm-1317	117	227	been	be	AUX
ajlm-1317	117	228	fully	fully	ADV
ajlm-1317	117	229	developed	develop	VERB
ajlm-1317	117	230	for	for	ADP
ajlm-1317	117	231	sars‑cov‑2	sars‑cov‑2	NOUN
ajlm-1317	117	232	and	and	CCONJ
ajlm-1317	117	233	their	their	PRON
ajlm-1317	117	234	true	true	ADJ
ajlm-1317	117	235	clinical	clinical	ADJ
ajlm-1317	117	236	performance	performance	NOUN
ajlm-1317	117	237	is	be	AUX
ajlm-1317	117	238	mostly	mostly	ADV
ajlm-1317	117	239	unknown.19	unknown.19	PRON
ajlm-1317	117	240	a	a	DET
ajlm-1317	117	241	satisfactory	satisfactory	ADJ
ajlm-1317	117	242	quality	quality	NOUN
ajlm-1317	117	243	assessment	assessment	NOUN
ajlm-1317	117	244	of	of	ADP
ajlm-1317	117	245	covid-19	covid-19	PROPN
ajlm-1317	117	246	diagnostics	diagnostic	NOUN
ajlm-1317	117	247	is	be	AUX
ajlm-1317	117	248	very	very	ADV
ajlm-1317	117	249	critical	critical	ADJ
ajlm-1317	117	250	.	.	PUNCT
ajlm-1317	118	1	recently	recently	ADV
ajlm-1317	118	2	,	,	PUNCT
ajlm-1317	118	3	quality	quality	NOUN
ajlm-1317	118	4	failure	failure	NOUN
ajlm-1317	118	5	-	-	PUNCT
ajlm-1317	118	6	related	relate	VERB
ajlm-1317	118	7	issues	issue	NOUN
ajlm-1317	118	8	have	have	AUX
ajlm-1317	118	9	been	be	AUX
ajlm-1317	118	10	reported	report	VERB
ajlm-1317	118	11	globally	globally	ADV
ajlm-1317	118	12	.	.	PUNCT
ajlm-1317	119	1	these	these	PRON
ajlm-1317	119	2	include	include	VERB
ajlm-1317	119	3	instances	instance	NOUN
ajlm-1317	119	4	such	such	ADJ
ajlm-1317	119	5	as	as	ADP
ajlm-1317	119	6	india	india	PROPN
ajlm-1317	119	7	stopping	stop	VERB
ajlm-1317	119	8	the	the	DET
ajlm-1317	119	9	use	use	NOUN
ajlm-1317	119	10	of	of	ADP
ajlm-1317	119	11	500	500	NUM
ajlm-1317	119	12	000	000	NUM
ajlm-1317	119	13	pocts	poct	NOUN
ajlm-1317	119	14	from	from	ADP
ajlm-1317	119	15	two	two	NUM
ajlm-1317	119	16	chinese	chinese	ADJ
ajlm-1317	119	17	firms	firm	NOUN
ajlm-1317	119	18	for	for	ADP
ajlm-1317	119	19	questionable	questionable	ADJ
ajlm-1317	119	20	efficacy,20	efficacy,20	NOUN
ajlm-1317	119	21	a	a	DET
ajlm-1317	119	22	report	report	NOUN
ajlm-1317	119	23	of	of	ADP
ajlm-1317	119	24	initial	initial	ADJ
ajlm-1317	119	25	pcr	pcr	ADJ
ajlm-1317	119	26	test	test	NOUN
ajlm-1317	119	27	kits	kit	NOUN
ajlm-1317	119	28	that	that	PRON
ajlm-1317	119	29	were	be	AUX
ajlm-1317	119	30	contaminated	contaminate	VERB
ajlm-1317	119	31	with	with	ADP
ajlm-1317	119	32	coronavirus	coronavirus	NOUN
ajlm-1317	119	33	synthetic	synthetic	ADJ
ajlm-1317	119	34	materials	material	NOUN
ajlm-1317	119	35	in	in	ADP
ajlm-1317	119	36	the	the	DET
ajlm-1317	119	37	united	united	PROPN
ajlm-1317	119	38	states,21	states,21	PROPN
ajlm-1317	119	39	britain	britain	PROPN
ajlm-1317	119	40	buying	buy	VERB
ajlm-1317	119	41	millions	million	NOUN
ajlm-1317	119	42	of	of	ADP
ajlm-1317	119	43	pocts	poct	NOUN
ajlm-1317	119	44	that	that	PRON
ajlm-1317	119	45	did	do	AUX
ajlm-1317	119	46	not	not	PART
ajlm-1317	119	47	work,22	work,22	AUX
ajlm-1317	119	48	first	first	ADJ
ajlm-1317	119	49	samples	sample	NOUN
ajlm-1317	119	50	of	of	ADP
ajlm-1317	119	51	pocts	poct	NOUN
ajlm-1317	119	52	manufactured	manufacture	VERB
ajlm-1317	119	53	in	in	ADP
ajlm-1317	119	54	india	india	PROPN
ajlm-1317	119	55	failing	fail	VERB
ajlm-1317	119	56	the	the	DET
ajlm-1317	119	57	quality	quality	NOUN
ajlm-1317	119	58	tests,23	tests,23	NOUN
ajlm-1317	119	59	and	and	CCONJ
ajlm-1317	119	60	spain	spain	PROPN
ajlm-1317	119	61	withdrawing	withdraw	VERB
ajlm-1317	119	62	chinese	chinese	ADJ
ajlm-1317	119	63	-	-	PUNCT
ajlm-1317	119	64	manufactured	manufacture	VERB
ajlm-1317	119	65	kits	kit	NOUN
ajlm-1317	119	66	with	with	ADP
ajlm-1317	119	67	a	a	DET
ajlm-1317	119	68	sensitivity	sensitivity	NOUN
ajlm-1317	119	69	of	of	ADP
ajlm-1317	119	70	30%.24	30%.24	NUM
ajlm-1317	119	71	it	it	PRON
ajlm-1317	119	72	is	be	AUX
ajlm-1317	119	73	noteworthy	noteworthy	ADJ
ajlm-1317	119	74	that	that	SCONJ
ajlm-1317	119	75	kit	kit	NOUN
ajlm-1317	119	76	11	11	NUM
ajlm-1317	119	77	,	,	PUNCT
ajlm-1317	119	78	which	which	PRON
ajlm-1317	119	79	failed	fail	VERB
ajlm-1317	119	80	in	in	ADP
ajlm-1317	119	81	this	this	DET
ajlm-1317	119	82	study	study	NOUN
ajlm-1317	119	83	,	,	PUNCT
ajlm-1317	119	84	is	be	AUX
ajlm-1317	119	85	from	from	ADP
ajlm-1317	119	86	the	the	DET
ajlm-1317	119	87	same	same	ADJ
ajlm-1317	119	88	company	company	NOUN
ajlm-1317	119	89	that	that	PRON
ajlm-1317	119	90	made	make	VERB
ajlm-1317	119	91	the	the	DET
ajlm-1317	119	92	kits	kit	NOUN
ajlm-1317	119	93	that	that	PRON
ajlm-1317	119	94	failed	fail	VERB
ajlm-1317	119	95	in	in	ADP
ajlm-1317	119	96	india	india	PROPN
ajlm-1317	119	97	.	.	PUNCT
ajlm-1317	120	1	all	all	DET
ajlm-1317	120	2	kits	kit	NOUN
ajlm-1317	120	3	need	need	VERB
ajlm-1317	120	4	to	to	PART
ajlm-1317	120	5	be	be	AUX
ajlm-1317	120	6	re	re	VERB
ajlm-1317	120	7	-	-	VERB
ajlm-1317	120	8	evaluated	evaluated	ADJ
ajlm-1317	120	9	using	use	VERB
ajlm-1317	120	10	standard	standard	ADJ
ajlm-1317	120	11	covid-19	covid-19	PROPN
ajlm-1317	120	12	igg	igg	PROPN
ajlm-1317	120	13	and	and	CCONJ
ajlm-1317	120	14	igm	igm	PROPN
ajlm-1317	120	15	to	to	PART
ajlm-1317	120	16	establish	establish	VERB
ajlm-1317	120	17	a	a	DET
ajlm-1317	120	18	gold	gold	ADJ
ajlm-1317	120	19	standard	standard	ADJ
ajlm-1317	120	20	poct	poct	NOUN
ajlm-1317	120	21	.	.	PUNCT
ajlm-1317	121	1	the	the	DET
ajlm-1317	121	2	kits	kit	NOUN
ajlm-1317	121	3	assessed	assess	VERB
ajlm-1317	121	4	in	in	ADP
ajlm-1317	121	5	this	this	DET
ajlm-1317	121	6	pre	pre	NOUN
ajlm-1317	121	7	-	-	NOUN
ajlm-1317	121	8	evaluation	evaluation	NOUN
ajlm-1317	121	9	should	should	AUX
ajlm-1317	121	10	be	be	AUX
ajlm-1317	121	11	limited	limit	VERB
ajlm-1317	121	12	to	to	PART
ajlm-1317	121	13	use	use	VERB
ajlm-1317	121	14	in	in	ADP
ajlm-1317	121	15	research	research	NOUN
ajlm-1317	121	16	and	and	CCONJ
ajlm-1317	121	17	sero	sero	NOUN
ajlm-1317	121	18	-	-	PUNCT
ajlm-1317	121	19	surveillance	surveillance	NOUN
ajlm-1317	121	20	only	only	ADV
ajlm-1317	121	21	.	.	PUNCT
ajlm-1317	122	1	furthermore	furthermore	ADV
ajlm-1317	122	2	,	,	PUNCT
ajlm-1317	122	3	there	there	PRON
ajlm-1317	122	4	is	be	VERB
ajlm-1317	122	5	a	a	DET
ajlm-1317	122	6	need	need	NOUN
ajlm-1317	122	7	for	for	ADP
ajlm-1317	122	8	continued	continue	VERB
ajlm-1317	122	9	evaluation	evaluation	NOUN
ajlm-1317	122	10	of	of	ADP
ajlm-1317	122	11	these	these	DET
ajlm-1317	122	12	kits	kit	NOUN
ajlm-1317	122	13	using	use	VERB
ajlm-1317	122	14	whole	whole	ADJ
ajlm-1317	122	15	blood	blood	NOUN
ajlm-1317	122	16	samples	sample	NOUN
ajlm-1317	122	17	with	with	ADP
ajlm-1317	122	18	larger	large	ADJ
ajlm-1317	122	19	sample	sample	NOUN
ajlm-1317	122	20	sets	set	NOUN
ajlm-1317	122	21	of	of	ADP
ajlm-1317	122	22	at	at	ADV
ajlm-1317	122	23	least	least	ADV
ajlm-1317	122	24	400	400	NUM
ajlm-1317	122	25	covid-19	covid-19	PROPN
ajlm-1317	122	26	-	-	PUNCT
ajlm-1317	122	27	positive	positive	ADJ
ajlm-1317	122	28	and	and	CCONJ
ajlm-1317	122	29	negative	negative	ADJ
ajlm-1317	122	30	samples	sample	NOUN
ajlm-1317	122	31	.	.	PUNCT
ajlm-1317	123	1	this	this	PRON
ajlm-1317	123	2	would	would	AUX
ajlm-1317	123	3	be	be	AUX
ajlm-1317	123	4	a	a	DET
ajlm-1317	123	5	full	full	ADJ
ajlm-1317	123	6	evaluation	evaluation	NOUN
ajlm-1317	123	7	of	of	ADP
ajlm-1317	123	8	the	the	DET
ajlm-1317	123	9	kits	kit	NOUN
ajlm-1317	123	10	and	and	CCONJ
ajlm-1317	123	11	would	would	AUX
ajlm-1317	123	12	increase	increase	VERB
ajlm-1317	123	13	the	the	DET
ajlm-1317	123	14	power	power	NOUN
ajlm-1317	123	15	of	of	ADP
ajlm-1317	123	16	the	the	DET
ajlm-1317	123	17	study	study	NOUN
ajlm-1317	123	18	.	.	PUNCT
ajlm-1317	124	1	there	there	PRON
ajlm-1317	124	2	is	be	VERB
ajlm-1317	124	3	also	also	ADV
ajlm-1317	124	4	a	a	DET
ajlm-1317	124	5	need	need	NOUN
ajlm-1317	124	6	to	to	PART
ajlm-1317	124	7	formulate	formulate	VERB
ajlm-1317	124	8	national	national	ADJ
ajlm-1317	124	9	and	and	CCONJ
ajlm-1317	124	10	international	international	ADJ
ajlm-1317	124	11	policies	policy	NOUN
ajlm-1317	124	12	on	on	ADP
ajlm-1317	124	13	the	the	DET
ajlm-1317	124	14	determination	determination	NOUN
ajlm-1317	124	15	of	of	ADP
ajlm-1317	124	16	shelf	shelf	NOUN
ajlm-1317	124	17	lives	life	NOUN
ajlm-1317	124	18	of	of	ADP
ajlm-1317	124	19	products	product	NOUN
ajlm-1317	124	20	that	that	PRON
ajlm-1317	124	21	are	be	AUX
ajlm-1317	124	22	developed	develop	VERB
ajlm-1317	124	23	during	during	ADP
ajlm-1317	124	24	medical	medical	ADJ
ajlm-1317	124	25	emergencies	emergency	NOUN
ajlm-1317	124	26	such	such	ADJ
ajlm-1317	124	27	as	as	ADP
ajlm-1317	124	28	the	the	DET
ajlm-1317	124	29	covid-19	covid-19	PROPN
ajlm-1317	124	30	pandemic	pandemic	NOUN
ajlm-1317	124	31	.	.	PUNCT
ajlm-1317	125	1	limitations	limitation	NOUN
ajlm-1317	125	2	this	this	DET
ajlm-1317	125	3	study	study	NOUN
ajlm-1317	125	4	only	only	ADV
ajlm-1317	125	5	used	use	VERB
ajlm-1317	125	6	plasma	plasma	NOUN
ajlm-1317	125	7	matrix	matrix	NOUN
ajlm-1317	125	8	.	.	PUNCT
ajlm-1317	126	1	there	there	PRON
ajlm-1317	126	2	is	be	VERB
ajlm-1317	126	3	a	a	DET
ajlm-1317	126	4	need	need	NOUN
ajlm-1317	126	5	to	to	PART
ajlm-1317	126	6	assess	assess	VERB
ajlm-1317	126	7	the	the	DET
ajlm-1317	126	8	performance	performance	NOUN
ajlm-1317	126	9	of	of	ADP
ajlm-1317	126	10	these	these	DET
ajlm-1317	126	11	poct	poct	NOUN
ajlm-1317	126	12	kits	kit	NOUN
ajlm-1317	126	13	using	use	VERB
ajlm-1317	126	14	whole	whole	ADJ
ajlm-1317	126	15	blood	blood	NOUN
ajlm-1317	126	16	samples	sample	NOUN
ajlm-1317	126	17	,	,	PUNCT
ajlm-1317	126	18	especially	especially	ADV
ajlm-1317	126	19	whole	whole	ADJ
ajlm-1317	126	20	blood	blood	NOUN
ajlm-1317	126	21	from	from	ADP
ajlm-1317	126	22	finger	finger	NOUN
ajlm-1317	126	23	pricks	prick	NOUN
ajlm-1317	126	24	and	and	CCONJ
ajlm-1317	126	25	serum	serum	NOUN
ajlm-1317	126	26	as	as	ADP
ajlm-1317	126	27	per	per	ADP
ajlm-1317	126	28	the	the	DET
ajlm-1317	126	29	manufacturers	manufacturer	NOUN
ajlm-1317	126	30	’	’	PART
ajlm-1317	126	31	instructions	instruction	NOUN
ajlm-1317	126	32	.	.	PUNCT
ajlm-1317	127	1	the	the	DET
ajlm-1317	127	2	sample	sample	NOUN
ajlm-1317	127	3	size	size	NOUN
ajlm-1317	127	4	used	use	VERB
ajlm-1317	127	5	in	in	ADP
ajlm-1317	127	6	this	this	DET
ajlm-1317	127	7	study	study	NOUN
ajlm-1317	127	8	was	be	AUX
ajlm-1317	127	9	less	less	ADJ
ajlm-1317	127	10	than	than	ADP
ajlm-1317	127	11	the	the	DET
ajlm-1317	127	12	400	400	NUM
ajlm-1317	127	13	samples	sample	NOUN
ajlm-1317	127	14	recommended	recommend	VERB
ajlm-1317	127	15	by	by	ADP
ajlm-1317	127	16	the	the	DET
ajlm-1317	127	17	world	world	PROPN
ajlm-1317	127	18	health	health	PROPN
ajlm-1317	127	19	organization	organization	NOUN
ajlm-1317	127	20	.	.	PUNCT
ajlm-1317	128	1	the	the	DET
ajlm-1317	128	2	suppliers	supplier	NOUN
ajlm-1317	128	3	of	of	ADP
ajlm-1317	128	4	the	the	DET
ajlm-1317	128	5	pocts	poct	NOUN
ajlm-1317	128	6	could	could	AUX
ajlm-1317	128	7	not	not	PART
ajlm-1317	128	8	provide	provide	VERB
ajlm-1317	128	9	the	the	DET
ajlm-1317	128	10	adequate	adequate	ADJ
ajlm-1317	128	11	number	number	NOUN
ajlm-1317	128	12	of	of	ADP
ajlm-1317	128	13	kits	kit	NOUN
ajlm-1317	128	14	required	require	VERB
ajlm-1317	128	15	.	.	PUNCT
ajlm-1317	129	1	conclusion	conclusion	NOUN
ajlm-1317	129	2	there	there	PRON
ajlm-1317	129	3	was	be	VERB
ajlm-1317	129	4	very	very	ADV
ajlm-1317	129	5	poor	poor	ADJ
ajlm-1317	129	6	igm	igm	NOUN
ajlm-1317	129	7	detection	detection	NOUN
ajlm-1317	129	8	by	by	ADP
ajlm-1317	129	9	most	most	ADJ
ajlm-1317	129	10	of	of	ADP
ajlm-1317	129	11	the	the	DET
ajlm-1317	129	12	poct	poct	NOUN
ajlm-1317	129	13	kits	kit	NOUN
ajlm-1317	129	14	assessed	assess	VERB
ajlm-1317	129	15	and	and	CCONJ
ajlm-1317	129	16	this	this	PRON
ajlm-1317	129	17	could	could	AUX
ajlm-1317	129	18	affect	affect	VERB
ajlm-1317	129	19	timely	timely	ADJ
ajlm-1317	129	20	detection	detection	NOUN
ajlm-1317	129	21	of	of	ADP
ajlm-1317	129	22	covid-19	covid-19	PROPN
ajlm-1317	129	23	early	early	ADJ
ajlm-1317	129	24	infection	infection	NOUN
ajlm-1317	129	25	and	and	CCONJ
ajlm-1317	129	26	spread	spread	VERB
ajlm-1317	129	27	as	as	ADP
ajlm-1317	129	28	compared	compare	VERB
ajlm-1317	129	29	to	to	ADP
ajlm-1317	129	30	rrt	rrt	NOUN
ajlm-1317	129	31	-	-	NOUN
ajlm-1317	129	32	pcr	pcr	ADJ
ajlm-1317	129	33	.	.	PUNCT
ajlm-1317	130	1	similarly	similarly	ADV
ajlm-1317	130	2	,	,	PUNCT
ajlm-1317	130	3	the	the	DET
ajlm-1317	130	4	serological	serological	NOUN
ajlm-1317	130	5	-	-	PUNCT
ajlm-1317	130	6	based	base	VERB
ajlm-1317	130	7	test	test	NOUN
ajlm-1317	130	8	kits	kit	NOUN
ajlm-1317	130	9	available	available	ADJ
ajlm-1317	130	10	in	in	ADP
ajlm-1317	130	11	the	the	DET
ajlm-1317	130	12	country	country	NOUN
ajlm-1317	130	13	can	can	AUX
ajlm-1317	130	14	only	only	ADV
ajlm-1317	130	15	detect	detect	VERB
ajlm-1317	130	16	up	up	ADV
ajlm-1317	130	17	to	to	PART
ajlm-1317	130	18	60	60	NUM
ajlm-1317	130	19	%	%	NOUN
ajlm-1317	130	20	of	of	ADP
ajlm-1317	130	21	the	the	DET
ajlm-1317	130	22	infected	infected	ADJ
ajlm-1317	130	23	population	population	NOUN
ajlm-1317	130	24	.	.	PUNCT
ajlm-1317	131	1	acknowledgements	acknowledgement	NOUN
ajlm-1317	131	2	this	this	DET
ajlm-1317	131	3	work	work	NOUN
ajlm-1317	131	4	was	be	AUX
ajlm-1317	131	5	supported	support	VERB
ajlm-1317	131	6	by	by	ADP
ajlm-1317	131	7	prof	prof	PROPN
ajlm-1317	131	8	.	.	PUNCT
ajlm-1317	131	9	yeri	yeri	PROPN
ajlm-1317	131	10	kombe	kombe	PROPN
ajlm-1317	131	11	,	,	PUNCT
ajlm-1317	131	12	director	director	NOUN
ajlm-1317	131	13	general	general	NOUN
ajlm-1317	131	14	,	,	PUNCT
ajlm-1317	131	15	kenya	kenya	PROPN
ajlm-1317	131	16	medical	medical	PROPN
ajlm-1317	131	17	research	research	PROPN
ajlm-1317	131	18	institute	institute	PROPN
ajlm-1317	131	19	,	,	PUNCT
ajlm-1317	131	20	to	to	PART
ajlm-1317	131	21	whom	whom	PRON
ajlm-1317	131	22	we	we	PRON
ajlm-1317	131	23	are	be	AUX
ajlm-1317	131	24	very	very	ADV
ajlm-1317	131	25	grateful	grateful	ADJ
ajlm-1317	131	26	.	.	PUNCT
ajlm-1317	132	1	we	we	PRON
ajlm-1317	132	2	are	be	AUX
ajlm-1317	132	3	also	also	ADV
ajlm-1317	132	4	grateful	grateful	ADJ
ajlm-1317	132	5	to	to	ADP
ajlm-1317	132	6	dr	dr	PROPN
ajlm-1317	132	7	fred	fred	PROPN
ajlm-1317	132	8	siyoi	siyoi	PROPN
ajlm-1317	132	9	,	,	PUNCT
ajlm-1317	132	10	chief	chief	ADJ
ajlm-1317	132	11	executive	executive	ADJ
ajlm-1317	132	12	officer	officer	NOUN
ajlm-1317	132	13	,	,	PUNCT
ajlm-1317	132	14	pharmacy	pharmacy	NOUN
ajlm-1317	132	15	and	and	CCONJ
ajlm-1317	132	16	poisons	poison	NOUN
ajlm-1317	132	17	board	board	PROPN
ajlm-1317	132	18	,	,	PUNCT
ajlm-1317	132	19	kenya	kenya	PROPN
ajlm-1317	132	20	,	,	PUNCT
ajlm-1317	132	21	for	for	ADP
ajlm-1317	132	22	his	his	PRON
ajlm-1317	132	23	unreserved	unreserved	ADJ
ajlm-1317	132	24	support	support	NOUN
ajlm-1317	132	25	for	for	ADP
ajlm-1317	132	26	this	this	DET
ajlm-1317	132	27	work	work	NOUN
ajlm-1317	132	28	.	.	PUNCT
ajlm-1317	133	1	the	the	DET
ajlm-1317	133	2	authors	author	NOUN
ajlm-1317	133	3	would	would	AUX
ajlm-1317	133	4	like	like	VERB
ajlm-1317	133	5	to	to	PART
ajlm-1317	133	6	confirm	confirm	VERB
ajlm-1317	133	7	that	that	SCONJ
ajlm-1317	133	8	the	the	DET
ajlm-1317	133	9	people	people	NOUN
ajlm-1317	133	10	mentioned	mention	VERB
ajlm-1317	133	11	in	in	ADP
ajlm-1317	133	12	this	this	DET
ajlm-1317	133	13	section	section	NOUN
ajlm-1317	133	14	have	have	AUX
ajlm-1317	133	15	granted	grant	VERB
ajlm-1317	133	16	permission	permission	NOUN
ajlm-1317	133	17	as	as	SCONJ
ajlm-1317	133	18	required	require	VERB
ajlm-1317	133	19	.	.	PUNCT
ajlm-1317	134	1	competing	compete	VERB
ajlm-1317	134	2	interests	interest	NOUN
ajlm-1317	134	3	the	the	DET
ajlm-1317	134	4	authors	author	NOUN
ajlm-1317	134	5	declare	declare	VERB
ajlm-1317	134	6	that	that	SCONJ
ajlm-1317	134	7	they	they	PRON
ajlm-1317	134	8	have	have	VERB
ajlm-1317	134	9	no	no	DET
ajlm-1317	134	10	financial	financial	ADJ
ajlm-1317	134	11	or	or	CCONJ
ajlm-1317	134	12	personal	personal	ADJ
ajlm-1317	134	13	relationships	relationship	NOUN
ajlm-1317	134	14	that	that	PRON
ajlm-1317	134	15	may	may	AUX
ajlm-1317	134	16	have	have	AUX
ajlm-1317	134	17	inappropriately	inappropriately	ADV
ajlm-1317	134	18	influenced	influence	VERB
ajlm-1317	134	19	them	they	PRON
ajlm-1317	134	20	in	in	ADP
ajlm-1317	134	21	writing	write	VERB
ajlm-1317	134	22	this	this	DET
ajlm-1317	134	23	article	article	NOUN
ajlm-1317	134	24	.	.	PUNCT
ajlm-1317	135	1	authors	author	NOUN
ajlm-1317	135	2	’	’	PART
ajlm-1317	135	3	contributions	contribution	NOUN
ajlm-1317	135	4	j.h.k	j.h.k	NOUN
ajlm-1317	135	5	.	.	PUNCT
ajlm-1317	135	6	,	,	PUNCT
ajlm-1317	135	7	a.a.g	a.a.g	PROPN
ajlm-1317	135	8	.	.	PROPN
ajlm-1317	135	9	,	,	PUNCT
ajlm-1317	135	10	r.i	r.i	PROPN
ajlm-1317	135	11	.	.	PROPN
ajlm-1317	135	12	,	,	PUNCT
ajlm-1317	135	13	p.w	p.w	PROPN
ajlm-1317	135	14	.	.	PROPN
ajlm-1317	135	15	,	,	PUNCT
ajlm-1317	135	16	f.s	f.s	PROPN
ajlm-1317	135	17	.	.	PROPN
ajlm-1317	135	18	,	,	PUNCT
ajlm-1317	135	19	d.m	d.m	PROPN
ajlm-1317	135	20	-	-	PUNCT
ajlm-1317	135	21	m.	m.	NOUN
ajlm-1317	135	22	,	,	PUNCT
ajlm-1317	135	23	c.w	c.w	PROPN
ajlm-1317	135	24	.	.	PROPN
ajlm-1317	135	25	,	,	PUNCT
ajlm-1317	135	26	j.z	j.z	PROPN
ajlm-1317	135	27	.	.	PROPN
ajlm-1317	135	28	,	,	PUNCT
ajlm-1317	135	29	m.	m.	PROPN
ajlm-1317	135	30	orina	orina	PROPN
ajlm-1317	135	31	,	,	PUNCT
ajlm-1317	135	32	l.m	l.m	PROPN
ajlm-1317	135	33	.	.	PROPN
ajlm-1317	135	34	,	,	PUNCT
ajlm-1317	135	35	j.t	j.t	PROPN
ajlm-1317	135	36	.	.	PROPN
ajlm-1317	135	37	,	,	PUNCT
ajlm-1317	135	38	l.n	l.n	PROPN
ajlm-1317	135	39	.	.	PROPN
ajlm-1317	135	40	,	,	PUNCT
ajlm-1317	135	41	e.w	e.w	PROPN
ajlm-1317	135	42	.	.	PROPN
ajlm-1317	135	43	,	,	PUNCT
ajlm-1317	135	44	j.m	j.m	PROPN
ajlm-1317	135	45	.	.	PROPN
ajlm-1317	135	46	,	,	PUNCT
ajlm-1317	135	47	a.m.	a.m.	ADV
ajlm-1317	135	48	,	,	PUNCT
ajlm-1317	135	49	s.o	s.o	PROPN
ajlm-1317	135	50	.	.	PROPN
ajlm-1317	135	51	,	,	PUNCT
ajlm-1317	135	52	a.w	a.w	PROPN
ajlm-1317	135	53	.	.	PROPN
ajlm-1317	135	54	,	,	PUNCT
ajlm-1317	135	55	s.m.n	s.m.n	PROPN
ajlm-1317	135	56	.	.	PUNCT
ajlm-1317	136	1	and	and	CCONJ
ajlm-1317	136	2	m.	m.	PROPN
ajlm-1317	136	3	ochwoto	ochwoto	PROPN
ajlm-1317	136	4	contributed	contribute	VERB
ajlm-1317	136	5	in	in	ADP
ajlm-1317	136	6	different	different	ADJ
ajlm-1317	136	7	capacities	capacity	NOUN
ajlm-1317	136	8	to	to	ADP
ajlm-1317	136	9	the	the	DET
ajlm-1317	136	10	design	design	NOUN
ajlm-1317	136	11	and	and	CCONJ
ajlm-1317	136	12	implementation	implementation	NOUN
ajlm-1317	136	13	of	of	ADP
ajlm-1317	136	14	the	the	DET
ajlm-1317	136	15	research	research	NOUN
ajlm-1317	136	16	,	,	PUNCT
ajlm-1317	136	17	to	to	ADP
ajlm-1317	136	18	the	the	DET
ajlm-1317	136	19	analysis	analysis	NOUN
ajlm-1317	136	20	of	of	ADP
ajlm-1317	136	21	the	the	DET
ajlm-1317	136	22	results	result	NOUN
ajlm-1317	136	23	and	and	CCONJ
ajlm-1317	136	24	to	to	ADP
ajlm-1317	136	25	the	the	DET
ajlm-1317	136	26	writing	writing	NOUN
ajlm-1317	136	27	of	of	ADP
ajlm-1317	136	28	the	the	DET
ajlm-1317	136	29	manuscript	manuscript	NOUN
ajlm-1317	136	30	.	.	PUNCT
ajlm-1317	137	1	sources	source	NOUN
ajlm-1317	137	2	of	of	ADP
ajlm-1317	137	3	support	support	NOUN
ajlm-1317	137	4	this	this	DET
ajlm-1317	137	5	work	work	NOUN
ajlm-1317	137	6	was	be	AUX
ajlm-1317	137	7	supported	support	VERB
ajlm-1317	137	8	by	by	ADP
ajlm-1317	137	9	the	the	DET
ajlm-1317	137	10	kenya	kenya	PROPN
ajlm-1317	137	11	medical	medical	PROPN
ajlm-1317	137	12	research	research	PROPN
ajlm-1317	137	13	institute	institute	PROPN
ajlm-1317	137	14	under	under	ADP
ajlm-1317	137	15	the	the	DET
ajlm-1317	137	16	grant	grant	PROPN
ajlm-1317	137	17	award	award	PROPN
ajlm-1317	137	18	kemri	kemri	PROPN
ajlm-1317	137	19	/	/	SYM
ajlm-1317	137	20	cov	cov	PROPN
ajlm-1317	137	21	/	/	SYM
ajlm-1317	137	22	innov/001	innov/001	PROPN
ajlm-1317	137	23	.	.	PUNCT
ajlm-1317	138	1	data	datum	NOUN
ajlm-1317	138	2	availability	availability	NOUN
ajlm-1317	138	3	repository	repository	NOUN
ajlm-1317	138	4	:	:	PUNCT
ajlm-1317	138	5	figure	figure	VERB
ajlm-1317	138	6	share	share	NOUN
ajlm-1317	138	7	https://doi.org/10.608/m9figshare12727037	https://doi.org/10.608/m9figshare12727037	NUM
ajlm-1317	138	8	.	.	PUNCT
ajlm-1317	139	1	this	this	DET
ajlm-1317	139	2	project	project	NOUN
ajlm-1317	139	3	contains	contain	VERB
ajlm-1317	139	4	the	the	DET
ajlm-1317	139	5	following	follow	VERB
ajlm-1317	139	6	underlying	underlie	VERB
ajlm-1317	139	7	data	datum	NOUN
ajlm-1317	139	8	:	:	PUNCT
ajlm-1317	139	9	data	datum	NOUN
ajlm-1317	139	10	file	file	NOUN
ajlm-1317	139	11	1	1	NUM
ajlm-1317	139	12	(	(	PUNCT
ajlm-1317	139	13	data	datum	NOUN
ajlm-1317	139	14	for	for	ADP
ajlm-1317	139	15	true	true	ADJ
ajlm-1317	139	16	negatives	negative	NOUN
ajlm-1317	139	17	)	)	PUNCT
ajlm-1317	139	18	.	.	PUNCT
ajlm-1317	140	1	data	datum	NOUN
ajlm-1317	140	2	file	file	VERB
ajlm-1317	140	3	2	2	NUM
ajlm-1317	140	4	(	(	PUNCT
ajlm-1317	140	5	data	datum	NOUN
ajlm-1317	140	6	for	for	ADP
ajlm-1317	140	7	true	true	ADJ
ajlm-1317	140	8	positives	positive	NOUN
ajlm-1317	140	9	)	)	PUNCT
ajlm-1317	140	10	.	.	PUNCT
ajlm-1317	141	1	data	datum	NOUN
ajlm-1317	141	2	file	file	VERB
ajlm-1317	141	3	3	3	NUM
ajlm-1317	141	4	(	(	PUNCT
ajlm-1317	141	5	pre	pre	ADJ
ajlm-1317	141	6	-	-	ADJ
ajlm-1317	141	7	evaluation	evaluation	ADJ
ajlm-1317	141	8	raw	raw	ADJ
ajlm-1317	141	9	data	datum	NOUN
ajlm-1317	141	10	)	)	PUNCT
ajlm-1317	141	11	.	.	PUNCT
ajlm-1317	142	1	data	datum	NOUN
ajlm-1317	142	2	are	be	AUX
ajlm-1317	142	3	available	available	ADJ
ajlm-1317	142	4	under	under	ADP
ajlm-1317	142	5	the	the	DET
ajlm-1317	142	6	terms	term	NOUN
ajlm-1317	142	7	of	of	ADP
ajlm-1317	142	8	creative	creative	ADJ
ajlm-1317	142	9	commons	common	NOUN
ajlm-1317	142	10	by	by	ADP
ajlm-1317	142	11	4.0	4.0	NUM
ajlm-1317	142	12	and	and	CCONJ
ajlm-1317	142	13	can	can	AUX
ajlm-1317	142	14	be	be	AUX
ajlm-1317	142	15	requested	request	VERB
ajlm-1317	142	16	from	from	ADP
ajlm-1317	142	17	the	the	DET
ajlm-1317	142	18	corresponding	corresponding	ADJ
ajlm-1317	142	19	author	author	NOUN
ajlm-1317	142	20	.	.	PUNCT
ajlm-1317	143	1	disclaimer	disclaimer	VERB
ajlm-1317	143	2	the	the	DET
ajlm-1317	143	3	views	view	NOUN
ajlm-1317	143	4	and	and	CCONJ
ajlm-1317	143	5	opinions	opinion	NOUN
ajlm-1317	143	6	expressed	express	VERB
ajlm-1317	143	7	in	in	ADP
ajlm-1317	143	8	this	this	DET
ajlm-1317	143	9	article	article	NOUN
ajlm-1317	143	10	are	be	AUX
ajlm-1317	143	11	those	those	PRON
ajlm-1317	143	12	of	of	ADP
ajlm-1317	143	13	the	the	DET
ajlm-1317	143	14	authors	author	NOUN
ajlm-1317	143	15	and	and	CCONJ
ajlm-1317	143	16	do	do	AUX
ajlm-1317	143	17	not	not	PART
ajlm-1317	143	18	necessarily	necessarily	ADV
ajlm-1317	143	19	reflect	reflect	VERB
ajlm-1317	143	20	the	the	DET
ajlm-1317	143	21	official	official	ADJ
ajlm-1317	143	22	policy	policy	NOUN
ajlm-1317	143	23	or	or	CCONJ
ajlm-1317	143	24	position	position	NOUN
ajlm-1317	143	25	of	of	ADP
ajlm-1317	143	26	any	any	DET
ajlm-1317	143	27	affiliated	affiliated	ADJ
ajlm-1317	143	28	agency	agency	NOUN
ajlm-1317	143	29	or	or	CCONJ
ajlm-1317	143	30	the	the	DET
ajlm-1317	143	31	authors	author	NOUN
ajlm-1317	143	32	.	.	PUNCT
ajlm-1317	144	1	references	reference	NOUN
ajlm-1317	144	2	john	john	PROPN
ajlm-1317	144	3	hopkins	hopkins	PROPN
ajlm-1317	144	4	university	university	PROPN
ajlm-1317	144	5	.	.	PUNCT
ajlm-1317	145	1	epidemic	epidemic	NOUN
ajlm-1317	145	2	map	map	NOUN
ajlm-1317	145	3	updated	update	VERB
ajlm-1317	145	4	in	in	ADP
ajlm-1317	145	5	real	real	ADJ
ajlm-1317	145	6	-	-	PUNCT
ajlm-1317	145	7	time	time	NOUN
ajlm-1317	145	8	.	.	PUNCT
ajlm-1317	146	1	baltimore	baltimore	PROPN
ajlm-1317	146	2	,	,	PUNCT
ajlm-1317	146	3	md	md	PROPN
ajlm-1317	146	4	:	:	PUNCT
ajlm-1317	146	5	center	center	NOUN
ajlm-1317	146	6	for	for	ADP
ajlm-1317	146	7	systems	system	NOUN
ajlm-1317	146	8	science	science	NOUN
ajlm-1317	146	9	and	and	CCONJ
ajlm-1317	146	10	engineering	engineering	NOUN
ajlm-1317	146	11	;	;	PUNCT
ajlm-1317	146	12	2020	2020	NUM
ajlm-1317	146	13	.	.	PUNCT
ajlm-1317	147	1	jeong	jeong	PROPN
ajlm-1317	147	2	sae	sae	PROPN
ajlm-1317	147	3	-	-	PROPN
ajlm-1317	147	4	im	im	PROPN
ajlm-1317	147	5	.	.	PUNCT
ajlm-1317	148	1	korea	korea	PROPN
ajlm-1317	148	2	approves	approve	VERB
ajlm-1317	148	3	2	2	NUM
ajlm-1317	148	4	more	more	ADJ
ajlm-1317	148	5	covid-19	covid-19	PROPN
ajlm-1317	148	6	detection	detection	NOUN
ajlm-1317	148	7	kits	kit	NOUN
ajlm-1317	148	8	for	for	ADP
ajlm-1317	148	9	urgent	urgent	ADJ
ajlm-1317	148	10	use	use	NOUN
ajlm-1317	148	11	.	.	PUNCT
ajlm-1317	149	1	korea	korea	PROPN
ajlm-1317	149	2	biomed	biome	VERB
ajlm-1317	149	3	rev	rev	PROPN
ajlm-1317	149	4	.	.	PROPN
ajlm-1317	149	5	2020	2020	NUM
ajlm-1317	149	6	.	.	PUNCT
ajlm-1317	150	1	liang	liang	PROPN
ajlm-1317	150	2	m	m	PROPN
ajlm-1317	150	3	,	,	PUNCT
ajlm-1317	150	4	du	du	PROPN
ajlm-1317	150	5	l	l	PROPN
ajlm-1317	150	6	,	,	PUNCT
ajlm-1317	150	7	liu	liu	PROPN
ajlm-1317	150	8	j	j	PROPN
ajlm-1317	150	9	,	,	PUNCT
ajlm-1317	150	10	et	et	PROPN
ajlm-1317	150	11	al	al	PROPN
ajlm-1317	150	12	.	.	PUNCT
ajlm-1317	151	1	sars	sars	PROPN
ajlm-1317	151	2	patients	patient	NOUN
ajlm-1317	151	3	-	-	PUNCT
ajlm-1317	151	4	derived	derive	VERB
ajlm-1317	151	5	human	human	ADJ
ajlm-1317	151	6	recombinant	recombinant	ADJ
ajlm-1317	151	7	antibodies	antibody	NOUN
ajlm-1317	151	8	to	to	ADP
ajlm-1317	151	9	s	s	PRON
ajlm-1317	151	10	and	and	CCONJ
ajlm-1317	151	11	m	m	PROPN
ajlm-1317	151	12	proteins	protein	NOUN
ajlm-1317	151	13	efficiently	efficiently	ADV
ajlm-1317	151	14	neutralize	neutralize	VERB
ajlm-1317	151	15	sars	sar	NOUN
ajlm-1317	151	16	-	-	PUNCT
ajlm-1317	151	17	coronavirus	coronavirus	NOUN
ajlm-1317	151	18	infectivity	infectivity	NOUN
ajlm-1317	151	19	.	.	PUNCT
ajlm-1317	152	1	biomed	biome	VERB
ajlm-1317	152	2	environ	environ	X
ajlm-1317	152	3	sci	sci	PROPN
ajlm-1317	152	4	.	.	PUNCT
ajlm-1317	153	1	2005;186(6):363	2005;186(6):363	X
ajlm-1317	153	2	.	.	PUNCT
ajlm-1317	154	1	sheridan	sheridan	PROPN
ajlm-1317	154	2	c.coronavirus	c.coronavirus	PROPN
ajlm-1317	154	3	and	and	CCONJ
ajlm-1317	154	4	the	the	DET
ajlm-1317	154	5	race	race	NOUN
ajlm-1317	154	6	to	to	PART
ajlm-1317	154	7	distribute	distribute	VERB
ajlm-1317	154	8	reliable	reliable	ADJ
ajlm-1317	154	9	diagnostics	diagnostic	NOUN
ajlm-1317	154	10	.	.	PUNCT
ajlm-1317	155	1	nat	nat	PROPN
ajlm-1317	155	2	biotechnol	biotechnol	NOUN
ajlm-1317	155	3	.	.	PUNCT
ajlm-1317	156	1	2020;38:382–384	2020;38:382–384	NUM
ajlm-1317	156	2	.	.	PUNCT
ajlm-1317	157	1	https://doi.org/10.1038/d41587-020-00002-2	https://doi.org/10.1038/d41587-020-00002-2	NUM
ajlm-1317	157	2	hopkins	hopkins	PROPN
ajlm-1317	157	3	j.	j.	PROPN
ajlm-1317	157	4	serology	serology	NOUN
ajlm-1317	157	5	-	-	PUNCT
ajlm-1317	157	6	based	base	VERB
ajlm-1317	157	7	tests	test	NOUN
ajlm-1317	157	8	for	for	ADP
ajlm-1317	157	9	covid-19	covid-19	PROPN
ajlm-1317	157	10	.	.	PROPN
ajlm-1317	157	11	baltimore	baltimore	PROPN
ajlm-1317	157	12	,	,	PUNCT
ajlm-1317	157	13	md	md	PROPN
ajlm-1317	157	14	:	:	PUNCT
ajlm-1317	157	15	johns	johns	PROPN
ajlm-1317	157	16	hopkins	hopkins	PROPN
ajlm-1317	157	17	;	;	PUNCT
ajlm-1317	157	18	2020	2020	NUM
ajlm-1317	157	19	.	.	PUNCT
ajlm-1317	158	1	zainol	zainol	NOUN
ajlm-1317	158	2	r	r	PROPN
ajlm-1317	158	3	,	,	PUNCT
ajlm-1317	158	4	othman	othman	PROPN
ajlm-1317	158	5	s	s	PROPN
ajlm-1317	158	6	,	,	PUNCT
ajlm-1317	158	7	abdul	abdul	PROPN
ajlm-1317	158	8	s	s	PROPN
ajlm-1317	158	9	,	,	PUNCT
ajlm-1317	158	10	et	et	PROPN
ajlm-1317	158	11	al	al	PROPN
ajlm-1317	158	12	.	.	PUNCT
ajlm-1317	159	1	diagnostic	diagnostic	ADJ
ajlm-1317	159	2	performance	performance	NOUN
ajlm-1317	159	3	of	of	ADP
ajlm-1317	159	4	covid-19	covid-19	PROPN
ajlm-1317	159	5	serology	serology	NOUN
ajlm-1317	159	6	assays	assay	NOUN
ajlm-1317	159	7	.	.	PUNCT
ajlm-1317	160	1	malaysian	malaysian	ADJ
ajlm-1317	160	2	j	j	PROPN
ajlm-1317	160	3	pathol	pathol	NOUN
ajlm-1317	160	4	.	.	PUNCT
ajlm-1317	161	1	2020;42(1):13–21	2020;42(1):13–21	X
ajlm-1317	161	2	.	.	PUNCT
ajlm-1317	162	1	vabret	vabret	PROPN
ajlm-1317	162	2	n	n	NOUN
ajlm-1317	162	3	,	,	PUNCT
ajlm-1317	162	4	graham	graham	PROPN
ajlm-1317	162	5	j	j	PROPN
ajlm-1317	162	6	,	,	PUNCT
ajlm-1317	162	7	conor	conor	PROPN
ajlm-1317	162	8	g	g	PROPN
ajlm-1317	162	9	,	,	PUNCT
ajlm-1317	162	10	et	et	PROPN
ajlm-1317	163	1	al	al	PROPN
ajlm-1317	163	2	.	.	PUNCT
ajlm-1317	163	3	immunology	immunology	NOUN
ajlm-1317	163	4	of	of	ADP
ajlm-1317	163	5	covid-19	covid-19	PROPN
ajlm-1317	163	6	current	current	ADJ
ajlm-1317	163	7	state	state	NOUN
ajlm-1317	163	8	of	of	ADP
ajlm-1317	163	9	the	the	DET
ajlm-1317	163	10	science	science	NOUN
ajlm-1317	163	11	.	.	PUNCT
ajlm-1317	164	1	immunity	immunity	NOUN
ajlm-1317	164	2	.	.	PUNCT
ajlm-1317	165	1	2020;42(2):910–941	2020;42(2):910–941	NUM
ajlm-1317	165	2	.	.	PUNCT
ajlm-1317	165	3	srikrishna	srikrishna	VERB
ajlm-1317	166	1	d	d	NOUN
ajlm-1317	166	2	,	,	PUNCT
ajlm-1317	166	3	dhillon	dhillon	PROPN
ajlm-1317	166	4	rs	rs	PROPN
ajlm-1317	166	5	,	,	PUNCT
ajlm-1317	166	6	beier	beier	VERB
ajlm-1317	166	7	d.	d.	PROPN
ajlm-1317	166	8	we	we	PRON
ajlm-1317	166	9	need	need	VERB
ajlm-1317	166	10	a	a	DET
ajlm-1317	166	11	cheap	cheap	ADJ
ajlm-1317	166	12	way	way	NOUN
ajlm-1317	166	13	to	to	PART
ajlm-1317	166	14	diagnose	diagnose	VERB
ajlm-1317	166	15	coronavirus	coronavirus	NOUN
ajlm-1317	166	16	.	.	PUNCT
ajlm-1317	167	1	harv	harv	PROPN
ajlm-1317	167	2	bus	bus	NOUN
ajlm-1317	167	3	rev	rev	PROPN
ajlm-1317	167	4	.	.	PROPN
ajlm-1317	167	5	2020	2020	NUM
ajlm-1317	167	6	.	.	PUNCT
ajlm-1317	168	1	hou	hou	PROPN
ajlm-1317	168	2	h	h	PROPN
ajlm-1317	168	3	,	,	PUNCT
ajlm-1317	168	4	wang	wang	PROPN
ajlm-1317	168	5	t	t	PROPN
ajlm-1317	168	6	,	,	PUNCT
ajlm-1317	168	7	zhang	zhang	PROPN
ajlm-1317	168	8	b	b	PROPN
ajlm-1317	168	9	,	,	PUNCT
ajlm-1317	168	10	et	et	PROPN
ajlm-1317	168	11	al	al	PROPN
ajlm-1317	168	12	.	.	PUNCT
ajlm-1317	168	13	detection	detection	NOUN
ajlm-1317	168	14	of	of	ADP
ajlm-1317	168	15	igm	igm	PROPN
ajlm-1317	168	16	and	and	CCONJ
ajlm-1317	168	17	igg	igg	PROPN
ajlm-1317	168	18	antibodies	antibodie	VERB
ajlm-1317	168	19	in	in	ADP
ajlm-1317	168	20	patients	patient	NOUN
ajlm-1317	168	21	with	with	ADP
ajlm-1317	168	22	coronavirus	coronavirus	NOUN
ajlm-1317	168	23	disease	disease	NOUN
ajlm-1317	168	24	2019	2019	NUM
ajlm-1317	168	25	.	.	PUNCT
ajlm-1317	169	1	clin	clin	PROPN
ajlm-1317	169	2	translational	translational	PROPN
ajlm-1317	169	3	immunol	immunol	NOUN
ajlm-1317	169	4	.	.	PUNCT
ajlm-1317	170	1	2020;9(5):e1136	2020;9(5):e1136	NUM
ajlm-1317	170	2	.	.	PUNCT
ajlm-1317	171	1	https://doi.org/10.1002/cti2.1136	https://doi.org/10.1002/cti2.1136	PROPN
ajlm-1317	171	2	world	world	PROPN
ajlm-1317	171	3	health	health	PROPN
ajlm-1317	171	4	organization	organization	PROPN
ajlm-1317	171	5	.	.	PUNCT
ajlm-1317	172	1	advice	advice	NOUN
ajlm-1317	172	2	on	on	ADP
ajlm-1317	172	3	the	the	DET
ajlm-1317	172	4	use	use	NOUN
ajlm-1317	172	5	of	of	ADP
ajlm-1317	172	6	point	point	NOUN
ajlm-1317	172	7	-	-	PUNCT
ajlm-1317	172	8	of	of	ADP
ajlm-1317	172	9	-	-	PUNCT
ajlm-1317	172	10	care	care	NOUN
ajlm-1317	172	11	immunodiagnostic	immunodiagnostic	ADJ
ajlm-1317	172	12	tests	test	NOUN
ajlm-1317	172	13	for	for	ADP
ajlm-1317	172	14	covid-19	covid-19	PROPN
ajlm-1317	172	15	:	:	PUNCT
ajlm-1317	172	16	scientific	scientific	ADJ
ajlm-1317	172	17	brief	brief	NOUN
ajlm-1317	172	18	.	.	PUNCT
ajlm-1317	173	1	geneva	geneva	NOUN
ajlm-1317	173	2	:	:	PUNCT
ajlm-1317	173	3	world	world	PROPN
ajlm-1317	173	4	health	health	NOUN
ajlm-1317	173	5	organization	organization	NOUN
ajlm-1317	173	6	;	;	PUNCT
ajlm-1317	173	7	2020	2020	NUM
ajlm-1317	173	8	.	.	PUNCT
ajlm-1317	174	1	world	world	PROPN
ajlm-1317	174	2	health	health	PROPN
ajlm-1317	174	3	organization	organization	PROPN
ajlm-1317	174	4	.	.	PUNCT
ajlm-1317	175	1	instructions	instruction	NOUN
ajlm-1317	175	2	for	for	ADP
ajlm-1317	175	3	submission	submission	NOUN
ajlm-1317	175	4	requirements	requirement	NOUN
ajlm-1317	175	5	:	:	PUNCT
ajlm-1317	175	6	in	in	ADP
ajlm-1317	175	7	vitro	vitro	X
ajlm-1317	175	8	diagnostics	diagnostic	NOUN
ajlm-1317	175	9	(	(	PUNCT
ajlm-1317	175	10	ivds	ivds	NOUN
ajlm-1317	175	11	)	)	PUNCT
ajlm-1317	175	12	detecting	detect	VERB
ajlm-1317	175	13	antibodies	antibody	NOUN
ajlm-1317	175	14	to	to	ADP
ajlm-1317	175	15	sars	sar	NOUN
ajlm-1317	175	16	-	-	PUNCT
ajlm-1317	175	17	cov-2	cov-2	PART
ajlm-1317	175	18	virus	virus	NOUN
ajlm-1317	175	19	.	.	PUNCT
ajlm-1317	176	1	geneva	geneva	PROPN
ajlm-1317	176	2	:	:	PUNCT
ajlm-1317	176	3	world	world	PROPN
ajlm-1317	176	4	health	health	NOUN
ajlm-1317	176	5	organization	organization	NOUN
ajlm-1317	176	6	;	;	PUNCT
ajlm-1317	176	7	2020	2020	NUM
ajlm-1317	176	8	.	.	PUNCT
ajlm-1317	177	1	drain	drain	NOUN
ajlm-1317	177	2	p	p	X
ajlm-1317	177	3	,	,	PUNCT
ajlm-1317	177	4	hyle	hyle	PROPN
ajlm-1317	177	5	e	e	PROPN
ajlm-1317	177	6	,	,	PUNCT
ajlm-1317	177	7	noubary	noubary	ADJ
ajlm-1317	177	8	f	f	PROPN
ajlm-1317	177	9	,	,	PUNCT
ajlm-1317	177	10	et	et	PROPN
ajlm-1317	177	11	al	al	PROPN
ajlm-1317	177	12	.	.	PUNCT
ajlm-1317	178	1	diagnostic	diagnostic	ADJ
ajlm-1317	178	2	point	point	NOUN
ajlm-1317	178	3	-	-	PUNCT
ajlm-1317	178	4	of	of	ADP
ajlm-1317	178	5	-	-	PUNCT
ajlm-1317	178	6	care	care	NOUN
ajlm-1317	178	7	tests	test	NOUN
ajlm-1317	178	8	in	in	ADP
ajlm-1317	178	9	resource	resource	NOUN
ajlm-1317	178	10	-	-	PUNCT
ajlm-1317	178	11	limited	limit	VERB
ajlm-1317	178	12	settings	setting	NOUN
ajlm-1317	178	13	.	.	PUNCT
ajlm-1317	179	1	lancet	lancet	PROPN
ajlm-1317	179	2	infect	infect	PROPN
ajlm-1317	179	3	dis	dis	PROPN
ajlm-1317	179	4	.	.	PUNCT
ajlm-1317	180	1	2014;14(3):239–249	2014;14(3):239–249	X
ajlm-1317	180	2	.	.	PUNCT
ajlm-1317	181	1	https://doi.org/10.1016/s1473-3099(13)70250-0	https://doi.org/10.1016/s1473-3099(13)70250-0	PROPN
ajlm-1317	181	2	world	world	PROPN
ajlm-1317	181	3	health	health	PROPN
ajlm-1317	181	4	organization	organization	NOUN
ajlm-1317	181	5	(	(	PUNCT
ajlm-1317	181	6	b	b	NOUN
ajlm-1317	181	7	)	)	PUNCT
ajlm-1317	181	8	.	.	PUNCT
ajlm-1317	182	1	establishing	establish	VERB
ajlm-1317	182	2	stability	stability	NOUN
ajlm-1317	182	3	of	of	ADP
ajlm-1317	182	4	in	in	ADP
ajlm-1317	182	5	vitro	vitro	X
ajlm-1317	182	6	diagnostic	diagnostic	ADJ
ajlm-1317	182	7	medical	medical	ADJ
ajlm-1317	182	8	devices	device	NOUN
ajlm-1317	182	9	.	.	PUNCT
ajlm-1317	183	1	(	(	PUNCT
ajlm-1317	183	2	no	no	INTJ
ajlm-1317	183	3	.	.	PUNCT
ajlm-1317	184	1	who	who	PRON
ajlm-1317	184	2	/	/	SYM
ajlm-1317	184	3	bs/2017.2304	bs/2017.2304	NOUN
ajlm-1317	184	4	)	)	PUNCT
ajlm-1317	184	5	.	.	PUNCT
ajlm-1317	185	1	geneva	geneva	PROPN
ajlm-1317	185	2	:	:	PUNCT
ajlm-1317	185	3	who	who	PRON
ajlm-1317	185	4	;	;	PUNCT
ajlm-1317	185	5	2019	2019	NUM
ajlm-1317	185	6	.	.	PUNCT
ajlm-1317	186	1	i.	i.	PROPN
ajlm-1317	186	2	n.	n.	PROPN
ajlm-1317	186	3	covid-19	covid-19	PROPN
ajlm-1317	186	4	.	.	PUNCT
ajlm-1317	187	1	abbott	abbott	PROPN
ajlm-1317	188	1	[	[	X
ajlm-1317	188	2	homepage	homepage	NOUN
ajlm-1317	188	3	on	on	ADP
ajlm-1317	188	4	the	the	DET
ajlm-1317	188	5	internet	internet	NOUN
ajlm-1317	188	6	]	]	PUNCT
ajlm-1317	188	7	.	.	PUNCT
ajlm-1317	189	1	[	[	X
ajlm-1317	189	2	cited	cite	VERB
ajlm-1317	189	3	2020	2020	NUM
ajlm-1317	189	4	june	june	PROPN
ajlm-1317	189	5	14	14	NUM
ajlm-1317	189	6	]	]	PUNCT
ajlm-1317	189	7	.	.	PUNCT
ajlm-1317	190	1	available	available	ADJ
ajlm-1317	190	2	from	from	ADP
ajlm-1317	190	3	:	:	PUNCT
ajlm-1317	190	4	https://www.alere.com/en/home/	https://www.alere.com/en/home/	PROPN
ajlm-1317	190	5	hogan	hogan	PROPN
ajlm-1317	190	6	c	c	X
ajlm-1317	190	7	,	,	PUNCT
ajlm-1317	190	8	sahoo	sahoo	PROPN
ajlm-1317	190	9	m	m	PROPN
ajlm-1317	190	10	,	,	PUNCT
ajlm-1317	190	11	huang	huang	PROPN
ajlm-1317	190	12	c	c	PROPN
ajlm-1317	190	13	,	,	PUNCT
ajlm-1317	190	14	et	et	PROPN
ajlm-1317	190	15	al	al	PROPN
ajlm-1317	190	16	.	.	PROPN
ajlm-1317	190	17	five	five	NUM
ajlm-1317	190	18	-	-	PUNCT
ajlm-1317	190	19	minute	minute	NOUN
ajlm-1317	190	20	point	point	NOUN
ajlm-1317	190	21	-	-	PUNCT
ajlm-1317	190	22	of	of	ADP
ajlm-1317	190	23	-	-	PUNCT
ajlm-1317	190	24	care	care	NOUN
ajlm-1317	190	25	testing	testing	NOUN
ajlm-1317	190	26	for	for	ADP
ajlm-1317	190	27	sars	sar	NOUN
ajlm-1317	190	28	-	-	PUNCT
ajlm-1317	190	29	cov-2	cov-2	NOUN
ajlm-1317	190	30	not	not	PART
ajlm-1317	190	31	there	there	ADV
ajlm-1317	190	32	yet	yet	ADV
ajlm-1317	190	33	.	.	PUNCT
ajlm-1317	191	1	j	j	PROPN
ajlm-1317	191	2	clin	clin	PROPN
ajlm-1317	191	3	virol	virol	PROPN
ajlm-1317	191	4	.	.	PUNCT
ajlm-1317	192	1	2020;128:104410	2020;128:104410	NUM
ajlm-1317	192	2	.	.	PUNCT
ajlm-1317	193	1	https://doi.org/10.1016/j.jcv.2020.104410	https://doi.org/10.1016/j.jcv.2020.104410	PROPN
ajlm-1317	193	2	hoffman	hoffman	PROPN
ajlm-1317	193	3	t	t	PROPN
ajlm-1317	193	4	,	,	PUNCT
ajlm-1317	193	5	nissen	nissen	PROPN
ajlm-1317	193	6	k	k	PROPN
ajlm-1317	193	7	,	,	PUNCT
ajlm-1317	193	8	krambrich	krambrich	PROPN
ajlm-1317	193	9	j	j	PROPN
ajlm-1317	193	10	,	,	PUNCT
ajlm-1317	193	11	et	et	PROPN
ajlm-1317	193	12	al	al	PROPN
ajlm-1317	193	13	.	.	PUNCT
ajlm-1317	193	14	evaluation	evaluation	NOUN
ajlm-1317	193	15	of	of	ADP
ajlm-1317	193	16	a	a	DET
ajlm-1317	193	17	covid-19	covid-19	PROPN
ajlm-1317	193	18	igm	igm	PROPN
ajlm-1317	193	19	and	and	CCONJ
ajlm-1317	193	20	igg	igg	PROPN
ajlm-1317	193	21	rapid	rapid	ADJ
ajlm-1317	193	22	test	test	NOUN
ajlm-1317	193	23	;	;	PUNCT
ajlm-1317	193	24	an	an	DET
ajlm-1317	193	25	efficient	efficient	ADJ
ajlm-1317	193	26	tool	tool	NOUN
ajlm-1317	193	27	for	for	ADP
ajlm-1317	193	28	assessment	assessment	NOUN
ajlm-1317	193	29	of	of	ADP
ajlm-1317	193	30	past	past	ADJ
ajlm-1317	193	31	exposure	exposure	NOUN
ajlm-1317	193	32	to	to	ADP
ajlm-1317	193	33	sars	sar	NOUN
ajlm-1317	193	34	-	-	PUNCT
ajlm-1317	193	35	cov-2	cov-2	NOUN
ajlm-1317	193	36	.	.	PUNCT
ajlm-1317	193	37	infect	infect	VERB
ajlm-1317	193	38	ecol	ecol	PROPN
ajlm-1317	193	39	epidemiol	epidemiol	PROPN
ajlm-1317	193	40	.	.	PUNCT
ajlm-1317	194	1	2020;10(1):1754538	2020;10(1):1754538	NUM
ajlm-1317	194	2	.	.	PUNCT
ajlm-1317	194	3	https://doi.org/10.1080/20008686.2020.1754538	https://doi.org/10.1080/20008686.2020.1754538	PROPN
ajlm-1317	195	1	li	li	PROPN
ajlm-1317	195	2	z	z	PROPN
ajlm-1317	195	3	,	,	PUNCT
ajlm-1317	195	4	yi	yi	PROPN
ajlm-1317	195	5	y	y	PROPN
ajlm-1317	195	6	,	,	PUNCT
ajlm-1317	195	7	luo	luo	PROPN
ajlm-1317	195	8	x	x	PROPN
ajlm-1317	195	9	,	,	PUNCT
ajlm-1317	195	10	et	et	PROPN
ajlm-1317	195	11	al	al	PROPN
ajlm-1317	195	12	.	.	PROPN
ajlm-1317	195	13	development	development	PROPN
ajlm-1317	195	14	and	and	CCONJ
ajlm-1317	195	15	clinical	clinical	ADJ
ajlm-1317	195	16	application	application	NOUN
ajlm-1317	195	17	of	of	ADP
ajlm-1317	195	18	a	a	DET
ajlm-1317	195	19	rapid	rapid	ADJ
ajlm-1317	195	20	igm	igm	PROPN
ajlm-1317	195	21	-	-	PUNCT
ajlm-1317	195	22	igg	igg	PROPN
ajlm-1317	195	23	combined	combine	VERB
ajlm-1317	195	24	antibody	antibody	NOUN
ajlm-1317	195	25	test	test	NOUN
ajlm-1317	195	26	for	for	ADP
ajlm-1317	195	27	sars	sar	NOUN
ajlm-1317	195	28	-	-	PUNCT
ajlm-1317	195	29	cov-2	cov-2	NOUN
ajlm-1317	195	30	infection	infection	NOUN
ajlm-1317	195	31	diagnosis	diagnosis	NOUN
ajlm-1317	195	32	.	.	PUNCT
ajlm-1317	196	1	j	j	PROPN
ajlm-1317	196	2	med	med	PROPN
ajlm-1317	196	3	virol	virol	NOUN
ajlm-1317	196	4	.	.	PUNCT
ajlm-1317	197	1	2020;92(9):1518–1524	2020;92(9):1518–1524	PROPN
ajlm-1317	197	2	.	.	PUNCT
ajlm-1317	198	1	https://doi.org/10.1002/jmv.25727	https://doi.org/10.1002/jmv.25727	PROPN
ajlm-1317	198	2	sun	sun	PROPN
ajlm-1317	198	3	b	b	PROPN
ajlm-1317	198	4	,	,	PUNCT
ajlm-1317	198	5	feng	feng	PROPN
ajlm-1317	198	6	y	y	PROPN
ajlm-1317	198	7	,	,	PUNCT
ajlm-1317	198	8	zheng	zheng	PROPN
ajlm-1317	198	9	p	p	PROPN
ajlm-1317	198	10	,	,	PUNCT
ajlm-1317	198	11	et	et	PROPN
ajlm-1317	198	12	al	al	PROPN
ajlm-1317	198	13	.	.	PUNCT
ajlm-1317	199	1	kinetics	kinetic	NOUN
ajlm-1317	199	2	of	of	ADP
ajlm-1317	199	3	sars	sar	NOUN
ajlm-1317	199	4	-	-	PUNCT
ajlm-1317	199	5	cov-2	cov-2	NOUN
ajlm-1317	199	6	specific	specific	ADJ
ajlm-1317	199	7	igm	igm	NOUN
ajlm-1317	199	8	and	and	CCONJ
ajlm-1317	199	9	igg	igg	PROPN
ajlm-1317	199	10	responses	response	NOUN
ajlm-1317	199	11	in	in	ADP
ajlm-1317	199	12	covid-19	covid-19	PROPN
ajlm-1317	199	13	patients	patient	NOUN
ajlm-1317	199	14	.	.	PUNCT
ajlm-1317	200	1	emerg	emerg	PROPN
ajlm-1317	200	2	microb	microb	NOUN
ajlm-1317	200	3	infect	infect	NOUN
ajlm-1317	200	4	.	.	PUNCT
ajlm-1317	201	1	2020;9(1):940–948	2020;9(1):940–948	X
ajlm-1317	201	2	.	.	PUNCT
ajlm-1317	201	3	https://doi.org/10.1080/22221751.2020.1762515	https://doi.org/10.1080/22221751.2020.1762515	PROPN
ajlm-1317	201	4	oecd	oecd	PROPN
ajlm-1317	201	5	.	.	PUNCT
ajlm-1317	201	6	home	home	NOUN
ajlm-1317	201	7	testing	testing	NOUN
ajlm-1317	201	8	for	for	ADP
ajlm-1317	201	9	covid-19	covid-19	PROPN
ajlm-1317	201	10	:	:	PUNCT
ajlm-1317	201	11	a	a	DET
ajlm-1317	201	12	way	way	NOUN
ajlm-1317	201	13	to	to	PART
ajlm-1317	201	14	lift	lift	VERB
ajlm-1317	201	15	confinement	confinement	ADJ
ajlm-1317	201	16	restrictions	restriction	NOUN
ajlm-1317	201	17	.	.	PUNCT
ajlm-1317	202	1	oecd	oecd	PROPN
ajlm-1317	202	2	.	.	PROPN
ajlm-1317	202	3	paris	paris	PROPN
ajlm-1317	202	4	;	;	PUNCT
ajlm-1317	202	5	2020	2020	NUM
ajlm-1317	202	6	.	.	PUNCT
ajlm-1317	203	1	hindustan	hindustan	PROPN
ajlm-1317	203	2	times	times	PROPN
ajlm-1317	203	3	new	new	PROPN
ajlm-1317	203	4	delhi	delhi	PROPN
ajlm-1317	203	5	china	china	PROPN
ajlm-1317	203	6	.	.	PUNCT
ajlm-1317	204	1	concerned	concerned	ADJ
ajlm-1317	204	2	as	as	SCONJ
ajlm-1317	204	3	india	india	PROPN
ajlm-1317	204	4	decides	decide	VERB
ajlm-1317	204	5	to	to	PART
ajlm-1317	204	6	stop	stop	VERB
ajlm-1317	204	7	use	use	NOUN
ajlm-1317	204	8	of	of	ADP
ajlm-1317	204	9	chines	chines	PROPN
ajlm-1317	204	10	covid-19	covid-19	PROPN
ajlm-1317	204	11	test	test	NOUN
ajlm-1317	204	12	kits	kit	NOUN
ajlm-1317	204	13	.	.	PUNCT
ajlm-1317	205	1	new	new	ADJ
ajlm-1317	205	2	delhi	delhi	PROPN
ajlm-1317	205	3	;	;	PUNCT
ajlm-1317	205	4	2020	2020	NUM
ajlm-1317	205	5	.	.	PUNCT
ajlm-1317	206	1	new	new	PROPN
ajlm-1317	206	2	york	york	PROPN
ajlm-1317	206	3	times	times	PROPN
ajlm-1317	206	4	.	.	PUNCT
ajlm-1317	207	1	cdc	cdc	PROPN
ajlm-1317	207	2	labs	labs	PROPN
ajlm-1317	207	3	were	be	AUX
ajlm-1317	207	4	contaminated	contaminate	VERB
ajlm-1317	207	5	delaying	delay	VERB
ajlm-1317	207	6	corona	corona	NOUN
ajlm-1317	207	7	virus	virus	NOUN
ajlm-1317	207	8	testing	test	VERB
ajlm-1317	207	9	official	official	NOUN
ajlm-1317	207	10	say	say	VERB
ajlm-1317	207	11	.	.	PUNCT
ajlm-1317	208	1	new	new	PROPN
ajlm-1317	208	2	york	york	PROPN
ajlm-1317	208	3	;	;	PUNCT
ajlm-1317	208	4	2020	2020	NUM
ajlm-1317	208	5	.	.	PUNCT
ajlm-1317	209	1	the	the	DET
ajlm-1317	209	2	sunday	sunday	PROPN
ajlm-1317	209	3	times	times	PROPN
ajlm-1317	209	4	.	.	PUNCT
ajlm-1317	210	1	britain	britain	PROPN
ajlm-1317	210	2	has	have	VERB
ajlm-1317	210	3	millions	million	NOUN
ajlm-1317	210	4	of	of	ADP
ajlm-1317	210	5	coronavirus	coronavirus	NOUN
ajlm-1317	210	6	antibody	antibody	NOUN
ajlm-1317	210	7	tests	test	NOUN
ajlm-1317	210	8	,	,	PUNCT
ajlm-1317	210	9	but	but	CCONJ
ajlm-1317	210	10	they	they	PRON
ajlm-1317	210	11	do	do	AUX
ajlm-1317	210	12	n’t	not	PART
ajlm-1317	210	13	work	work	VERB
ajlm-1317	210	14	.	.	PUNCT
ajlm-1317	211	1	london	london	PROPN
ajlm-1317	211	2	;	;	PUNCT
ajlm-1317	211	3	2020	2020	NUM
ajlm-1317	211	4	.	.	PUNCT
ajlm-1317	212	1	nidheesh	nidheesh	PROPN
ajlm-1317	212	2	la	la	PROPN
ajlm-1317	212	3	.	.	PUNCT
ajlm-1317	213	1	first	first	ADJ
ajlm-1317	213	2	samples	sample	NOUN
ajlm-1317	213	3	of	of	ADP
ajlm-1317	213	4	hll	hll	PROPN
ajlm-1317	213	5	’s	’s	PART
ajlm-1317	213	6	india	india	PROPN
ajlm-1317	213	7	-	-	PUNCT
ajlm-1317	213	8	made	make	VERB
ajlm-1317	213	9	rapid	rapid	ADJ
ajlm-1317	213	10	testing	testing	NOUN
ajlm-1317	213	11	fail	fail	VERB
ajlm-1317	213	12	quality	quality	NOUN
ajlm-1317	213	13	test	test	NOUN
ajlm-1317	213	14	in	in	ADP
ajlm-1317	213	15	kerala	kerala	PROPN
ajlm-1317	213	16	.	.	PUNCT
ajlm-1317	214	1	new	new	ADJ
ajlm-1317	214	2	delhi	delhi	PROPN
ajlm-1317	214	3	:	:	PUNCT
ajlm-1317	214	4	livemint	livemint	NOUN
ajlm-1317	214	5	;	;	PUNCT
ajlm-1317	214	6	2020	2020	NUM
ajlm-1317	214	7	.	.	PUNCT
ajlm-1317	215	1	the	the	DET
ajlm-1317	215	2	guardian	guardian	PROPN
ajlm-1317	215	3	.	.	PUNCT
ajlm-1317	216	1	coronavirus	coronavirus	PROPN
ajlm-1317	216	2	test	test	NOUN
ajlm-1317	216	3	kits	kit	NOUN
ajlm-1317	216	4	withdrawn	withdraw	VERB
ajlm-1317	216	5	in	in	ADP
ajlm-1317	216	6	spain	spain	PROPN
ajlm-1317	216	7	over	over	ADP
ajlm-1317	216	8	poor	poor	ADJ
ajlm-1317	216	9	accuracy	accuracy	NOUN
ajlm-1317	216	10	rate	rate	NOUN
ajlm-1317	216	11	.	.	PUNCT
ajlm-1317	217	1	madrid	madrid	PROPN
ajlm-1317	217	2	;	;	PUNCT
ajlm-1317	217	3	2020	2020	NUM
ajlm-1317	217	4	.	.	PUNCT